EP1532266A2 - Method for producing ketocarotinoids in plant fruit - Google Patents

Method for producing ketocarotinoids in plant fruit

Info

Publication number
EP1532266A2
EP1532266A2 EP03792349A EP03792349A EP1532266A2 EP 1532266 A2 EP1532266 A2 EP 1532266A2 EP 03792349 A EP03792349 A EP 03792349A EP 03792349 A EP03792349 A EP 03792349A EP 1532266 A2 EP1532266 A2 EP 1532266A2
Authority
EP
European Patent Office
Prior art keywords
ketolase
plant
seq
genetically modified
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03792349A
Other languages
German (de)
French (fr)
Inventor
Christel Renate Schopfer
Ralf Flachmann
Karin Herbers
Irene Kunze
Matt Sauer
Martin Klebsattel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SunGene GmbH
Original Assignee
SunGene GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10238979A external-priority patent/DE10238979A1/en
Priority claimed from DE2002138980 external-priority patent/DE10238980A1/en
Priority claimed from DE10238978A external-priority patent/DE10238978A1/en
Priority claimed from DE2002153112 external-priority patent/DE10253112A1/en
Priority claimed from DE2002158971 external-priority patent/DE10258971A1/en
Application filed by SunGene GmbH filed Critical SunGene GmbH
Publication of EP1532266A2 publication Critical patent/EP1532266A2/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0069Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K10/00Animal feeding-stuffs
    • A23K10/30Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/179Colouring agents, e.g. pigmenting or dyeing agents
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/80Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • A23L33/155Vitamins A or D
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/40Colouring or decolouring of foods
    • A23L5/42Addition of dyes or pigments, e.g. in combination with optical brighteners
    • A23L5/43Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives
    • A23L5/44Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives using carotenoids or xanthophylls
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B61/00Dyes of natural origin prepared from natural sources, e.g. vegetable sources
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8222Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation
    • C12N15/823Reproductive tissue-specific promoters
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/825Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving pigment biosynthesis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P23/00Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/80Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
    • Y02A40/81Aquaculture, e.g. of fish
    • Y02A40/818Alternative feeds for fish, e.g. in aquacultures

Definitions

  • the present invention relates to a process for the production of ketocarotenoids by cultivating genetically modified plants which have a ketolase activity in fruits, the genetically modified plants, and their use as food or feed and for the production of ketocarotenoid extracts.
  • Ketocarotenoids are synthesized de novo in bacteria, algae, fungi and plants.
  • ketocarotenoids and especially astaxanthin are used as pigmenting aids in animal nutrition, especially in trout, salmon and shrimp farming.
  • Natural ketocarotenoids such as natural astaxanthin
  • WO 98/18910 describes the synthesis of ketocarotenoids in nectaries of tobacco flowers by introducing a ketolase gene into tobacco.
  • WO 01/20011 describes a DNA construct for the production of ketocarotenoids, in particular astaxanthin, in seeds of oilseed plants such as oilseed rape, sunflower, soybean and mustard using a seed-specific promoter and a ketolase from Haematococcus.
  • the methods disclosed in the prior art provide genetically modified plants which contain ketocarotenoids in specific tissues, but have the disadvantage that the level of the ketocarotenoids and the purity, in particular astaxanthin, are not yet satisfactory ,
  • the object of the invention was therefore to provide an alternative process for the production of ketocarotenoids by cultivating plants, or to provide further transgenic plants which produce ketocarotenoids which have optimized properties, such as a higher ketocarotenoid content , and do not have the described disadvantage of the prior art.
  • ketocarotenoids Accordingly, a method for producing ketocarotenoids has been found by cultivating genetically modified plants that have ketolase activity in fruits.
  • Ketolase activity means the enzyme activity of a ketolase.
  • a ketolase is understood to mean a protein which has the enzymatic activity of introducing a keto group on the optionally substituted ⁇ -ionone ring of carotenoids.
  • ketolase is understood to mean a protein which has the enzymatic activity of converting ⁇ -carotene into cantaxanthin.
  • ketolase activity is understood to mean the amount of ⁇ -carotene converted or the amount of canthaxanthin formed in a certain time by the protein ketolase.
  • genetically modified plants which express a ketolase in fruits are used in order to have ketoase activity in the fruits of the genetically modified plants.
  • Genetically modified plants which contain at least one nucleic acid, coding for a ketolase, are therefore preferably used in the method according to the invention.
  • No plants are known which have a ketolase activity as a wild type in fruits.
  • the preferred plants described below in fruits as wild type have no ketolase activity.
  • the ketolase activity in fruits of the genetically modified plants is caused by the genetic modification of the parent plant.
  • the genetically modified plant according to the invention thus has a ketolase activity in fruits in comparison to the genetically unmodified starting plant and is therefore preferably able to express a ketolase in fruits.
  • parent plant or wild type is understood to mean the corresponding non-genetically modified parent plant.
  • genetically modified plant is preferably understood to mean a plant which is genetically modified in comparison with the starting plant.
  • plant can mean the starting plant (wild type) or a genetically modified plant according to the invention or both.
  • the gene expression of a nucleic acid encoding a ketolase is caused in the fruits of the plants preferably by introducing nucleic acids encoding ketolases into the starting plant.
  • the invention therefore relates in particular to the method described above, characterized in that genetically modified plants are used, into which, starting from a starting plant, at least one nucleic acid coding for a ketolase has been introduced.
  • any ketolase gene ie any nucleic acid encoding a ketolase, can be used for this.
  • nucleic acids mentioned in the description can be, for example, an RNA, DNA or cDNA sequence.
  • nucleic acid sequences which have already been processed such as the corresponding cDNAs
  • nucleic acids encoding a ketolase and the corresponding ketolases which can be used in the method according to the invention or in the genetically modified plants according to the invention described below are, for example, sequences from
  • Haematoccus pluvialis especially from Haematoccus pluvialis Flotow em. Wille (Accession No. X86782; nucleic acid: SEQ ID No. 1, protein SEQ ID No. 2),
  • Agrobacterium aurantiacum (Accession No. D58420; nucleic acid: SEQ. ID. No. 5, protein SEQ ID No. 6),
  • Paracoccus marcusii (Accession No. Y15112; nucleic acid:
  • Synechocystis sp. Strain PC6803 (Accession No. S76617, NP442491; nucleic acid: SEQ ID No. 11, protein SEQ ID N ⁇ . 12).
  • Bradyrhizobium sp. (Accession No. AF218415, BAB 74888; nucleic acid: SEQ ID No. 13, protein SEQ ID No. 14).
  • Haematococcus pluvialis (Accession NO: AF534876, AAN03484; nucleic acid: SEQ ID NO: 37, protein: SEQ ID NO: 38)
  • Paracoccus sp. MBIC1143 (Accession NO: D58420, P54972; nucleic acid: SEQ ID NO: 39, protein: SEQ ID NO: 40)
  • Brevundimonas aurantiaca (Accession NO: AY166610, AAN86030; Nucleic acid: SEQ ID NO: 41, Protein: SEQ ID NO: 42)
  • Nodularia spu igena NSOR10 (Accession NO: AY210783, AA064399; nucleic acid: SEQ ID NO: 43, protein: SEQ ID NO: 44)
  • Nostoc punctiforme ATCC 29133 (Accession NO: NZ_AABC01000195, ZP_00111258; nucleic acid: SEQ ID NO: 45, protein: SEQ ID NO: 46)
  • Nostoc punctiforme ATCC 29133 (Accession NO: NZ_AABC01000196; nucleic acid: SEQ ID NO: 47, protein: SEQ ID NO: 48)
  • ketolases and ketolase genes which can be used in the process according to the invention can be obtained, for example, from different organisms, the genome sequence of which is known, by comparing the identity of the amino acid sequences or the corresponding back-translated nucleic acid sequences from databases with the databases described above Sequences and in particular with the sequences SEQ ID NO. 2 and / or SEQ ID NO. 16 easy to find.
  • ketolases and ketolase genes can also be derived from the nucleic acid sequences described above, in particular from the sequences SEQ ID. No 1 and / or SEQ ID NO. 15 from different organisms, the genomic sequence of which is not known, can easily be found by hybridization techniques in a manner known per se. x
  • the hybridization can take place under moderate (low stringency) or preferably under stringent (high stringency) conditions.
  • the conditions during the washing step can be selected from the range of conditions limited by those with low stringency (with 2X SSC at 50 ° C) and those with high stringency (with 0.2X SSC at 50 ° C, preferably at 65 ° C) (20X SSC: 0.3 M sodium citrate, 3 M sodium chloride, pH 7.0).
  • the temperature during the washing step can be raised from moderate conditions at room temperature, 22 ° C, to stringent conditions at 65 ° C.
  • Both parameters, salt concentration and temperature, can be varied at the same time, one of the two parameters can also be kept constant and only the other can be varied.
  • denaturing agents such as Formamide or SDS can be used.
  • the hybridization is preferably carried out at 42 ° C.
  • nucleic acids are encoded which encode a protein containing the amino acid sequence SEQ ID NO. 2 or a sequence derived from this sequence by substitution, insertion or deletion of amino acids and having an identity of at least 20%, preferably at least 30%, more preferably at least 40%, more preferably at least 50%, more preferably at least 60%, preferably at least 70 %, more preferably at least 80%, particularly preferably at least 90% at the amino acid level with the sequence SEQ ID NO. 2 and has the enzymatic property of a ketolase.
  • This can be a natural ketolase sequence that can be found as described above by comparing the identity of the sequences from other organisms or an artificial ketolase sequence that starts from the sequence SEQ ID NO. 2 has been modified by artificial variation, for example by substitution, insertion or deletion of amino acids.
  • nucleic acids are encoded which encode a protein containing the amino acid sequence SEQ ID NO. 16 or a sequence derived from this sequence by substitution, insertion or deletion of amino acids, which has an identity of at least 20%, preferably at least 30%, more preferably at least 40%, more preferably at least 50%, more preferably at least 60%, more preferably at least 70 %, more preferably at least 80%, particularly preferably at least 90% at the amino acid level with the sequence SEQ ID NO. 16 and has the enzymatic property of a ketolase.
  • This can be a natural ketolase sequence that can be found as described above by comparing the identity of the sequences from other organisms or an artificial ketolase sequence that starts from the sequence SEQ ID NO. 16 was modified by artificial variation, for example by substitution, insertion or deletion of amino acids.
  • substitution is to be understood as meaning the replacement of one or more amino acids by one or more amino acids. So-called conservative exchanges are preferably carried out, in which the replaced amino acid has a similar property to the original amino acid, for example exchange of Glu by Asp, Gin by Asn, Val by Ile, Leu by Ile, Ser by Thr.
  • Deletion is the replacement of an amino acid with a direct link.
  • Preferred positions for deletions are the termini of the polypeptide and the links between the individual protein domains.
  • Inserts are insertions of amino acids into the polypeptide chain, whereby a direct bond is formally replaced by one or more amino acids.
  • Identity between two proteins is understood to mean the identity of the amino acids over the respective total protein length, in particular the identity that is obtained by comparison using the laser gene software from DNASTAR, inc. Madison, Wisconsin (USA) using the clustal method (Higgins DG, Sharp PM. Fast and sensitive multiple sequence alignments on a microcomputer. Comput Appl. Biosci. 1989 Apr; 5 (2): 151-1) is calculated using the following parameters: x
  • Gap penalty 10 Gap length penalty 10
  • a protein is accordingly understood which, when its sequence is compared with the sequence SEQ ID NO. 2 or 16, in particular according to the above program algorithm with the above parameter set, has an identity of at least 20%.
  • Suitable nucleic acid sequences can be obtained, for example, by back-translating the polypeptide sequence in accordance with the genetic code.
  • Those codons which are frequently used in accordance with the plant-specific codon usage are preferably used for this.
  • the codon usage can easily be determined on the basis of computer evaluations of other known genes of the organisms concerned.
  • a nucleic acid containing the sequence SEQ ID NO is brought. 1, in the plant.
  • nucleic acid containing the sequence SEQ ID NO is brought. 15, in the plant.
  • ketolase genes can also be produced in a manner known per se by chemical synthesis from the nucleotide building blocks, for example by fragment condensation of individual overlapping, complementary nucleic acid building blocks of the double helix.
  • the chemical synthesis of oligonucleotides can, for example, in a known manner, according to the phosphoamidite method (Voet, Voet, 2nd edition, Wiley Press New York, page
  • genetically modified plants are used which have the highest expression rate of a ketolase in fruits.
  • the gene expression of the ketolase takes place under the control of a fruit-specific promoter.
  • the nucleic acids described above, as described in detail below are introduced into the plant in a nucleic acid construct, functionally linked to a fruit-specific promoter.
  • plants are preferably understood to mean plants which have chromoplasts as wild type in fruits.
  • Further preferred plants have, as wild type in the fruit, carotenoids, in particular ⁇ -carotene, zeaxanthin, neoxanthine, violaxanthin or lutein.
  • carotenoids in particular ⁇ -carotene, zeaxanthin, neoxanthine, violaxanthin or lutein.
  • Further preferred plants have a hydroxylase activity as wild type in the fruit.
  • Hydroxylase activity means the enzyme activity of a hydroxylase.
  • a hydroxylase is understood to mean a protein which has the enzymatic activity of introducing a hydroxyl group on the optionally substituted ⁇ -ionone ring of carotenoids.
  • a hydroxylase is understood to mean a protein which has the enzymatic activity to convert ⁇ -carotene into zeaxanthin or canthaxanthin into astaxanthin.
  • hydroxylase activity is understood to mean the amount of ⁇ -carotene or canthaxanthin converted or the amount of zeaxanthin or astaxanthin formed in a certain time by the protein hydroxylase.
  • plants are cultivated which, in addition to the wild type, have an increased hydroxylase activity and / or ⁇ -cyclase activity.
  • Hydroxylase activity means the enzyme activity of a hydroxylase.
  • a hydroxylase is understood to mean a protein which has the enzymatic activity of introducing a hydroxyl group on the optionally substituted ⁇ -ionone ring of carotenoids.
  • a hydroxylase is understood to mean a protein which has the enzymatic activity to convert ⁇ -carotene into zeaxanthin or cantaxanthin into astaxanthin.
  • hydroxyase activity is understood to mean the amount of ⁇ -carotene or cantaxanthin converted or the amount of zeaxanthin or astaxanthin formed in a certain time by the protein hydroxylase.
  • the amount of ⁇ -carotene or cantaxantin or the amount of zeaxanthin or astaxanthin formed is increased in a certain time by the protein hydroxylase compared to the wild type.
  • This increase in hydroxylase activity is preferably at least 5%, more preferably at least 20%, more preferably at least 50%, more preferably at least 100%, more preferably at least 300%, even more preferably at least 500%, in particular at least 600% of the hydroxylase Wild type activity.
  • ⁇ -cyclase activity means the enzyme activity of a ⁇ -cyclase.
  • a ß-cyclase is understood to be a protein which has the enzymatic activity to convert a terminal, linear residue of lycopene into a ß-ionone ring.
  • a ⁇ -cyclase is understood to be a protein which has the enzymatic activity to convert ⁇ -carotene into ⁇ -carotene.
  • ⁇ -cyclase activity is understood to mean the amount of ⁇ -carotene converted or the amount of ⁇ -carotene formed in a certain time by the protein ß-cyclase.
  • the amount of ⁇ -carotene converted or the amount of ⁇ -carotene formed is increased by the protein ß-cyclase in a certain time compared to the wild type.
  • This increase in the ⁇ -cyclase activity is preferably at least 5%, more preferably at least 20%, more preferably at least 50%, more preferably at least 100%, more preferably at least 300%, even more preferably at least 500%, in particular at least 600% of the ⁇ - Wild-type cyclase activity.
  • wild type is understood to mean the corresponding non-genetically modified starting plant.
  • wild type is used to increase the hydroxylase activity, to increase the ⁇ -cyclase activity and to increase the ketocarotenoid content in each case understood a reference plant.
  • This reference plant is preferably Lycopersicon esculentum.
  • hydroxylase activity in genetically modified plants according to the invention and in wild-type or reference plants is preferably determined under the following conditions:
  • the activity of the hydroxylase is according to Bouvier et al. (Biochim. Biophys. Acta 1391 (1998), 320-328) in vi tro. Ferredoxin, ferredoxin-NADP oxidoreductase, catalase, NADPH and beta-carotene with mono- and digalact psylglycerides are added to a certain amount of plant extract.
  • the hydroxylase activity is particularly preferably determined under the following conditions according to Bouvier, Keller, d'Harginue and Camara (xanthophyll biosynthesis: molecular and functional characterization of carotenoid hydroxylases from pepper 5 fruits (Capsicum annuum L .; Biochim. Biophys Acta 1391 (1998) 320-328):
  • the in vitro assay is carried out in a volume of 0.250 ml volume.
  • the batch contains 50 mM potassium phosphate (pH 7.6),
  • reaction mixture 15 plant extract in different volumes.
  • the reaction mixture is incubated for 2 hours at 30C.
  • the reaction products are extracted with organic solvent such as acetone or chloroform / methanol (2: 1) and determined by means of HPLC.
  • ⁇ -cyclase activity in genetically modified plants according to the invention and in wild-type or reference plants is preferably carried out under the following conditions:
  • the activity of the ⁇ -cyclase is determined in vitro according to Fräser and Sandmann (Bio-25 formerly Biophys. Res. Comm. 185 (1) (1992) 9-15). Potassium phosphate as a buffer (pH 7.6), lycopene as a substrate, paprika stromal protein, NADP +, NADPH and ATP are added to a certain amount of plant extract.
  • the hydroxylase activity is particularly preferably determined under the following conditions according to Bouvier, d'Harlingue and Camara (Molecular Analysis of carotenoid cyclae inhibition; Aren. Biochem. Biophys. 346 (1) (1997) 53-64):
  • NADP / NADPH and ATP are in
  • the hydroxylase activity and / or ⁇ -cyclase activity can be increased in various ways, for example by switching off inhibitory regulatory mechanisms at the expression and protein level or by increasing the gene expression of nucleic acids encoding a hydroxylase and / or of nucleic acids encoding a ⁇ -cyclase the wild type.
  • the increase in the gene expression of the nucleic acids encoding a hydroxylase and / or the increase in the gene expression of the nucleic acid encoding a ⁇ -cyclase compared to the wild type can likewise be carried out in various ways, for example by inducing the hydroxylase gene and / or ⁇ -cyclase gene by activators or by introducing one or more hydroxylase gene copies and / or ⁇ -cyclase gene copies, ie by introducing at least one nucleic acid encoding a hydroxylase and / or at least one nucleic acid encoding an ⁇ -cyclase into the plant.
  • Increasing the gene expression of a nucleic acid encoding a hydroxylase and / or ⁇ -cyclase is also understood according to the invention to mean the manipulation of the expression of the plants' own endogenous hydroxylase and / or ⁇ -cyclase.
  • an altered or increased expression of an endogenous hydroxylase and / or ⁇ -cyclase gene can be achieved in that a regulator protein which does not occur in the non-transformed plant interacts with the promoter of this gene.
  • a regulator protein which does not occur in the non-transformed plant interacts with the promoter of this gene.
  • Such a regulator can represent a chimeric protein which consists of a DNA binding domain and a transcription activator domain, as described for example in WO 96/06166.
  • the gene expression of a nucleic acid encoding a hydroxylase is increased and / or the gene expression of a nucleic acid encoding a ⁇ -cyclase is increased by introducing at least one nucleic acid encoding a hydroxylase and / or by introducing at least one nucleic acid encoding one ß-cyclase into the plant.
  • any hydroxylase gene or each ⁇ -cyclase gene that is to say any nucleic acid which codes for a hydroxylase and any nucleic acid which codes for a ⁇ -cyclase, can be used for this purpose.
  • genomic hydroxylase or. ⁇ -cyclase nucleic acid sequences from eukaryotic sources which contain introns are preferably already processed in the event that the host plant is unable or cannot be able to express the corresponding hydroxylase or ⁇ -cyclase Nucleic acid sequences, how to use the corresponding cDNAs.
  • hydroxylase genes are nucleic acids
  • hydroxylase is the hydroxylase from tomato (nucleic acid: SEQ. ID. No. 55; protein: SEQ. ID. No. 56)
  • b-cyclase genes are nucleic acids encoding a b-cyclase from tomato (Accession X86452). (Nucleic acid: SEQ ID NO; 53, protein: SEQ ID NO: 54), and b-cyclase genes of the following accession numbers:
  • AAF18989 lycopene beta-cyclase [Daucus carota] ZP_001140 hypothetical protein [Prochlorococcus marinus str.
  • ZP_001050 hypothetical protein [Prochlorococcus marinus subsp. pastoris str. CCMP1378]
  • ZP_001046 hypothetical protein [Prochlorococcus marinus subsp. pastoris str. CCMP1378]
  • ZP_001134 hypothetical protein [Prochlorococcus marinus str.
  • ZP_001150 hypothetical protein [Synechococcus sp. WH 8102] AAF10377 lycopene cyclase [Deinococcus radiodurans] BAA29250 393aa long hypothetical protein [Pyrococcus horikoshii]
  • AAF78200 lycopene cyclase [Bradyrhizobium sp. ORS278] BAB79602 crtY [Pantoea agglomerans pv. Milletiae] CAA64855 lycopene cyclase [Streptomyces griseus] AAA21262 dycopene cyclase [Pantoea agglomerans] C37802 crtY protein - Erwinia uredovora BAB79602 crtYans [Pantoea millglomer. AAA64980 lycopene cyclase [Pantoea agglomerans]
  • CAA67331 lycopene cyclase [Narcissus pseudonarcissus]
  • a particularly preferred ⁇ -cyclase is also the chromoplast-specific b-cyclase from tomato (AAG21133) (nucleic acid: SEQ. ID. No. 57; protein: SEQ. ID. No. 58)
  • the preferred transgenic plants according to the invention therefore have at least one further hydroxylase gene and / or ⁇ -cyclase gene compared to the wild type.
  • the genetically modified plant has, for example, at least one exogenous nucleic acid, coding for a hydroxylase or at least two endogenous nucleic acids, coding for a hydroxylase and / or at least one exogenous nucleic acid, coding for a ⁇ -cyclase or at least two endogenous nucleic acids, coding for one ⁇ -cyclase.
  • nucleic acids encoding proteins are preferably used which contain the amino acid sequence SEQ ID NO: 52 or a sequence derived from this sequence by substitution, insertion or deletion of amino acids and having an identity of at least 30 %, preferably at least 50%, more preferably at least 70%, even more preferably at least 90%, most preferably at least 95% at the amino acid level with the sequence SEQ. ID. NO: 52, and which have the enzymatic property of a hydroxylase.
  • hydroxylases and hydroxylase genes can be obtained, for example, from various organisms whose genomic sequence is known, as described above, by comparing the amino acids or the corresponding ones with homology back-translated nucleic acid sequences from databases with the SeQ ID. NO: 52 easy to find.
  • hydroxylases and hydroxylase genes can also be found, for example, based on the sequence
  • SEQ ID NO: 51 from various organisms whose genomic sequence is not known, as described above, can easily be found by hybridization and PCR techniques in a manner known per se.
  • nucleic acids are introduced into organisms which encode proteins containing the amino acid sequence of the hydroxylase of the sequence SEQ ID NO: 52.
  • Suitable nucleic acid sequences can be obtained, for example, by back-translating the polypeptide sequence in accordance with the genetic code.
  • codons that are frequently used in accordance with the plant-specific codon usage are preferably used for this.
  • the codon usage can easily be determined on the basis of computer evaluations of other, known genes of the organisms in question.
  • a nucleic acid containing the sequence SEQ is brought. ID. NO: 51 in the organism.
  • the ⁇ -cyclase genes used are preferably nucleic acids which encode proteins containing the amino acid sequence SEQ ID NO: 54 or a sequence derived from this sequence by substitution, insertion or deletion of amino acids and which have an identity of at least 30%, preferably at least 50%, more preferably at least 35 at least 70%, even more preferably at least 90%, most preferably at least 95% at the amino acid level with the sequence SEQ ID NO: 54, and which have the enzymatic property of a ⁇ -cyclase.
  • ⁇ -cyclases and ⁇ -cyclase genes can be obtained, for example, from various organisms whose genomic sequence is known, as described above, by comparing the homology of the amino acid sequences or the corresponding back-translated nucleic acid sequences from databases with the SEQ ID NO:
  • ⁇ -cyclases and ⁇ -cyclase genes can also be easily found, for example, starting from the sequence SEQ ID NO: 53 from various organisms whose genomic sequence is not known, using hybridization and PCR techniques in a manner known per se.
  • nucleic acids are introduced into organisms which encode proteins containing the amino acid sequence of the ⁇ -cyclase of the sequence SEQ. ID. NO: 54.
  • Suitable nucleic acid sequences can be obtained, for example, by back-translating the polypeptide sequence in accordance with the genetic code.
  • codons that are frequently used in accordance with the plant-specific codon usage are preferably used for this.
  • the codon usage can easily be determined on the basis of computer evaluations of other, known genes of the organisms in question.
  • a nucleic acid containing the sequence SEQ is brought. ID. NO: 53 in the organism.
  • hydroxylase genes or ⁇ -cyclase genes can also be produced in a manner known per se by chemical synthesis from the nucleotide building blocks, for example by fragment condensation of individual overlapping, complementary nucleic acid building blocks of the double helix.
  • the chemical synthesis of oligonucleotides can, for example, be known
  • Particularly preferred plants are plants selected from the plant genera Actinophloeus, Aglaeonema, pineapple, Arbutus, Archontophoenix, Area, Aronia, Asparagus, Attalea, Berberis, Bixia, Brachychilum, Bryonia, Caliptocalix, Capsicum, Carica, Celastrus, Citrullus, Citrus, Convallaria Cotoneaster, Crataegus, Cucumis, Cucurbita, Cuscuta, Cycas, Cyphomandra, Dioscorea, Diospyrus, Dura, Elaeagnus, Elaeis, Erythroxylon, Euonymus, Ficus, Fortunella, Fragaria, Gardinia, Gonocaryum, Gossypium, Guava, Guilielma, Guilielma, Guilielma, Guilielma, Guilielma, Guilielma, Guilielma, Guilielma, Guilielma
  • the ketolase activity in genetically modified plants according to the invention is determined in accordance with the method of Frazer et al. , (J. Biol. Chem. 272 (10): 6128-6135, 1997).
  • the ketolase activity in plant extracts is determined with the substrates beta-carotene and canthaxanthin in the presence of lipid (soy lecithin) and detergent (sodium cholate).
  • Substrate / product ratios from the ketolase assays are determined by means of HPLC.
  • the cultivation step of the genetically modified plants is preferably followed by harvesting the plants and isolating ketocarotenoids from the fruits of the plants.
  • the transgenic plants are raised in a manner known per se
  • Ketocarotenoids are isolated from the harvested fruits in a manner known per se, for example by drying and subsequent extraction and, if appropriate, further chemical or physical purification processes, such as, for example, precipitation methods, crystallography, thermal separation processes, such as rectification processes or physical separation processes, such as chromatography. Ketocarotenoids are isolated from the fruit, for example, preferably by organic solvents such as acetone, hexane, ether or tert. Methyl butyl ether.
  • ketocarotenoids are described, for example, in Egger and Kleinig (Phytochemistry (1967) 6, 437-440) and Egger (Phytochemistry (1965) 4, 609-618).
  • ketocarotenoids are preferably selected from the group astaxanthin, canthaxanthin, echinenone, 3-hydroxyechinenone, 3'-hydroxyechinenone, adonirubin and adonixanthin.
  • ketocarotenoid is astaxanthin.
  • the transgenic plants are preferably produced by transforming the starting plants, using a nucleic acid construct which contains at least one, preferably also more than one of the above-described nucleic acids which are functionally linked to one or more regulatory signals which ensure transcription and translation in plants ,
  • nucleic acid constructs in which the coding nucleic acid sequence is functionally linked to one or more regulatory signals which ensure transcription and translation in plants, are also called expression cassettes below.
  • the regulation signals preferably contain one or more 15 promoters which ensure transcription and translation in plants.
  • the expression cassettes contain regulatory signals, that is, regulatory nucleic acid sequences which express the expression of the
  • an expression cassette comprises upstream, i.e. at the 5 'end of the coding sequence, a promoter and downstream, i.e. at the 3 'end, a polyadenylation signal and optionally further regulatory elements which are associated with
  • An operative link is understood to mean the sequential arrangement of promoter, coding sequence, terminator and possibly other regulatory elements such that each of the regulatory
  • 30 elements can perform its function as intended in the expression of the coding sequence.
  • nucleic acid constructs, expression cassettes and vectors for plants and methods for producing transgenic plants and the transgenic plants themselves are described below by way of example.
  • sequences preferred but not limited to the operative linkage are targeting sequences to ensure
  • any promoter which can control the expression of foreign genes in plants is suitable as promoters of the expression cassette.
  • Constant promoter means those promoters that have a
  • a vegetable one is preferably used
  • Promoter or a promoter derived from a plant virus is particularly preferred.
  • the promoter of the 35S transcript of the CaMV cauliflower mosaic virus (Franck et al. (1980) Cell 21: 285-294; Odell et al. (1985) Nature 313: 810-812; Shewmaker et al. (1985) Virology 140 : 281-288; Gardner et al. (1986) Plant Mol Biol
  • Another suitable constitutive promoter is the pds Prooter (Pecker et al. (1992) Proc. Natl. Acad. Be USA 89: 4962-4966) or the "Rubisco small subunit (SSU)" promoter (US 4,962,028) , the LeguminB promoter (GenBank Acc.No. X0S677), the promoter of nopaline synthase from Agrobacterium, the TR double promoter, the OCS (octopine synthase) promoter from Agrobacterium, the ubiquitin promoter (Holtorf S et al. (1995 ) Plant Mol Biol 29: 637-649), the Ubiquitin 1 promoter (Christensen et al.
  • the expression cassettes can also contain a chemically inducible promoter (review article: Gatz et al. (1997) Annu Rev Plant Physiol Plant Mol Biol 48: 89-108), by means of which the expression of the ketolase gene in the plant is controlled at a specific point in time can.
  • a chemically inducible promoter such as the PRPl promoter (Ward et al. (1993) Plant Mol Biol 22: 361-366), salicylic acid-inducible promoter (WO 95/19443), a benzenesulfonamide-inducible promoter (EP 0 388 186), a promoter inducible by tetracycline (Gatz et al.
  • Promoters which are induced by biotic or abiotic stress are also preferred, for example the pathogen-inducible promoter of the PRPL gene (Ward et al. (1993) Plant Mol Biol 22: 361-366), the heat-inducible hsp70 or hsp80 Promoter from tomato (US Pat. No. 5,187,267), the cold-inducible alpha-amylase promoter from the potato (WO 96/12814), the light-inducible PPDK promoter or the wound-induced pinII promoter (EP375091).
  • the pathogen-inducible promoter of the PRPL gene Ward et al. (1993) Plant Mol Biol 22: 361-366
  • the heat-inducible hsp70 or hsp80 Promoter from tomato US Pat. No. 5,187,267
  • the cold-inducible alpha-amylase promoter from the potato WO 96/12814
  • Pathogen-inducible promoters include those of genes induced by pathogen attack such as genes from PR proteins, SAR proteins, b-1, 3-glucanase, chitinase etc. (e.g. Redolfi et al. (1983) Neth J Plant Pathol 89: 245-254; Uknes, et al. (1992) The Plant
  • wound-inducible promoters such as that of the pinll gene (Ryan (1990) Ann Rev Phytopath 28: 425-449; Duan et al. (1996) Nat Biotech 14: 494-498), the wunl and wun2 gene (US 5,428,148), the winl and win2 genes (Stanford et al. (1989) Mol Gen Genet 215: 200-208), the systemin (McGurl et al. (1992) Science 225: 1570-1573), the WIPl gene (Rohmeier et al. (1993) Plant Mol Biol 22: 783-792; Ekelkamp et al. (1993) FEBS Letters 323: 73-76), the MPI gene (Corderok et al. (1994) The Plant J 6 ( 2): 141-150) and the like.
  • promoters are, for example, fruit ripening-specific promoters, such as, for example, the fruit ripening-specific promoter from tomato (WO 94/21794, EP 409 625).
  • Development-dependent promoters partly include the tissue-specific promoters, since the formation of individual tissues is naturally development-dependent.
  • promoters are particularly preferred which ensure expression in tissues or parts of plants in which, for example, the biosynthesis of ketocarotenoids or their precursors takes place.
  • promoters with specificities for the anthers, ovaries, petals, sepals, flowers, leaves, stems, roots and fruits and combinations thereof are preferred.
  • Tuber-, storage root- or root-specific promoters are, for example, the patatin class I promoter (B33) or the potato cathepsin D inhibitor promoter.
  • Leaf-specific promoters are, for example, the promoter of the cytosolic FBPase from potato (WO 97/05900), the SSU promoter (small subunit) of Rubisco (ribulose-1, 5-bisphosphate carboxylase) or the ST-LSI promoter from potato (Stockhaus et al (1989) EMBO J 8: 2445-2451).
  • Flower-specific promoters are, for example, the phytoene synthesis promoter (WO 92/16635) or the promoter of the P-rr gene (WO
  • Anther-specific promoters are, for example, the 5126 promoter (US 5,689,049, US 5,689,051), the gl ⁇ b-1 promoter or the g-zein promoter.
  • Fruit-specific promoters are, for example
  • the cucumisin promoter (Yamagata, H., Yonesu, K., Hirata, A. and Aizono, Y., TGTCACA Motif Is a Novel cis-Regulatory Enhancer Element Involved in Fruit-specific Expression of the cucumisin Gene J. Biol. Chem. 277 (13), 11582-11590 (2002), SEQ ID NO. 19, the promoter of the endogalacturonase gene (Redondo-Nevado, J., Medina-Escobar, N., Caballero-Repullo, JL and Munoz-Blanco, J.
  • constitutive and in particular fruit-specific promoters are particularly preferred.
  • the present invention therefore relates in particular to a nucleic acid construct containing functionally linked a fruit-specific promoter, particularly preferably a fruit-specific promoter described above, and a nucleic acid encoding a ketolase.
  • An expression cassette is preferably produced by fusing a suitable promoter with a nucleic acid described above, encoding a ketolase and preferably a nucleic acid inserted between promoter and nucleic acid sequence, which codes for a plastid-specific transit peptide, and a polyadenylation signal in accordance with current standards Recombination and cloning techniques, as described, for example, in T. Maniatis, EF Fritsch and J.
  • nucleic acids encoding a plastic transit peptide ensure localization in plastids and in particular in chromoplasts.
  • Expression cassettes the nucleic acid sequence of which codes for a ketolase fusion protein, can also be used, part of the fusion protein being a transit peptide which controls the translocation of the polypeptide.
  • Preferred transit peptides are preferred for the chromoplasts, which are cleaved enzymatically from the ketolase part after translocation of the ketolase into the chromoplasts.
  • Nucleic acid sequences of three cassettes of the plastid transit peptide of plastid transketolase from tobacco in three reading frames are particularly preferred as Kpnl / BamHI fragments with an ATG codon in the Ncol interface:
  • a plastid transit peptide examples include the transit peptide of the plastid isopentenyl pyrophosphate isomerase-2 (IPP-2) from Arabisopsis thaliana and the transit peptide of the small subunit of the ribulose bisphosphate carboxylase (rbcS) from pea (Guerineau, F, Woolston, S Brooks, L, Mullineaux, P (1988) An expression cassette for targeting foreign proteins into the chloroplstas. Nucl. Acids Res. 16: 11380).
  • IPP-2 plastid isopentenyl pyrophosphate isomerase-2
  • rbcS ribulose bisphosphate carboxylase
  • nucleic acids according to the invention can be produced synthetically or obtained naturally or contain a mixture of synthetic and natural nucleic acid constituents, and can consist of different heterologous gene segments from different organisms.
  • various DNA fragments can be manipulated in order to obtain a nucleotide sequence which expediently reads in the correct direction and which is equipped with a correct reading frame.
  • adapters or linkers can be attached to the fragments.
  • the promoter and terminator regions can expediently be provided in the transcription direction with a linker or polylinker which contains one or more restriction sites for the insertion of this sequence.
  • the linker has 1 to 10, usually 1 to 8, preferably 2 to 6, restriction sites.
  • the linker has a size of less than 100 bp within the regulatory areas, often less than 60 bp, but at least 5 bp.
  • the promoter can be native or homologous as well as foreign or heterologous to the host plant his.
  • the expression cassette preferably contains in the 5 '-3' transcription direction the promoter, a coding nucleic acid sequence or a nucleic acid construct and a region for the transcriptional termination. Different termination areas are interchangeable.
  • a terminator is the 35S terminator (Guerineau et al. (1988) Nucl Acids Res. 16: 11380), the nos terminator (Depicker A, Stachel S, Dhaese P, Zambryski P, Goodman HM. Nopaline synthase: transcript mapping and DNA sequence. J Mol Appl Genet.
  • Preferred polyadenylation signals are plant polyadenylation signals, preferably those which essentially correspond to T-DNA polyadenylation signals from Agrobacterium tumefaciens, in particular gene 3 of T-DNA (octopine synthase) of the Ti plasmid pTiACH5 (Gielen et al., EMBO J. 3 (1984), 835 ff) or functional equivalents.
  • transformation The transfer of foreign genes into the genome of a plant is called transformation.
  • Suitable methods for the transformation of plants are the protoplast transformation by polyethylene glycol-induced DNA uptake, the biolistic method with the gene gun - the so-called particle bombardment method, the electroporation, the incubation of dry embryos in DNA-containing solution, the micro- injection and Agrobacterium-mediated gene transfer described above.
  • the methods mentioned are described, for example, in B. Jenes et al., Techniques for Gene Transfer, in: Transgenic Plants, Vol. 1, Engineering and Utilization, edited by SD Kung and R. Wu, Academic Press (1993), 128- 143 and in Potrykus, Annu. Rev. Plant Physiol. Plant Molec. Biol. 42 (1991), 205-225).
  • the construct to be expressed is preferably cloned into a vector which is suitable for transforming Agrobacterium tumefaciens, for example pBin19 (Bevan et al., Nucl. Acids Res. 12 (1984), 8711) or particularly preferably pSUN2, pSUN3, pSUN4 or pSUN5 (WO 02/00900).
  • Agrobacteria transformed with an expression plasmid can be used in a known manner to transform plants, e.g. by bathing wounded leaves or leaf pieces in an agrobacterial solution and then cultivating them in suitable media.
  • the fused expression cassette which expresses a ketolase, is cloned into a vector, for example pBin19 or in particular pSUN2, which is suitable for being transformed into Agrobacterium tumefaciens
  • Agrobacteria transformed with such a vector can then be used in a known manner to transform plants, in particular crop plants, for example by bathing wounded leaves or leaf pieces in an agrobacterial solution and then cultivating them in suitable media.
  • transgenic plants From the transformed cells of the wounded leaves or leaf pieces, transgenic plants can be regenerated in a known manner, which plants contain a gene encoding the expression cassette for the expression of a nucleic acid encoding a ketolase.
  • an expression cassette is inserted as an insert into a recombinant vector whose vector DNA contains additional functional regulatory signals, for example Contains sequences for replication or integration.
  • additional functional regulatory signals for example Contains sequences for replication or integration.
  • Suitable vectors are described in "Methods in Plant Molecular Biology and Biotechnology" (CRC Press), Chap. 6/7, pp. 71-119 (1993).
  • the expression cassettes can be cloned into suitable vectors which enable their multiplication, for example in E. coli.
  • suitable cloning vectors include pJITH7 (Guerineau et al. (1988) Nucl. Acids Res. 16: 11380), pBR332, pUC series, Ml3mp series, pACYC184, pMC1210, pMcl 210 and pCLl920.
  • Binary vectors which can replicate both in E. coli and in agrobacteria are particularly suitable.
  • the expression can be constitutive or preferably specific in the fruit.
  • the invention further relates to a method for producing genetically modified plants, characterized in that a nucleic acid construct containing functionally linked, a fruit-specific promoter and nucleic acids encoding a ketolase is introduced into the genome of the starting plant.
  • the invention further relates to the genetically modified plants which have a ketolase activity in fruits compared to the starting plant.
  • the ketolase activity is achieved in that the genetically modified plant expresses a ketolase in the fruit.
  • the preferred, genetically modified plants therefore contain at least one nucleic acid encoding a keto-glass in fruits.
  • the gene expression of a nucleic acid, coding for a ketolase is caused by introducing nucleic acids, coding for a ketolase, into the starting plant.
  • the invention therefore particularly preferably relates to a genetically modified plant described above, characterized in that, starting from a starting plant, at least one nucleic acid coding for a ketolase has been introduced into the plant.
  • the invention relates in particular to genetically modified plants selected from the plant genera Actinophloeus, Aglaeo-nema, pineapple, Arbutus, Archontophoenix, Area, Aronia, Asparagus, Attalea, Berberis, Bixia, Brachychilum, Bryonia, Caliptocalix, Capsicum, Carica, Celastrus, Citrullus, Citrus, Convallaria, Cotoneaster, Crataegus, Cucumis, Cucurbita, Cuscuta, Cycas, Cyphomandra, Dioscorea, Diospyrus, Dura, Elaeagnus, Elaeis, Erythroxylon, Euonymus, Ficus, Fortunella, Fragaria, Gardinia, Gonocaryum, Goss
  • Very particularly preferred plant genera are pineapple, asparagus, capsicum, citrus, cucumis, cucurbita, citrullus, lycopersicum, passiflora, prunus, physalis, solanum, vaccinium and vitis, containing at least one transgenic nucleic acid, encoding a ketolase.
  • the ketolase is expressed in the fruits in preferred transgenic plants, particularly preferably the expression of the ketolase is highest in the fruits.
  • genetically modified plants additionally have an increased hydroxylase activity and / or ⁇ -cyclase activity compared to a wild plant. Further preferred embodiments are described above in the method according to the invention.
  • the present invention further relates to the transgenic plants, their propagation material, and their plant cells, tissue or parts, in particular their fruits.
  • the genetically modified plants can, as described above, be used to produce ketocarotenoids, in particular astaxanthin.
  • Genetically modified plants according to the invention with an increased content of ketocarotenoids which can be consumed by humans and animals can also be used, for example, directly or after processing known per se as food or feed or as feed and food supplements. Furthermore, the genetically modified plants for the production of ketocarotenoids extracts of the plants containing noid and / or for the production of feed and food supplements.
  • the genetically modified plants have an increased ketocarotenoid content compared to the wild type.
  • An increased ketocarotenoid content is generally understood to mean an increased total ketocarotenoid content.
  • ketocarotenoids is also understood to mean, in particular, a changed content of the preferred ketocarotenoids, without the total carotenoid content necessarily having to be increased.
  • the genetically modified plants according to the invention have an increased astaxanthin content compared to the wild type.
  • the sequencing of recombinant DNA molecules was carried out with a laser fluorescence DNA sequencer from Licor (sales by MWG Biotech, Ebersbach) according to the method of Sanger (Sanger et al., Proc. Natl. Acad. Sci. USA 74 (1977) , 5463-5467).
  • Example 1 Amplification of a cDNA which contains the entire primary sequence of the ketolase from Haematococcus pluvialis Floow em. Will encodes
  • the cDNA coding for the ketolase from Haematococcus pluvialis was amplified by PCR from Haematococcus pluvialis (strain 40 192.80 from the "Collection of algal cultures of the University of Göttingen") suspension culture.
  • RNA For the preparation of total RNA from a suspension culture of Haematococcus pluvialis (strain 192.80), which has been used for 2 weeks with direct sunlight at room temperature in Haer ⁇ atococcus medium (1 - .2 g / 1 sodium acetate, 2 g / 1 yeast extract, 0.2 g / 1 MgC12x6H20, 0.02 CaCl2x2H20; pH 6.8; after autoclaving, add 400 mg / 1 L-asparagine, 10 mg / 1 FeS04xH20), the cells were harvested, frozen in liquid nitrogen and pulverized in a mortar.
  • Haer ⁇ atococcus medium (1 - .2 g / 1 sodium acetate, 2 g / 1 yeast extract, 0.2 g / 1 MgC12x6H20, 0.02 CaCl2x2H20; pH 6.8; after autoclaving, add 400 mg / 1 L-asparagine, 10 mg / 1
  • RNA For the cDNA synthesis, 2.5 ⁇ g of total RNA were denatured for 10 min at 60 ° C., cooled on ice for 2 min and using a cDNA kit (ready-to-go-you-prime beads, Pharmacia Biotech) according to the manufacturer's instructions rewritten into cDNA using an antisense specific primer (PRI SEQ ID No. 29).
  • the nucleic acid encoding a ketolase from Haematococcus x pluvialis was determined using the polymerase chain reaction
  • PCR from Haematococcus pluvialis using a sense-specific primer (PR2 SEQ ID No. 30) and an antisense-specific primer (PRI SEQ ID No. 29).
  • the PCR conditions were as follows:
  • the PCR for the amplification of the cDNA which codes for a ketolase protein consisting of the entire primary sequence, was carried out in a 50 ⁇ l reaction mixture which contained:
  • the PCR was carried out under the following cycle conditions:
  • PCR amplification with SEQ ID No. 29 and SEQ ID No. 30 resulted in an 1155 bp fragment coding for a protein consisting of the entire primary sequence (SEQ ID No. 22).
  • the amplificate was cloned into the PCR cloning vector pGEM-Teasy (Promega) and the clone pGKET02 was obtained.
  • This clone was therefore used for cloning into the expression vector pJITH7 (Guerineau et al. 1988, Nucl. Acids Res. 16: 11380).
  • the cloning was carried out by isolating the 1027 bp SpHI fragment from pGKET02 and ligation into the SpHI-cut vector pJIT117.
  • the clone that contains the Haematococcus pluvialis ketola gene in the correct orientation as an N-terminal translational fusion with the rbcs transit peptide sequence is called pJKET02.
  • Example 2 Amplification of a cDNA which contains the ketolase from Haematococcus pluvialis Flotow em. Will encoded with an N-terminus shortened by 14 amino acids
  • the cDNA which codes for the ketolase from Haematococcus pluvialis (strain 192.80) with an N-terminus shortened by 14 amino acids, was amplified by PCR from Haematococcus pluvialis suspension culture (strain 192.80 from the "Collection of algal cultures of the University of Göttingen") ,
  • Total RNA was prepared from a suspension culture of Haematococcus pluvialis (strain 192.80) as described in Example 1.
  • the nucleic acid encoding a ketolase from Haema tococcus pluvialis (strain 192.80) with an N-terminus shortened by 14 amino acids was extracted by means of polymerase chain reaction (PCR)
  • the PCR conditions were as follows:
  • the PCR for the amplification of the cDNA which codes for a ketolase protein with an N-terminus shortened by 14 amino acids, was carried out in a 50 ⁇ l reaction mixture which contained:
  • the PCR was carried out under the following cycle conditions;
  • PCR amplification with SEQ ID No.29 and SEQ ID No. 31 resulted in an 1111 bp fragment coding for a ketolase protein in which the N-terminal amino acids (position 2-16) are replaced by 30 a single amino acid (leucine).
  • the amplificate was cloned into the PCR cloning vector pGEM-Teasy (Promega) using standard methods and the clone pGKET03 was obtained. Sequencing with the primers T7 and
  • the cloning was carried out by isolating the 985 bp SpHI fragment from pGKET03 and ligation with the SpHI-cut vector pJITH7.
  • the clone that contains the correct Haematococcus pluvialis ketolase with 45 N-terminus shortened by 14 amino acids Containing orientation as an N-terminal translational fusion with the rbcs transit peptide is called pJKET03.
  • Example 3 Amplification of a cDNA which contains the ketolase from Haema-5 tococcus pluvialis Flotow em. Will (tribe 192.80 the ketolase from Haema-5 tococcus pluvialis Flotow em. Will (tribe 192.80 the ketolase from Haema-5 tococcus pluvialis Flotow em. Will (tribe 192.80 the
  • the cDNA coding for the ketolase from Haematococcus pluvialis (strain 192.80) consisting of the entire primary sequence and fused C-terminal myc tag was PCR-analyzed using the plasmid pGKET02 (described in Example 1) and the primer PR15 (SEQ ID No. 32).
  • the PR15 primer SEQ ID No. 32.
  • the nucleic acid encoding a ketolase from Haematococcus 35 pluvialis (strain 192.80) consisting of the entire primary sequence and fused C-terminal myc tag was determined by means of polymerase chain reaction (PCR) from Haematococcus pluvialis using a sense-specific primer (PR2 SEQ ID No. 30 ) and an antisense-specific primer (PR15 SEQ ID No. 32).
  • the PCR conditions were as follows:
  • the PCR for the amplification of the cDNA which codes for a ketolase protein with a fused C-terminal myc tag, was carried out in a 45 50 ⁇ l reaction mixture which contained: - 1 ul of an annealing reaction (prepared as described above) 0.25 mM dNTPs
  • the PCR was carried out under the following cycle conditions:
  • PCR amplification with SEQ ID No. 32 and SEQ ID No. 30 resulted in a 1032 bp fragment coding for a protein consisting of the entire primary sequence of the ketolase from Haematococcus pluvialis as a double translational fusion with the rbcS transit peptide at the N-terminus and the myc tag at the C-terminus.
  • the amplificate was cloned into the PCR cloning vector pGEM-Teasy (Promega) using standard methods and the clone pGKET04 was obtained. Sequencing with the primers T7 and SP6 confirmed a sequence SEQ ID no. 22 identical sequence, the 3 'region (position 993-1155) of SEQ ID No. 22 in the amplificate SEQ ID No. 26 was replaced by one in the different sequence from 39 bp. This clone was therefore made for
  • the cloning was carried out by isolating the 1038 bp EcoRI-SpHI fragment from pGKET04 and ligation with the EcoRI-SpHI cut vector pJITH7. The ligation creates a translational fusion between the C-terminus of the rbcS transit peptide sequence and the N-terminus of the ketolase sequence.
  • the clone which contains the Haematococcus pluvialis ketolase with fused C-terminal myc tag in the correct orientation as a translational N-terminal fusion with the rbcs transit peptide is called pJKET4.
  • Example 4 Production of expression vectors for the constitutive expression of the Haematococcus pluvialis ketolase in
  • fragment d35S contains the duplicated 35S promoter (747 bp), fragment rbcS the rbcS transit peptide from pea (204 bp), fragment KET03 (985 bp) the primary sequence shortened by 14 N-terminal amino acids coding for the Haematococcus pluvialis Ketolase, fragment term (761 bp) the polyadenylation signal of CaMV.
  • fragment d35S contains the duplicated 35S promoter ((747 bp), fragment rbcS the rbcS transit peptide from pea (204 bp), fragment KET04 (1038 bp) the entire primary sequence coding for the Haematococcus pluvialis ketolase with C-terminal myc- Day, fragment term (761 bp) the polyadenylation signal of CaMV.
  • Example 5 Production of expression vectors for the expression of Haematococcus pluvialis ketolase in Lycopersicon esculentum
  • the DNA fragment which contains the AP3 promoter region -902 to +15 from Arabidopsis thaliana, was analyzed by means of PCR
  • genomic DNA isolated from Arabidopsis thaliana according to standard methods
  • primers PR7 and PR10 SEQ ID No. 36
  • the PCR conditions were as follows:
  • the PCR for the amplification of the DNA which contains the AP3 promoter fragment (-902 to +15), was carried out in a 50 ⁇ l reaction mixture, which contained:
  • the PCR was carried out under the following cycle conditions:
  • the 922 bp amplificate was cloned into the PCR cloning vector pCR 2.1 (Invitrogen) using standard methods and the plasmid pTAP3 was obtained.
  • Sequencing of the clone pTAP3 confirmed a sequence consisting only of an insertion (a G in position 9765 of the sequence AL132971) and a base exchange (a G instead of an A in position 9726 of the sequence AL132971) from the published AP3 sequence (AL132971, nucleotide region 9298-10200) differs. These nucleotide differences were reproduced in an independent amplification experiment and thus represent the actual nucleotide sequence in the Arabidopsis thaliana plants used.
  • the modified version AP3P was produced by recombinant PCR using the plasmid pTAP3. The region 10200-9771 was amplified with the primers PR7 (SEQ ID No.
  • the PCR conditions were as follows:
  • the PCR was carried out under the following cycle conditions:
  • the recombinant PCR includes annealing of the amplificates A7 / 9 and A8 / 10, which overlap over a sequence of 25 nucleotides, completion into a double strand and subsequent amplification.
  • the denaturation (5 min at 95 ° C.) and annealing (slow cooling at room temperature to 40 ° C.) of both amplificates A7 / 9 and A8 / 10 was carried out in a 17.6 1 reaction, which contained:
  • the nucleic acid coding for the modified promoter version AP3P was amplified by means of PCR using a sense-specific primer (PR7 SEQ ID No. 28) and an antisense-specific primer (PR10 SEQ ID No. 36).
  • the PCR conditions were as follows:
  • the PCR for the amplification of the AP3P fragment was carried out in a 50 ⁇ l reaction mixture, which contained:
  • the PCR was carried out under the following cycle conditions:
  • PCR amplification with SEQ ID No. 33 and SEQ ID No. 36 resulted in a 778 bp fragment coding for the modified promoter version AP3P.
  • the amplificate was cloned into the cloning vector pCR .1 (Invitrogen) and the clone pTAP3P was obtained. Sequencing with the primers T7 and M13 confirmed a sequence identical to the sequence AL132971, region 10200-9298, the internal region 9285-9526 being deleted. This clone was therefore used for the cloning into the expression vector pJIT117 (Guerineau et al. 1988, Nucl. Acids Res. 16: 11380).
  • the cloning was carried out by isolating the 771 bp SacI-HindIII fragment from pTAP3P and ligating into the SacI-HindIII cut vector pJITH7.
  • the clone that contains the AP3P promoter instead of the original d35S promoter is called pJAP3P.
  • the 1027 bp SpHI fragment KET02 (described in Example 1) was cloned into the SpHI-cut vector pJAP3P.
  • the clone that contains the fragment KET02 in the correct orientation as an N-terminal fusion with the rbcS transit peptide is called pJAP3PKET02.
  • the 1032 bp SpHI-EcoRI fragment KET04 (described in Example 3) was cloned into the SpHI-EcoRI cut vector pJAP3P.
  • the clone that contains the fragment KET04 in the correct orientation as an N-terminal fusion with the rbcS transit peptide is called pJAP3PKET04.
  • An expression vector for the Agrobacterium -mediated transformation of the AP3P-controlled ketolase from Haematococcus pluvialis into L. esculentum was produced using the binary vector pSUN3 (WO02 / 00900).
  • fragment AP3P contains the modified AP3P promoter (771 bp), fragment rbcS the rbcS transit peptide from pea (204 bp), fragment KET02 (1027 bp) the entire primary sequence coding for the Haematococcus pluvialis ketolase, fragment term (761 Bp) the polyadenylation signal from CaMV.
  • fragment AP3P contains the modified AP3P promoter (771 bp), fragment rbcS the rbcS transit peptide from pea (204 bp), fragment KET04 (1038 bp) the entire primary sequence coding for the Haematococcus pluvialis ketolase with C-terminal myc tag , Fragment term (761 bp) the polyadenylation signal of CaMV.
  • Example 6 Production of transgenic Lycopersicon esculentum plants Transformation and regeneration of tomato plants was carried out according to the published method by Ling and co-workers (Plant Cell Reports (1998), 17: 843-847). For the microtome variety, higher kanamycin concentrations (100 mg / L) were selected. 5
  • the starting explant for the transformation was cotyledons and hypocotyls, seven to ten day old seedlings of the Microtome line.
  • the culture medium according to Murashige and Skoog (1962: Murashige and Skoog, 1962, Physiol. Plant 15,
  • MSZ2 medium MS pH 6, 1 + 3% sucrose, 2 mg / 1 zeatin, 100 mg / 1 kanamycin,
  • the fruit material of the transgenic plants was ground in liquid nitrogen and the powder (about 250 to 500 mg) extracted with 100% acetone (three times 500 ul each). The solvent was evaporated and the carotenoids resuspended in 100 ul acetone.
  • Solvent B 80% methanol, 0.2% ammonium acetate
  • Solvent C 100% t-butyl methyl ether
  • the spectra were determined using a photodiode array detector.
  • the carotenoids were absorbed through their Spectra and their retention times compared to standard samples identified.
  • Table 1 shows the carotenoid profile in tomato fruits of the transgenic tomatoes and control tomato plants produced according to the examples described above. Compared to the genetically unmodified control plant, the genetically modified plants have a ketocarotenoid content and in particular astaxanthin content.
  • Table 2a shows the amounts of carotenoids in ripe fruit of transgenic tomatoes and control plants.
  • the data are mean values of various linines and are given as a percentage of the total carotenoid content.
  • Table 2b shows the amounts of carotenoids in ripening fruits of transgenic tomatoes and control plants.
  • the data are mean values of various linines and are given as a percentage of the total carotenoid content.
  • the DNA encoding the NP196 ketolase from Nostoc punctiform ATCC 29133 was amplified by PCR from Nostoc punctiform ATCC 15 29133 (strain of the "American Type Culture Collection").
  • the bacterial cells were pelleted from a 10 ml liquid culture by centrifugation at 8000 rpm for 10 minutes. The bacterial cells were then washed in liquid nitrogen with a mortar.
  • the cell suspension was incubated for 3 hours at 37 ° C. in 100 ⁇ l proteinase K (concentration: 20 mg / ml). Then was
  • PCR polymerase chain reaction
  • the PCR conditions were as follows:
  • the PCR for the amplification of the DNA which codes for a ketolase protein consisting of the entire primary sequence, was carried out in a 50 ⁇ l reaction mixture which contained:
  • the PCR was carried out under the following cycle conditions:
  • the amplificate was cloned into the PCR cloning vector pCR 2.1 (Invitrogen) and the clone pNP196 was obtained.
  • This clone pNPl96 was therefore used for cloning into the expression vector pJAP3P (described in Example 5).
  • PJAP3P was modified by the 35S terminator through the OCS terminator (octopine synthase) of the Ti plasmid pTil5955 from Agrobacterium tumefaciens (database entry X00493 from position 10 12.541-12.350, Gielen et al. (1984) EMBO J. 3 835-846 ) was replaced.
  • the DNA fragment containing the OCS terminator region was isolated by PCR using the plasmid pHELLSGATE (database entry 15 AJ311874, Wesley et al. (2001) Plant J. 27 581-590, isolated from E. coli by standard methods) as well as the primer OCS-1 (SEQ ID No. 63) and OCS-2 (SEQ ID No. 64).
  • the PCR conditions were as follows:
  • the PCR for the amplification of the DNA which contains the octopine synthase (OCS) terminator region (SEQ ID 65), was carried out in a 50 ⁇ l reaction mixture which contained:
  • the PCR was carried out under the following cycle conditions:
  • the 210 bp amplificate was cloned into the PCR cloning vector pCR 2.1 (Invitrogen) using standard methods and the plasmid pOCS was obtained.
  • Sequencing of the clone pOCS confirmed a sequence which corresponds to a sequence section on the Ti plasmid pTil5955 from Agrobacterium tumefaciens (database entry X00493) from positions 12,541 to 12,350.
  • the cloning was carried out by isolating the 210 bp Sall-Xhol fragment from pOCS and ligation into the Sall-Xhol cut vector pJAP3P.
  • This clone is called pJOAP and was therefore used for cloning into the expression vector pJOAP: NP196.
  • the cloning was carried out by isolating the 782 bp Sphl fragment from pNPl96 and ligating into the SphI cut vector pJOAP.
  • the clone that contains the Nostoc punctiforme NPl96 ketolase in the correct orientation as an N-terminal translational fusion with the rbcS transit peptide is called pJOAP: NPl96.
  • An expression vector for the Agrobacterium -mediated transformation of the AP3P-controlled NPl96 ketolase from Nostoc punctiform ATCC 29133 into L. esculentum was produced using the binary vector pSUN3 (WO02 / 00900).
  • fragment AP3P PROM contains the AP3P promoter (765 bp), fragment rbcS TP FRAGMENT the rbcS transit peptide from pea (194 bp), fragment NP196 KETO CDS (761 bp), coding for the nos toc punctiform NPl96 ketolase, fragment OCS terminator (192 bp) the octopine synthase polyadenylation signal.
  • AP3P PROM contains the AP3P promoter (765 bp), fragment rbcS TP FRAGMENT the rbcS transit peptide from pea (194 bp), fragment NP196 KETO CDS (761 bp), coding for the nos toc punctiform NPl96 ketolase, fragment OCS terminator (192 bp) the octopine synthase polyadenylation signal.
  • Example 11 Example 11:
  • the DNA coding for the NOST ketolase from Nostoc punctiform PCC 7120 was amplified by means of PCR from Nostoc PCC 7120 (strain of the "Pasteur Culture Collection of Cyanobacterium”).
  • the bacterial cells were removed from a 10 ml liquid culture by 10
  • the cell suspension was incubated for 3 hours at 37 ° C. in 30 100 ⁇ l proteinase K (concentration: 20 mg / ml). The suspension was then extracted with 500 ⁇ l of phenol. After centrifugation at 13,000 rpm for 5 minutes, the upper, aqueous phase was transferred to a new 2 ml Eppendorf reaction vessel. The extraction
  • DNA was precipitated by adding 1/10 volume of 3 M sodium acetate (pH 5.2) and 0.6 volume of isopropanol and then washed with 70% ethanol.
  • the DNA pellet was dried at room temperature, taken up in 25 ⁇ l of water and dissolved with heating to 65 ° C.
  • the nucleic acid encoding a ketolase from Nostoc PCC 7120 was determined by means of a "polymerase chain reaction” (PCR) from Nostoc PCC 7120 using a sense-specific primer (NOST-1, SEQ ID No. 66) and an antisense-specific primer NOST-2
  • the PCR for the amplification of the DNA which codes for a ketolase protein consisting of the entire primary sequence, was carried out in a 50 ⁇ l reaction mixture which contained:
  • the PCR was carried out under the following cycle conditions:
  • PCR amplification with SEQ ID No. 66 and SEQ ID No. 67 resulted in an 809 bp fragment that codes for a protein consisting of the entire primary sequence (SEQ ID No. 68).
  • the amplificate was cloned into the PCR cloning vector pGEM-T (Promega) and the clone pNOST was obtained.
  • This clone pNOST was therefore used for the cloning into the expression vector pJOAP (described in Example 9).
  • the cloning was carried out by isolating the 799 bp Sphl fragment from pNOST and ligation into the SphI-cut vector pJOAP.
  • the clone that contains the NOSToc PCC7120 NOST ketolase in the correct orientation as an N-terminal translational fusion with the rbcS transit peptide is called pJOAP: NOST Example 12:
  • NOST ketolase from Nostoc spp. PCC 7120 in L. Esculentum occurred with the pea transit peptide rbcS (Anderson et al. 1986, Biochem J. 240: 709-715). Expression was carried out under the control of the AP3P promoter from Arabidopsis thaliana (described in Example 5).
  • fragment AP3P PROM contains the AP3P promoter (765 bp), fragment rbcS TP FRAGMENT the rbcS transit peptide from pea (194 bp), fragment NOST KETO CDS (774 bp), coding for the Nostoc spp. PCC 7120 NOST-Ketolase, fragment OCS terminator (192 bp) the polyadenylation signal of octopine synthase.
  • the DNA which codes for the NPl95 ketolase from Nostoc punctiform ATCC 29133 was amplified by means of PCR from Nostoc punctiform ATCC 29133 (strain of the "American Type Culture Collection"). The preparation of genomic DNA from a suspension culture of Nostoc punctiforme ATCC 29133 was described in Example 9.
  • PCR polymerase chain reaction
  • the PCR conditions were as follows: The PCR for the amplification of the DNA, which codes for a ketolase protein consisting of the entire primary sequence, was carried out in a 50 ⁇ l reaction mixture which contained:
  • the PCR was carried out under the following cycle conditions:
  • This clone pNPl95 was therefore used for the cloning into the expression vector pJOAP (described in Example 9).
  • the cloning was carried out by isolating the 709 bp Sphl fragment from pNPl95 and ligating into the SphI-cut vector pJOAP.
  • the clone which contains the NPl95 ketolase from Nostoc punctiforme ATCC 29133 in the correct orientation as an N-terminal translational fusion with the rbcS transit peptide is called pJOAP: NPl95.
  • fragment AP3P PROM contains the AP3P promoter (765 bp), fragment rbcS TP FRAGMENT the rbcS transit peptide from pea (194 bp), fragment NP195 KETO CDS (789 bp), coding for the nostoc punctiform ATCC 29133 NP195 ketolase, Fragment OCS terminator (192 bp) the polyadenylation signal from octopine synthase.
  • the DNA encoding the ketolase from Nodularia spumignea NSOR10 was amplified by PCR from Nodularia spumignea NSOR10.
  • the bacterial cells were pelleted from a 10 ml liquid culture by centrifugation at 8000 rpm for 10 minutes. The bacterial cells were then crushed and ground in liquid nitrogen using a mortar. The cell material was resuspended in 1 ml 10mM Tris_HCl (pH 7.5) and transferred to an Eppendorf reaction vessel (2ml volume). After adding 100 ⁇ l Proteinase K (concentration: 20 mg / ml), the cell suspension was incubated for 3 hours at 37 ° C. The suspension was then extracted with 500 ⁇ l of phenol. After centrifugation at 13,000 rpm for 5 minutes, the upper, aqueous phase was transferred to a new 2 ml Eppendorf reaction vessel.
  • the extraction with phenol was repeated 3 times.
  • the DNA was precipitated by adding 1/10 volume of 3 M sodium acetate (pH 5.2) and 0.6 volume of isopropanol and then washed with 70% ethanol.
  • the DNA pellet was dried at room temperature, taken up in 25 ⁇ l of water and dissolved with heating to 65 ° C. x
  • PCR polymerase chain reaction
  • the PCR conditions were as follows:
  • the PCR for the amplification of the DNA which codes for a ketolase protein consisting of the entire primary sequence, was carried out in a 50 ⁇ l reaction mixture which contained:
  • the PCR was carried out under the following cycle conditions;
  • PCR amplification with SEQ ID No. 74 and SEQ ID No. 75 resulted in a 720 bp fragment coding for a protein consisting of the entire primary sequence (NODK, SEQ ID No. 76).
  • the amplificate was cloned into the PCR cloning vector pCR 2.1 (Invitrogen) and the clone pNODK was obtained.
  • the cloning was carried out by isolating the 710 bp Sphl fragment from pNODK and ligation into the SphI-cut vector pJOAP.
  • the clone that contains the NODK ketolase from Nodularia spumignea NSORIO in the correct orientation as an N-terminal translational fusion with the rbcS transit peptide is called pJOAP: NODK.
  • NODK ketolase from Nodularia spumignea NSORIO was expressed in L. esculentum with the transit peptide rbcS from pea (Anderson et al. 1986, Biochem J. 240: 709-715). The expression was carried out under the control of the AP3P promoter from Arabidopsis thaliana (described in Example 5).
  • fragment AP3P PROM contains the AP3P promoter (765 bp), fragment rbcS TP FRAGMENT the rbcS transit peptide from pea (194 bp), fragment NODK KETO CDS (690 bp), coding for the Nodularia spumignea NSORIO NODK ketolase, fragment OCS terminator (192 bp) the octopine synthase polyadenylation signal.
  • Example 17 Production of an expression cassette for fruit-specific overexpression of the chromoplast-specific b-hydroxylase from Lycopersicon esculentum.
  • chromoplast-specific ⁇ -hydroxylase from Lycopersicon esculentum in tomato takes place under the control of the fruit-specific promoter AP3P from Arabidopsis (Example 2).
  • LB3 database entry AX696005
  • Vicia faba is used as the terminator element.
  • the sequence of the chromoplast-specific ⁇ -hydroxylase was produced by RNA isolation, reverse transcription and PCR.
  • the DNA fragment containing the LB3 terminator region was isolated by PCR.
  • Genomic DNA from Vicia faJba tissue is isolated and used by genomic PCR using the primers PR206 (SEQ ID No. 78) and PR207 (SEQ ID No. 79).
  • the PCR for the amplification of this LB3 DNA fragment is carried out in a 50 ⁇ l reaction mixture which contains:
  • genomic DNA prepared as described above 0.25 mM dNTPs
  • PCR amplification with SEQ ID No. 78 and SEQ ID No. 79 results in a 307 bp fragment (SEQ ID No. 80) which contains the LB terminator.
  • the amplificate was cloned into the PCR cloning vector pCR 2.1 (Invitrogen) and the clone pLB3 was obtained. Sequencing of the clone pLB3 with the M13F and the M13R primer confirmed a sequence which corresponds to the DNA sequence from 3-298 of the database entry AX696005 is identical. This clone is called pLB3 and is therefore used for cloning into the vector pJAP3P (see example 5).
  • the expression cassette pJAP3P was modified by replacing the 35S- 5 terminator with the Legumin LB3 terminator from Vicia faba (database entry AX696005; WO03 / 008596) (see below).
  • Total RNA is used to produce the ß-hydr -xylase sequence
  • RNA is precipitated with a volume of isopropanol, washed with 75% ethanol and the pellet is dissolved in DEPC water (overnight incubation of water with 1/1000 volume of diethyl pyrocarbonate at room temperature, then autoclaved).
  • DEPC water overnight incubation of water with 1/1000 volume of diethyl pyrocarbonate at room temperature, then autoclaved.
  • RNA concentration 20 concentration is determined photometrically.
  • cDNA synthesis 2.5 ⁇ g of total RNA are denatured for 10 min at 60 a C, cooled on ice for 2 min and using a cDNA kit (Ready-to-go-you-prime beads, Pharmacia Biotech) according to the manufacturer's instructions using an antisense specific primer (PR215 SEQ ID No.
  • the nucleic acid encoding the ⁇ -hydroxylase was extracted from tomato by means of a "polymerase chain reaction” (PCR) using a sense-specific primer (VPR204, SEQ ID No. 81) and an antisense-specific primer (PR215 SEQ ID No . 82) amplified.
  • PCR polymerase chain reaction
  • the PCR for the amplification of the DNA which codes for a ⁇ -hydroxylase protein consisting of the entire primary sequence, was carried out in a 50 ⁇ l reaction mixture which contained:
  • the PCR amplification with VPR204 and PR215 results in a 1,040 bp fragment (SEQ ID No. 83) which codes for the b-hydroxylase.
  • the amplificate is cloned into the PCR cloning vector pCR 2.1 (Invitrogen). This clone is called pCrtR-b2.
  • Sequencing of the clone pCrtR-b2 with the primers M13-R and M13-R confirmed a sequence which is identical to the DNA sequence from 33-558 of the database entry BE354440 and with the DNA sequence from 1-1009 of the database entry Y14810 is identical.
  • the clone pCrtR-b2 is therefore used for the cloning into the vector pCSP02 (see below).
  • the first cloning step is carried out by isolating the 1,034 bp HindIII-EcoRI fragment from pCrtR-b2, derived from the cloning vector pCR-2.1 (Invitrogen), and ligation with the HindIII-EcoRI cut vector pJAP3P (see Example 5).
  • the clone that contains the b-hydroxylase fragment CrtR-b2 is called pCSP02.
  • the second cloning step is carried out by isolating the 301 bp EcoRI-XhoI fragment from pLB3, derived from the cloning vector pCR-2.1 (Invitrogen), and ligation with the EcoRI-XhoI cut vector pCSP02.
  • the clone that contains the 296 bp terminator L ⁇ 3 is called pCSP03.
  • the ligation creates a transcriptional fusion between the terminator LB3 and the b-hydroxylase fragment CrtR-b2.
  • a transcriptional fusion occurs between the AP3P promoter and the b-hydroxylase fragment.
  • Example 18 Production of an expression cassette for fruit-specific overexpression of the B gene from Lycopersicon esculenurn.
  • the expression of the B gene from Lycopersicon esculentum in Tomat takes place under the control of the fruit-specific promoter PDS (phytoene desaturase; database entry U46919) from Lycopersicon esculentum. 35S from CaMV is used as the terminator element.
  • the sequence of the B gene was generated by PCR from genomic DNA from Lycopersicon esculentum.
  • the oligonucleotide primers BGEN-1 (SEQ ID No. 85) and BGEN-2 (SEQ ID No. 86) were used to isolate the B gene by means of PCR with genomic DNA from Lycopersicon esculentum.
  • the genomic DNA was isolated from Lycopersicon esculentum as described (Galbiati M et al. Funct. Integr. Genomics 2000, 20 1: 25-34).
  • the PCR amplification was carried out as follows:
  • the amplificate is in the PCR cloning vector pCR-2.1
  • genomic DNA from Lycopersicon esculentum tissue is isolated according to standard methods and used by genomic PCR using the primers PDS-1 and PDS-2.
  • the PCR for the amplification of this PDS-PRomotor fragment is carried out in a 50 ul. Reaction batch which contains: 35
  • 0.2 uM PDS-1 (SEQ ID No. 89) 0.2 uM PDS-2 (SEQ ID No. 90) 40 - 5 ul 10X Pfu-Turbo Polymerase (Stratagene) - 1 ul Pfu-Turbo Polymerase (Stratagene) 28.8 ul Aq. Dest.
  • the PCR amplification with PDS-1 and PDS-2 results in a fragment that contains the sequence for the PDS promoter.
  • the amplificate is cloned into the pCR4-BLUNT (Invitrogen). This clone is called pPDS.
  • the first cloning step is carried out by isolating the 1,499 bp Ncol / EcoRI fragment from pBGEN, derived from the cloning vector pCR2.1 (Invitrogen).
  • pBGEN is cut with BamHI, the 3 'ends are filled in according to standard methods (30 min at 30 ° C.) (Klenow-fill-in) and then a partial digestion is carried out with Ncol, in which the resulting 1,499 kb fragment is isolated.
  • This fragment was then cloned into pCSP02, which had previously been cut with EcoRI, the 3 'ends filled in according to standard methods (30 min at 30 ° C.) (Klenow fill-in) and then cut with Ncol.
  • the clone that contains the 1,497 bp B gene fragment BGEN is called pJAP: BGEN.
  • the ligation creates a transcriptional fusion between the 35S terminator and the B gene.
  • the second cloning step is carried out by isolating the 2,078 bp PDS PROM fragment from pPDS.
  • pPDS is cut with Smal and then a partial digestion with Sacl is carried out, in which the resulting 2,088 bp fragment is isolated.
  • Sacl is carried out, in which the resulting 2,088 bp fragment is isolated.
  • This fragment was then cloned into the pJAP: BGEN, which had previously been cut with BamHI, the 3 'ends filled in using standard methods (30 min at 30 ° C.) (Klenow fill-in) and then cut with SacI.
  • the ligation creates a transcriptional fusion between the promoter PDS and the B gene.
  • the clone that contains the 2,078 bp PDS promoter BGEN is called pJPDS: BGEN.
  • Example 19 Production of a triple expression vector for the overexpression of the B gene, the expression of the Nostoc punctiform ketolase NP196, and the overexpression of the chromoplast-specific B-hydroxylase from Lycopersicon esculentum fruit-specifically in Lycopersicon esculentum.
  • a double construct which contains expression cassettes for the overexpression of the Nostoc punctiform ATCC 29133 NP196 ketolase and for the overexpression of the B-hydroxylase.
  • fragment AP3P b-hydroxy lase: LB3, which contains the B-hydroxylase expression cassette, as a 2104 bp Ecll36lI-XhoI fragment isolated from pCSP03 (described in Example 18).
  • the 3 'ends (30 min at 30 a C) are filled using standard methods (Klenow fill-in).
  • this fragment was cut in the vector MSP120 (described in Example 10) with Ecll36ll and EcoRI, the 3 'ends were filled in according to standard methods (30 min at 30 ° C.) (Klenow fill-in).
  • the ligation results in a T-DNA which contains two expression cassettes: firstly a cassette for the chromoplast-specific overexpression of the B-hydroxylase from Lycopersicon esculentum, and secondly a cassette for the overexpression of the ketolase NP196 from Nostoc punctiforme.
  • the B-hydroxylase downregulation cassette can ligate into the vector in two orientations.
  • the version in which both expression cassettes match in their orientation is preferred (see Figure 14). This version can be identified by PCR as described:
  • the PCR for the amplification of the PR206-PR010 plasmid fragment which contains the compound of LB3 terminator of the B-hydroxylase cassette and the AP3P promoter of the ketolase cassette, is carried out in a 50 ⁇ l reaction mixture which contains:
  • PCR amplification with PR010 and PR206 results in a 1,080 bp fragment, which indicates the presence of the above-described connection of LB3 terminator and AP3P promoter, and thus the preferred orientation of both expression cassettes.
  • This clone is called pBHYX: NPl96.
  • this B gene overexpression cassette into expression vectors for the Agrobacterium -mediated transformation of tomato, isolation of the 4,362 bp EcoRV-XhoI fragment from pJPDS-.BGEN (see Example 19) and ligation in the Smal-Xhol-cut vector pBHYX: NPl96 (described above).
  • the ligation results in a T-DNA which contains three expression cassettes: first a cassette for overexpressing the B gene, secondly a cassette for overexpressing the ketolase NP196-1 from Nostoc punctiforme, and thirdly a cassette for chromoplast-specific overexpression of the B-hydroxylase Lycopersicon esculentum ( Figure 14, construct map).
  • This clone is called MSP124.
  • fragment AP3P PROM (765 bp) contains the AP3P promoter, fragment BHYX b2 CDS (2 bp) the B-hydroxylase CrtRb2, fragment LB3 TERM (296 bp) the LB3 terminator.
  • Fragment AP3P PROM (765 bp) also contains the AP3P promoter, fragment rbcS TP FRAGMENT (194 bp) the transit peptide of the rbcS gene from pea, NP196 KETO CDS (761 bp) the ketolase from Noctoc punctiform ATCC29133, and OCS TERM (192 bp) the polyadenylation signal of the octopine synthase gene.
  • fragment PDS PROM (2078 bp) contains the PDS promoter, fragment BGEN CDS (1,497 bp) the B gene sequence, and fragment 35S TERM (746 bp) the 35S terminator.
  • MSP121 MSP121-1, MSP121-2, MSP121-3
  • MSP123 MSP123-1, MSP123-2, MSP123-3

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Animal Husbandry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Insects & Arthropods (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Birds (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Fodder In General (AREA)

Abstract

The present invention relates to a process for preparing ketocarotenoids by cultivation of genetically modified organisms which, compared with the wild type, have a modified ketolase activity, to the genetically modified organisms, and to the use thereof as human and animal foods and for producing ketocarotenoid extracts.

Description

Verfahren zur Herstellung von Ketocarotinoiden in Früchten von PflanzenProcess for the production of ketocarotenoids in fruit of plants
Beschreibungdescription
Die vorliegende Erfindung betrifft ein Verfahren zur Herstellung von Ketocarotinoiden durch Kultivierung von genetisch veränderten Pflanzen, die in Früchten eine Ketolase-Aktivität aufweisen, die- genetisch veränderten Pflanzen, sowie deren Verwendung als Nahrungs- oder Futtermittel und zur Herstellung von Ketocaroti- noidextrakte .The present invention relates to a process for the production of ketocarotenoids by cultivating genetically modified plants which have a ketolase activity in fruits, the genetically modified plants, and their use as food or feed and for the production of ketocarotenoid extracts.
Carotinoide werden de novo in Bakterien, Algen, Pilzen und Pflanzen synthetisiert. Ketocarotinoide, also Carotinoide, die mindestens eine Keto-Gruppe enthalten, wie beispielsweise Astaxanthin, Canthaxanthin, Echinenon, 3-Hydroxyechinenon, 3 ' -Hydroxyechi- nenon, Adonirubin oder Adonixanthin sind natürliche Antioxi- dantien und Pigmente, die von einigen Algen und Mikroorganismen als Sekundärmetabolite produziert werden.Carotenoids are synthesized de novo in bacteria, algae, fungi and plants. Ketocarotenoids, ie carotenoids, which contain at least one keto group, such as, for example, astaxanthin, canthaxanthin, echinenone, 3-hydroxyechinenone, 3 '-hydroxyechinenone, adonirubin or adonixanthin are natural antioxidants and pigments which some algae and microorganisms use as Secondary metabolites are produced.
Aufgrund ihrer farbgebenden Eigenschaften werden die Ketocarotinoide und insbesondere Astaxanthin als Pigmentierhilfsstoffe in der Tierernährung, insbesondere in der Forellen-, Lachs- und Shrimpszucht verwendet.Due to their coloring properties, the ketocarotenoids and especially astaxanthin are used as pigmenting aids in animal nutrition, especially in trout, salmon and shrimp farming.
Die Herstellung von Astaxanthin erfolgt heutzutage größtenteils durch chemische Syntheseverfahren. Natürliche Ketocarotinoide, wie beispielsweise natürliches Astaxanthin, werden heutzutage in biotechnologischen Verfahren in kleinen Mengen durch Kultivierung von Algen, beispielsweise Haematococcus pluvialis, oder durch Fermentation von gentechnologisch optimierten Mikroorganismen und anschließender Isolierung gewonnen.Nowadays, astaxanthin is mainly produced using chemical synthesis processes. Natural ketocarotenoids, such as natural astaxanthin, are nowadays obtained in small amounts in biotechnological processes by cultivating algae, for example Haematococcus pluvialis, or by fermentation of genetically optimized microorganisms and subsequent isolation.
Ein wirtschaftliches biotechnologisches Verfahren zur Herstellung von natürlichen Ketocarotinoiden ist daher von großer Bedeutung.An economical biotechnological process for the production of natural ketocarotenoids is therefore of great importance.
WO 98/18910 beschreibt die Synthese von Ketocarotinoiden in Nek- tarien von Tabakblüten durch Einbringen eines Ketolase-Gens in Tabak.WO 98/18910 describes the synthesis of ketocarotenoids in nectaries of tobacco flowers by introducing a ketolase gene into tobacco.
WO 01/20011 beschreibt ein DNA Konstrukt zur Produktion von Ketocarotinoiden, insbesondere Astaxanthin, in Samen von Ölsaatpflan- zen wie Raps, Sonnenblume, Sojabohne und Senf unter Verwendung eines Samen-spezifischen Promotors und einer Ketolase aus Haematococcus . Die im Stand der Technik offenbarten Verfahren liefern zwar genetisch veränderte Pflanzen, die in spezifischen Geweben einen Gehalt an Ketocarotinoiden aufweisen, weisen jedoch den Nachteil auf, dass die Höhe des Gehalts an Ketocarotinoiden und die Rein- heit, insbesondere an Astaxanthin, noch nicht zufriedenstellend ist .WO 01/20011 describes a DNA construct for the production of ketocarotenoids, in particular astaxanthin, in seeds of oilseed plants such as oilseed rape, sunflower, soybean and mustard using a seed-specific promoter and a ketolase from Haematococcus. The methods disclosed in the prior art provide genetically modified plants which contain ketocarotenoids in specific tissues, but have the disadvantage that the level of the ketocarotenoids and the purity, in particular astaxanthin, are not yet satisfactory ,
Der Erfindung lag daher die Aufgabe zugrunde, ein alternatives Verfahren zur Herstellung von Ketocarotinoiden durch Kultivierung von Pflanzen zur Verfügung zu stellen, bzw. weitere transgene Pflanzen, die Ketocarotinoide herstellen, zur Verfügung zu stellen, die optimierte Eigenschaften, wie beispielsweise einen höheren Gehalt an Ketocarotinoiden, aufweisen und den geschilderten Nachteil des Standes der Technik nicht aufweisen.The object of the invention was therefore to provide an alternative process for the production of ketocarotenoids by cultivating plants, or to provide further transgenic plants which produce ketocarotenoids which have optimized properties, such as a higher ketocarotenoid content , and do not have the described disadvantage of the prior art.
Demgemäß wurde ein Verfahren zur Herstellung von Ketocarotinoiden gefunden, indem man genetisch veränderte Pflanzen kultiviert, die in Früchten eine Ketolase-Aktivität aufweisen.Accordingly, a method for producing ketocarotenoids has been found by cultivating genetically modified plants that have ketolase activity in fruits.
Unter Ketolase-Aktivität wird die Enzymaktivität einer Ketolase verstanden. sKetolase activity means the enzyme activity of a ketolase. s
Unter einer Ketolase wird ein Protein verstanden, das die enzyma- tische Aktivität aufweist, am, gegebenenfalls substituierten, ß-Ionon-Ring von Carotinoiden eine Keto-Gruppe einzuführen.A ketolase is understood to mean a protein which has the enzymatic activity of introducing a keto group on the optionally substituted β-ionone ring of carotenoids.
Insbesondere wird unter einer Ketolase ein Protein verstanden, das die enzymatische Aktivität aufweist, ß-Carotin in Cantha- xanthin umzuwandeln.In particular, a ketolase is understood to mean a protein which has the enzymatic activity of converting β-carotene into cantaxanthin.
Dementsprechend wird unter Ketolase-Aktivität die in einer bestimmten Zeit durch das Protein Ketolase umgesetzte Menge ß-Caro- tin bzw. gebildete Menge Canthaxanthin verstanden.Accordingly, ketolase activity is understood to mean the amount of β-carotene converted or the amount of canthaxanthin formed in a certain time by the protein ketolase.
Um in den Früchten der genetisch veränderten Pflanzen eine Keto- laseaktivität aufzuweisen, werden in einer bevorzugten Ausführungsform genetisch veränderte Pflanzen verwendet, die inFrüchten eine Ketolase exprimieren.In a preferred embodiment, genetically modified plants which express a ketolase in fruits are used in order to have ketoase activity in the fruits of the genetically modified plants.
Vorzugsweise werden daher im erfindungsgemäßen Verfahren genetisch veränderte Pflanzen verwendet, die in Früchten mindestens eine Nukleinsäure, kodierend eine Ketolase, enthalten. Es sind keine Pflanzen bekannt, die als Wildtyp in Früchten eine Ketolase-Aktivität aufweisen. Insbesondere weisen die nachstehend beschriebenen, bevorzugten Pflanzen in Früchten als Wildtyp keine Ketolase-Aktivität auf.Genetically modified plants which contain at least one nucleic acid, coding for a ketolase, are therefore preferably used in the method according to the invention. No plants are known which have a ketolase activity as a wild type in fruits. In particular, the preferred plants described below in fruits as wild type have no ketolase activity.
In der vorliegenden Erfindung wird die Ketolase-Aktivität in Früchten der genetisch veränderten Pflanzen durch die genetische Veränderung der Ausgangspflanze verursacht . Die erfindungsgemäße genetisch veränderte Pflanze weist somit, im Vergleich zur genetisch nicht veränderten Ausgangspflanze eine Ketolase- Aktivität in Früchten auf und ist somit vorzugsweise in der Lage, in Früchten eine Ketolase zu exprimieren.In the present invention, the ketolase activity in fruits of the genetically modified plants is caused by the genetic modification of the parent plant. The genetically modified plant according to the invention thus has a ketolase activity in fruits in comparison to the genetically unmodified starting plant and is therefore preferably able to express a ketolase in fruits.
Unter dem Begriff "Ausgangspflanze" oder "Wildtyp" wird die ent- sprechende nicht genetisch veränderte Ausgangspflanze verstanden.The term “parent plant” or “wild type” is understood to mean the corresponding non-genetically modified parent plant.
Unter dem Begriff "genetisch veränderte Pflanze" wird vorzugsweise eine im Vergleich zur Ausgangspflanze genetisch veränderte Pflanze verstanden.The term "genetically modified plant" is preferably understood to mean a plant which is genetically modified in comparison with the starting plant.
Je nach Zusammenhang kann unter dem Begriff "Pflanze" die Ausgangspflanze (Wildtyp) oder eine erfindungsgemäße, genetisch veränderte Pflanze oder beides verstanden werden.Depending on the context, the term "plant" can mean the starting plant (wild type) or a genetically modified plant according to the invention or both.
Die Verursachung der Genexpression einer Nukleinsäure, kodierend eine Ketolase, in den Früchten der Pflanzen erfolgt vorzugsweise durch Einbringen von Nukleinsäuren, die Ketolasen kodieren, in die Ausgangspflanze.The gene expression of a nucleic acid encoding a ketolase is caused in the fruits of the plants preferably by introducing nucleic acids encoding ketolases into the starting plant.
Die Erfindung betrifft daher insbesondere das vorstehend beschriebene Verfahren, dadurch gekennzeichnet, dass man genetisch veränderte Pflanzen verwendet, in die man ausgehend von einer Ausgangspflanze, mindestens eine Nukleinsäure, kodierend eine Ketolase, eingebracht hat.The invention therefore relates in particular to the method described above, characterized in that genetically modified plants are used, into which, starting from a starting plant, at least one nucleic acid coding for a ketolase has been introduced.
Dazu kann prinzipiell jedes Ketolase-Gen, also jede Nukleinsäure die eine Ketolase kodiert, verwendet werden.In principle, any ketolase gene, ie any nucleic acid encoding a ketolase, can be used for this.
Alle in der Beschreibung erwähnten Nukleinsäuren können beispielsweise eine RNA-, DNA- oder cDNA-Sequenz sein.All nucleic acids mentioned in the description can be, for example, an RNA, DNA or cDNA sequence.
Bei genomischen Ketolase-Sequenzen aus eukaryontisehen Quellen, die Introns enthalten, sind für den Fall, dass die Wirtspflanze nicht in der Lage ist oder nicht in die Lage versetzt werden kann, die entsprechenden Ketolase zu exprimieren, bevorzugt bereits prozessierte Nukleinsäuresequenzen, wie die entsprechenden cDNAs, zu verwenden. Beispiele für Nukleinsäuren, kodierend eine Ketolase, und die entsprechenden Ketolasen, die im erfindungsgemäßen Verfahren bzw. in den nachstehend beschriebenen erfindungsgemäßen genetisch veränderten Pflanzen verwendet werden können, sind beispielsweise Sequenzen ausIn the case of genomic ketolase sequences from eukaryotic sources which contain introns, in the event that the host plant is unable or unable to express the corresponding ketolase, nucleic acid sequences which have already been processed, such as the corresponding cDNAs, are preferred , to use. Examples of nucleic acids encoding a ketolase and the corresponding ketolases which can be used in the method according to the invention or in the genetically modified plants according to the invention described below are, for example, sequences from
Haematoccus pluvialis, insbesondere aus Haematoccus pluvialis Flotow em. Wille (Accession No. X86782; Nukleinsäure: SEQ ID No. 1, Protein SEQ ID No . 2),Haematoccus pluvialis, especially from Haematoccus pluvialis Flotow em. Wille (Accession No. X86782; nucleic acid: SEQ ID No. 1, protein SEQ ID No. 2),
Haematoccus pluvialis, NIES-144 (Accession No . D45881; Nukleinsäure: SEQ ID No. 3, Protein SEQ ID No . 4),Haematoccus pluvialis, NIES-144 (Accession No. D45881; nucleic acid: SEQ ID No. 3, protein SEQ ID No. 4),
Agrobacterium aurantiacum (Accession No . D58420; Nukleinsäure: SEQ. ID. No. 5, Protein SEQ ID No . 6),Agrobacterium aurantiacum (Accession No. D58420; nucleic acid: SEQ. ID. No. 5, protein SEQ ID No. 6),
Alicaligenes spec . (Accession No . D58422; Nukleinsäure: SEQ ID No. 7, Protein SEQ ID No . 8),Alicaligenes spec. (Accession No. D58422; nucleic acid: SEQ ID No. 7, protein SEQ ID No. 8),
Paracoccus marcusii (Accession No. Y15112; Nukleinsäure:Paracoccus marcusii (Accession No. Y15112; nucleic acid:
SEQ ID No. 9, Protein SEQ ID No . 10). xSEQ ID No. 9, protein SEQ ID No. 10). x
Synechocystis sp . Strain PC6803 (Accession No. S76617, NP442491; Nukleinsäure: SEQ ID No . 11, Protein SEQ ID Nό . 12) .Synechocystis sp. Strain PC6803 (Accession No. S76617, NP442491; nucleic acid: SEQ ID No. 11, protein SEQ ID Nό. 12).
Bradyrhizobium sp. (Accession No. AF218415, BAB 74888; Nukleinsäure: SEQ ID No. 13, Protein SEQ ID No . 14).Bradyrhizobium sp. (Accession No. AF218415, BAB 74888; nucleic acid: SEQ ID No. 13, protein SEQ ID No. 14).
Nostoc sp. Strain PCC7120 (Accession No. AP003592; Nukleinsäure: SEQ ID No. 15, Protein SEQ ID No. 16).Nostoc sp. Strain PCC7120 (Accession No. AP003592; nucleic acid: SEQ ID No. 15, protein SEQ ID No. 16).
Haematococcus pluvialis (Accession NO: AF534876, AAN03484; Nukleinsäure: SEQ ID NO: 37, Protein: SEQ ID NO : 38)Haematococcus pluvialis (Accession NO: AF534876, AAN03484; nucleic acid: SEQ ID NO: 37, protein: SEQ ID NO: 38)
Paracoccus sp. MBIC1143 (Accession NO: D58420, P54972; Nukleinsäure: SEQ ID NO: 39, Protein: SEQ ID NO: 40)Paracoccus sp. MBIC1143 (Accession NO: D58420, P54972; nucleic acid: SEQ ID NO: 39, protein: SEQ ID NO: 40)
Brevundimonas aurantiaca (Accession NO: AY166610, AAN86030; Nukleinsäure: SEQ ID NO: 41, Protein: SEQ ID NO: 42)Brevundimonas aurantiaca (Accession NO: AY166610, AAN86030; Nucleic acid: SEQ ID NO: 41, Protein: SEQ ID NO: 42)
Nodularia spu igena NSOR10 (Accession NO: AY210783, AA064399; Nukleinsäure: SEQ ID NO: 43, Protein: SEQ ID NO: 44)Nodularia spu igena NSOR10 (Accession NO: AY210783, AA064399; nucleic acid: SEQ ID NO: 43, protein: SEQ ID NO: 44)
Nostoc punctiforme ATCC 29133 (Accession NO: NZ_AABC01000195 , ZP_00111258; Nukleinsäure: SEQ ID NO: 45, Protein: SEQ ID NO: 46) Nostoc punctiforme ATCC 29133 (Accession NO: NZ_AABC01000196 ; Nukleinsäure: SEQ ID NO: 47, Protein: SEQ ID NO: 48)Nostoc punctiforme ATCC 29133 (Accession NO: NZ_AABC01000195, ZP_00111258; nucleic acid: SEQ ID NO: 45, protein: SEQ ID NO: 46) Nostoc punctiforme ATCC 29133 (Accession NO: NZ_AABC01000196; nucleic acid: SEQ ID NO: 47, protein: SEQ ID NO: 48)
Deinococcus radiodurans Rl (Accession NO: E75561, AE001872; Nu- kleinsäure: SEQ ID NO: 49, Protein: SEQ ID NO: 50)Deinococcus radiodurans Rl (Accession NO: E75561, AE001872; nucleic acid: SEQ ID NO: 49, protein: SEQ ID NO: 50)
Weitere natürliche Beispiele für Ketolasen und Ketolase-Gene, die im erfindungsgemäßen Verfahren verwendet werden können, lassen sich beispielsweise aus verschiedenen Organismen, deren genomi- sehe Sequenz bekannt ist, durch Identitätsvergleiche der Aminosäuresequenzen oder der entsprechenden rückübersetzten Nuklein- säuresequenzen aus Datenbanken mit den vorstehend beschriebenen Sequenzen und insbesondere mit den Sequenzen SEQ ID NO. 2 und/ oder SEQ ID NO. 16 leicht auffinden.Further natural examples of ketolases and ketolase genes which can be used in the process according to the invention can be obtained, for example, from different organisms, the genome sequence of which is known, by comparing the identity of the amino acid sequences or the corresponding back-translated nucleic acid sequences from databases with the databases described above Sequences and in particular with the sequences SEQ ID NO. 2 and / or SEQ ID NO. 16 easy to find.
Weitere natürliche Beispiele für Ketolasen und Ketolase-Gene lassen sich weiterhin ausgehend von den vorstehend beschriebenen Nukleinsäuresequenzen, insbesondere ausgehend von den Sequenzen SEQ ID. No 1 und/oder SEQ ID NO. 15 aus verschiedenen Organismen, deren genomische Sequenz nicht bekannt ist, durch Hybridisie- rungstechniken in an sich bekannter Weise leicht auffinden. xFurther natural examples of ketolases and ketolase genes can also be derived from the nucleic acid sequences described above, in particular from the sequences SEQ ID. No 1 and / or SEQ ID NO. 15 from different organisms, the genomic sequence of which is not known, can easily be found by hybridization techniques in a manner known per se. x
Die Hybridisierung kann unter moderaten (geringe Stringenz) oder vorzugsweise unter stringenten (hohe Stringenz) Bedingungen erfolgen.The hybridization can take place under moderate (low stringency) or preferably under stringent (high stringency) conditions.
Solche Hybridisierungsbedingungen sind beispielsweise bei Sam- brook, J., Fritsch, E.F., Maniatis, T. , in: Molecular Cloning (A Laboratory Manual), 2. Auflage, Gold Spring Harbor Laboratory Press, 1989, Seiten 9.31-9.57 oder in Current Protocols in Molecular Biology, John Wiley & Sons, N.Y. (1989), 6.3.1-6.3.6 beschrieben.Such hybridization conditions are described, for example, by Sambrook, J., Fritsch, EF, Maniatis, T., in: Molecular Cloning (A Laboratory Manual), 2nd edition, Gold Spring Harbor Laboratory Press, 1989, pages 9.31-9.57 or in Current Protocols in Molecular Biology, John Wiley & Sons, NY (1989), 6.3.1-6.3.6.
Beispielhaft können die Bedingungen während des Waschschrittes ausgewählt sein aus dem Bereich von Bedingungen begrenzt von solchen mit geringer Stringenz (mit 2X SSC bei 50°C) und solchen mit hoher Stringenz (mit 0.2X SSC bei 50°C, bevorzugt bei 65°C) (20X SSC: 0,3 M Natriumeitrat, 3 M Natriumchlorid, pH 7.0).For example, the conditions during the washing step can be selected from the range of conditions limited by those with low stringency (with 2X SSC at 50 ° C) and those with high stringency (with 0.2X SSC at 50 ° C, preferably at 65 ° C) (20X SSC: 0.3 M sodium citrate, 3 M sodium chloride, pH 7.0).
Darüberhinaus kann die Temperatur während des Waschschrittes von moderaten Bedingungen bei Raumtemperatur, 22°C, bis zu stringenten Bedingungen bei 65°C angehoben werden.In addition, the temperature during the washing step can be raised from moderate conditions at room temperature, 22 ° C, to stringent conditions at 65 ° C.
Beide Parameter, Salzkonzentration und Temperatur, können gleich- zeitig variiert werden, auch kann einer der beiden Parameter konstant gehalten und nur der andere variiert werden. Während der Hybridisierung können auch denaturierende Agenzien wie zum Bei- spiel Formamid oder SDS eingesetzt werden. In Gegenwart von 50 R Formamid wird die Hybridisierung bevorzugt bei 42°C ausgeführt.Both parameters, salt concentration and temperature, can be varied at the same time, one of the two parameters can also be kept constant and only the other can be varied. During the hybridization, denaturing agents such as Formamide or SDS can be used. In the presence of 50 R formamide, the hybridization is preferably carried out at 42 ° C.
Einige beispielhafte Bedingungen für Hybridisierung und Wasch- schritt sind infolge gegeben:Some exemplary conditions for hybridization and washing step are given as a result:
(1) Hybridisierungsbedingungen mit zum Beispiel(1) Hybridization conditions with, for example
(i) 4X SSC bei 65°c oder(i) 4X SSC at 65 ° C or
(ii) 6X SSC bei 45°C, oder(ii) 6X SSC at 45 ° C, or
(iii) 6X SSC bei 68°C, 100 mg/ml denaturierter Fischsperma- DNA, oder(iii) 6X SSC at 68 ° C, 100 mg / ml denatured fish sperm DNA, or
(iv) 6X SSC, 0,5 % SDS, 100 mg/ml denaturierte, fragmentierte Lachssperma-DNA bei 68°C, oder(iv) 6X SSC, 0.5% SDS, 100 mg / ml denatured, fragmented salmon sperm DNA at 68 ° C, or
(v) 6XSSC, 0,5 % SDS, 100 mg/ml denaturierte, fragmentierte Lachssperma-DNA, 50 % Formamid bei 42°C, oder(v) 6XSSC, 0.5% SDS, 100 mg / ml denatured, fragmented salmon sperm DNA, 50% formamide at 42 ° C, or
(vi) 50 % Formamid, 4X SSC bei 42°C, oder(vi) 50% formamide, 4X SSC at 42 ° C, or
(vii) 50 % (vol/vol) Formamid, 0,1 % Rinderseru albumin, 0,1 % Ficoll, 0,1 % Polyvinylpyrrolidon, 50 mM Natrium- phosphatpuffer pH 6 , 5 , 750 mM NaCl, 75 mM Natriumeitrat bei 42°C, oder(vii) 50% (vol / vol) formamide, 0.1% bovine serum albumin, 0.1% Ficoll, 0.1% polyvinylpyrrolidone, 50 mM sodium phosphate buffer pH 6.5, 750 mM NaCl, 75 mM sodium citrate at 42 ° C, or
(viii) 2X oder 4X SSC bei 50°C (moderate Bedingungen) , oder(viii) 2X or 4X SSC at 50 ° C (moderate conditions), or
(ix) 30 bis 40 % Formamid, 2X oder 4X SSC bei 42° (moderate Bedingungen) .(ix) 30 to 40% formamide, 2X or 4X SSC at 42 ° (moderate conditions).
(2) Waschschritte für jeweils 10 Minuten mit zum Beispiel(2) washing steps for 10 minutes each with for example
(i) 0,015 M aCl/0,0015 M Natriumeitrat/0 , 1 % SDS bei 50°C, oder(i) 0.015 M aCl / 0.0015 M sodium citrate / 0.1% SDS at 50 ° C, or
(ii) 0,1X SSC bei 65°C, oder(ii) 0.1X SSC at 65 ° C, or
(iii) 0,1X SSC, 0.5 % SDS bei 68°C, oder(iii) 0.1X SSC, 0.5% SDS at 68 ° C, or
(iv) 0,1X SSC, 0.5 % SDS, 50 % Formamid bei 42°C, oder(iv) 0.1X SSC, 0.5% SDS, 50% formamide at 42 ° C, or
(v) 0,2X SSC, 0.1 % SDS bei 42°C, oder (vi) 2X SSC bei 65°C (moderate Bedingungen) .(v) 0.2X SSC, 0.1% SDS at 42 ° C, or (vi) 2X SSC at 65 ° C (moderate conditions).
In einer bevorzugten Ausführungsform der erfindungsgemäßen Verfahrens bringt man Nukleinsäuren ein, die ein Protein kodieren, enthaltend die Aminosäuresequenz SEQ ID NO. 2 oder eine von dieser Sequenz durch Substitution, Insertion oder Deletion von Aminosäuren abgeleitete Sequenz, die eine Identität von mindestens 20 %, vorzugsweise mindestens 30 %, bevorzugter mindestens 40 %, bevorzugter mindestens 50 %, bevorzugter mindestens 60 %, bevor- zugter mindestens 70 %, bevorzugter mindestens 80 %, besonders bevorzugt mindestens 90 % auf Aminosäureebene mit der Sequenz SEQ ID NO. 2 und die enzymatische Eigenschaft einer Ketolase aufweist .In a preferred embodiment of the method according to the invention, nucleic acids are encoded which encode a protein containing the amino acid sequence SEQ ID NO. 2 or a sequence derived from this sequence by substitution, insertion or deletion of amino acids and having an identity of at least 20%, preferably at least 30%, more preferably at least 40%, more preferably at least 50%, more preferably at least 60%, preferably at least 70 %, more preferably at least 80%, particularly preferably at least 90% at the amino acid level with the sequence SEQ ID NO. 2 and has the enzymatic property of a ketolase.
Dabei kann es sich um eine natürliche Ketolase-Sequenz handeln, die wie vorstehend beschrieben durch Identitätsvergleich der Sequenzen aus anderen Organismen gefunden werden kann oder um eine künstliche Ketolase-Sequenz die ausgehend von der Sequenz SEQ ID NO. 2 durch künstliche Variation, beispielsweise durch Substitution, Insertion oder Deletion von Aminosäuren abgewandelt wurde.This can be a natural ketolase sequence that can be found as described above by comparing the identity of the sequences from other organisms or an artificial ketolase sequence that starts from the sequence SEQ ID NO. 2 has been modified by artificial variation, for example by substitution, insertion or deletion of amino acids.
In einer weiteren bevor-zugten Ausführungsform der erfindungsgemäßen Verfahren bringt man man Nukleinsäuren ein, die ein Pro- tein kodieren, enthaltend die Aminosäuresequenz SEQ ID NO. 16 oder eine von dieser Sequenz durch Substitution, Insertion oder Deletion von Aminosäuren abgeleitete Sequenz, die eine Identität von mindestens 20 %, vorzugsweise mindestens 30 %, bevorzugter mindestens 40 %, bevorzugter mindestens 50 %, bevorzugter minde- stens 60 %, bevorzugter mindestens 70 %, bevorzugter mindestens 80 %, besonders bevorzugt mindestens 90 % auf Aminosäureebene mit der Sequenz SEQ ID NO. 16 und die enzymatische Eigenschaft einer Ketolase aufweist.In a further preferred embodiment of the method according to the invention, nucleic acids are encoded which encode a protein containing the amino acid sequence SEQ ID NO. 16 or a sequence derived from this sequence by substitution, insertion or deletion of amino acids, which has an identity of at least 20%, preferably at least 30%, more preferably at least 40%, more preferably at least 50%, more preferably at least 60%, more preferably at least 70 %, more preferably at least 80%, particularly preferably at least 90% at the amino acid level with the sequence SEQ ID NO. 16 and has the enzymatic property of a ketolase.
Dabei kann es sich um eine natürliche Ketolase-Sequenz handeln, die wie vorstehend beschrieben durch Identitätsvergleich der Sequenzen aus anderen Organismen gefunden werden kann oder um eine künstliche Ketolase-Sequenz die ausgehend von der Sequenz SEQ ID NO. 16 durch künstliche Variation, beispielsweise durch Substitution, Insertion oder Deletion von Aminosäuren abgewandelt wurde .This can be a natural ketolase sequence that can be found as described above by comparing the identity of the sequences from other organisms or an artificial ketolase sequence that starts from the sequence SEQ ID NO. 16 was modified by artificial variation, for example by substitution, insertion or deletion of amino acids.
Unter dem Begriff "Substitution" ist in der Beschreibung der Austausch einer oder mehrerer Aminosäuren durch eine oder mehrere Aminosäuren zu verstehen. Bevorzugt werden sog. konservative Austausche durchgeführt, bei denen die ersetzte Aminosäure eine ähnliche Eigenschaft hat wie die ursprüngliche Aminosäure, beispielsweise Austausch von Glu durch Asp, Gin durch Asn, Val durch Ile, Leu durch Ile, Ser durch Thr .In the description, the term “substitution” is to be understood as meaning the replacement of one or more amino acids by one or more amino acids. So-called conservative exchanges are preferably carried out, in which the replaced amino acid has a similar property to the original amino acid, for example exchange of Glu by Asp, Gin by Asn, Val by Ile, Leu by Ile, Ser by Thr.
Deletion ist das Ersetzen einer Aminosäure durch eine direkte Bindung. Bevorzugte Positionen für Deletionen sind die Termini des Polypeptides und die Verknüpfungen zwischen den einzelnen Proteindomänen.Deletion is the replacement of an amino acid with a direct link. Preferred positions for deletions are the termini of the polypeptide and the links between the individual protein domains.
Insertionen sind Einfügungen von Aminosäuren in die Polypeptid- kette, wobei formal eine direkte Bindung durch ein oder mehrere Aminosäuren ersetzt wird.Inserts are insertions of amino acids into the polypeptide chain, whereby a direct bond is formally replaced by one or more amino acids.
Unter Identität zwischen zwei Proteinen wird die Identität der Aminosäuren über die jeweils gesamte Proteinlänge verstanden, insbesondere die Identität die durch Vergleich mit Hilfe der Lasergene Software der Firma DNASTAR, inc.Madison, Wisconsin (USA) unter Anwendung der Clustal Methode (Higgins DG, Sharp PM. Fast and sensitive multiple sequence alignments on a microcompu- ter. Comput Appl. Biosci. 1989 Apr; 5 (2 ) : 151-1) unter Einstellung folgender Parameter berechnet wird: xIdentity between two proteins is understood to mean the identity of the amino acids over the respective total protein length, in particular the identity that is obtained by comparison using the laser gene software from DNASTAR, inc. Madison, Wisconsin (USA) using the clustal method (Higgins DG, Sharp PM. Fast and sensitive multiple sequence alignments on a microcomputer. Comput Appl. Biosci. 1989 Apr; 5 (2): 151-1) is calculated using the following parameters: x
Multiple align ent parameter:Multiple align ent parameters:
Gap penalty 10 Gap length penalty 10Gap penalty 10 Gap length penalty 10
Pairwise alignment parameter:Pairwise alignment parameters:
K-tuple 1K-tuple 1
Gap penalty 3Gap penalty 3
Window 5 Diagonals saved 5Window 5 Diagonals saved 5
Unter einem Protein, das eine Identität von mindestens 20 % auf Aminosäureebene mit der Sequenz SEQ ID NO. 2 oder 16 aufweist, wird dementsprechend ein Protein verstanden, das bei einem Vergleich seiner Sequenz mit der Sequenz SEQ ID NO. 2 oder 16, insbesondere nach obigen Programmalgorithmus mit obigem Parametersatz eine Identität von mindestens 20 % aufweist.Under a protein that has an identity of at least 20% at the amino acid level with the sequence SEQ ID NO. 2 or 16, a protein is accordingly understood which, when its sequence is compared with the sequence SEQ ID NO. 2 or 16, in particular according to the above program algorithm with the above parameter set, has an identity of at least 20%.
Geeignete Nukleinsäuresequenzen sind beispielsweise durch Rück- Übersetzung der Polypeptidsequenz gemäß dem genetischen Code erhältlich.Suitable nucleic acid sequences can be obtained, for example, by back-translating the polypeptide sequence in accordance with the genetic code.
Bevorzugt werden dafür solche Kodons verwendet, die entsprechend der pflanzespezifischen codon usage häufig verwendet werden. Die codon usage lässt sich anhand von Computerauswertungen anderer, bekannter Gene der betreffenden Organismen leicht ermitteln. In einer besonders bevorzugten Ausführungsform bringt man eine Nukleinsäure, enthaltend die Sequenz SEQ ID NO. 1, in den Pflanze ein.Those codons which are frequently used in accordance with the plant-specific codon usage are preferably used for this. The codon usage can easily be determined on the basis of computer evaluations of other known genes of the organisms concerned. In a particularly preferred embodiment, a nucleic acid containing the sequence SEQ ID NO is brought. 1, in the plant.
In einer weiteren besonders bevorzugten Ausführungsform bringt man eine Nukleinsäure, enthaltend die Sequenz SEQ ID NO. 15, in den Pflanze ein.In a further particularly preferred embodiment, a nucleic acid containing the sequence SEQ ID NO is brought. 15, in the plant.
Alle vorstehend erwähnten Ketolase-Gene sind weiterhin in an sich bekannter Weise durch chemische Synthese aus den Nukleotidbau- steinen wie beispielsweise durch Fragmentkondensation einzelner überlappender, komplementärer Nukleinsäurebausteine der Doppel- helix herstellbar. Die chemische Synthese von Oligonukleotiden kann beispielsweise, in bekannter Weise, nach der Phosphoamidit- methode (Voet, Voet, 2. Auflage, Wiley Press New York, SeiteAll of the above-mentioned ketolase genes can also be produced in a manner known per se by chemical synthesis from the nucleotide building blocks, for example by fragment condensation of individual overlapping, complementary nucleic acid building blocks of the double helix. The chemical synthesis of oligonucleotides can, for example, in a known manner, according to the phosphoamidite method (Voet, Voet, 2nd edition, Wiley Press New York, page
896-897) erfolgen. Die Anlagerung synthetischer Oligonukleotide und Auffüllen von Lücken mithilfe des Klenow-Fragmentes der DNA-896-897). The attachment of synthetic oligonucleotides and the filling of gaps using the Klenow fragment of the DNA
Polymerase und Ligationsreaktionen sowie allgemeine Klonierungs- verfahren werden in Sambrook et al . (1989), Molecular cloning: A laboratory manual, Cold Spring Harbor Laboratory Press, beschrieben. xPolymerase and ligation reactions as well as general cloning procedures are described in Sambrook et al. (1989) Molecular cloning: A laboratory manual, Cold Spring Harbor Laboratory Press. x
In einer besonderes bevorzugten Ausführungsform der erfindungsgemäßen Verfahrens verwendet man genetisch veränderte Pflanzen, die in Früchten die höchste Expressionsrate einer Ketolase aufweisen.In a particularly preferred embodiment of the method according to the invention, genetically modified plants are used which have the highest expression rate of a ketolase in fruits.
Vorzugsweise wird dies dadurch erreicht, dass die Genexpression der Ketolase unter Kontrolle eines fruchtspezifischen Promotors erfolgt. Beispielsweise werden dazu die vorstehend beschriebenen Nukleinsäuren, wie nachstehend ausführlich beschrieben, in einem Nukleinsäurekonstrukt, funktioneil verknüpft mit einem fruchtspezifischen Promotor, in die Pflanze eingebracht.This is preferably achieved in that the gene expression of the ketolase takes place under the control of a fruit-specific promoter. For example, the nucleic acids described above, as described in detail below, are introduced into the plant in a nucleic acid construct, functionally linked to a fruit-specific promoter.
Unter Pflanzen werden erfindungsgemäß vorzugsweise Pflanzen verstanden, die als Wildtyp in Früchten Chromoplasten aufweisen.According to the invention, plants are preferably understood to mean plants which have chromoplasts as wild type in fruits.
Weiter bevorzugte Pflanzen weisen als Wildtyp in den Früchten zusätzlich Carotinoide, insbesondere ß-Carotin, Zeaxanthin, Neo- xanthin, Violaxanthin oder Lutein auf.Further preferred plants have, as wild type in the fruit, carotenoids, in particular β-carotene, zeaxanthin, neoxanthine, violaxanthin or lutein.
Weiter bevorzugte Pflanzen weisen als Wildtyp in den Früchten zusätzlich eine Hydroxylase-Aktivität auf.Further preferred plants have a hydroxylase activity as wild type in the fruit.
Unter Hydroxylase-Aktivität wird die Enzymaktivität einer Hydro- xylase verstanden. Unter einer Hydroxylase wird ein Protein verstanden, das die enzymatische Aktivität aufweist, am, gegebenenfalls substituierten, ß-Ionon-Ring von Carotinoiden eine Hydroxy-Gruppe einzuführen.Hydroxylase activity means the enzyme activity of a hydroxylase. A hydroxylase is understood to mean a protein which has the enzymatic activity of introducing a hydroxyl group on the optionally substituted β-ionone ring of carotenoids.
Insbesondere wird unter einer Hydroxylase ein Protein verstanden, das die enzymatische Aktivität aufweist, ß-Carotin in Zeaxanthin oder Canthaxanthin in Astaxanthin umzuwandeln.In particular, a hydroxylase is understood to mean a protein which has the enzymatic activity to convert β-carotene into zeaxanthin or canthaxanthin into astaxanthin.
Dementsprechend wird unter Hydroxylase-Aktivität die in einer bestimmten Zeit durch das Protein Hydroxylase umgesetzte Menge ß-Carotin oder Canthaxanthin bzw. gebildete Menge Zeaxanthin oder Astaxanthin verstanden.Accordingly, hydroxylase activity is understood to mean the amount of β-carotene or canthaxanthin converted or the amount of zeaxanthin or astaxanthin formed in a certain time by the protein hydroxylase.
In einer bevorzugten Ausführungsform werden Pflanzen kultiviert, die gegenüber dem Wildtyp zusätzlich eine erhöhte Hydroxylase-Aktivität und/oder ß-Cyclase-Aktivität aufweisen.In a preferred embodiment, plants are cultivated which, in addition to the wild type, have an increased hydroxylase activity and / or β-cyclase activity.
Unter Hydroxylase-Aktivität wird die Enzymaktivität einer Hydro- xylase verstanden.Hydroxylase activity means the enzyme activity of a hydroxylase.
Unter einer Hydroxylase wird ein Protein verstanden, das die enzymatische Aktivität aufweist, am, gegebenenfalls substituierten, ß-Ionon-Ring von Carotinoiden eine Hydroxy-Gruppe einzuführen.A hydroxylase is understood to mean a protein which has the enzymatic activity of introducing a hydroxyl group on the optionally substituted β-ionone ring of carotenoids.
Insbesondere wird unter einer Hydroxylase ein Protein verstanden, das die enzymatische Aktivität aufweist, ß-Carotin in Zeaxanthin oder Cantaxanthin in Astaxanthin umzuwandeln.In particular, a hydroxylase is understood to mean a protein which has the enzymatic activity to convert β-carotene into zeaxanthin or cantaxanthin into astaxanthin.
Dementsprechend wird unter Hydroxyase-Aktivität die in einer bestimmten Zeit durch das Protein Hydroxylase umgesetzte Menge ß-Carotin oder Cantaxanthin bzw. gebildete Menge Zeaxanthin oder Astaxanthin verstanden.Accordingly, hydroxyase activity is understood to mean the amount of β-carotene or cantaxanthin converted or the amount of zeaxanthin or astaxanthin formed in a certain time by the protein hydroxylase.
Bei einer erhöhten Hydroxylase-Aktivität gegenüber dem Wildtyp wird somit im Vergleich zum Wildtyp in einer bestimmten Zeit durch das Protein Hydroxylase die umgesetzte Menge ß-Carotin oder Cantaxantin bzw. die gebildete Menge Zeaxanthin oder Astaxanthin erhöht .With an increased hydroxylase activity compared to the wild type, the amount of β-carotene or cantaxantin or the amount of zeaxanthin or astaxanthin formed is increased in a certain time by the protein hydroxylase compared to the wild type.
Vorzugsweise beträgt diese Erhöhung der Hydroxylase-Aktivität mindestens 5 %, weiter bevorzugt mindestens 20 %, weiter bevorzugt mindestens 50 %, weiter bevorzugt mindestens 100 %, bevorzugter mindestens 300 %, noch bevorzugter mindestens 500 %, ins- besondere mindestens 600 % der Hydroxylase-Aktivität des Wildtyps. Unter ß-Cyclase-Aktivität wird die Enzymaktivität einer ß-Cyclase verstanden.This increase in hydroxylase activity is preferably at least 5%, more preferably at least 20%, more preferably at least 50%, more preferably at least 100%, more preferably at least 300%, even more preferably at least 500%, in particular at least 600% of the hydroxylase Wild type activity. Β-cyclase activity means the enzyme activity of a β-cyclase.
Unter einer ß-Cyclase wird ein Protein verstanden, das die enzyma- tische Aktivität aufweist, einen endständigen, linearen Rest von Lycopin in einen ß-Ionon-Ring zu überführen.A ß-cyclase is understood to be a protein which has the enzymatic activity to convert a terminal, linear residue of lycopene into a ß-ionone ring.
Insbesondere wird unter einer ß-Cyclase ein Protein verstanden, das die enzymatische Aktivität aufweist, γ-Carotin in ß-Carotin umzuwandeln.In particular, a β-cyclase is understood to be a protein which has the enzymatic activity to convert γ-carotene into β-carotene.
Dementsprechend wird unter ß-Cyclase-Aktivität die in einer bestimmten Zeit durch das Protein ß-Cyclase umgesetzte Menge γ-Caro- tin bzw. gebildete Menge ß-Carotin verstanden.Accordingly, β-cyclase activity is understood to mean the amount of γ-carotene converted or the amount of β-carotene formed in a certain time by the protein ß-cyclase.
Bei einer erhöhten ß-Cyclase -Aktivität gegenüber dem Wildtyp wird somit im Vergleich zum Wildtyp in einer bestimmten Zeit durch das Protein ß-Cyclase die umgesetzte Menge γ-Carotin bzw. die gebildete Menge ß-Carotin erhöht.If the β-cyclase activity is higher than that of the wild type, the amount of γ-carotene converted or the amount of β-carotene formed is increased by the protein ß-cyclase in a certain time compared to the wild type.
Vorzugsweise beträgt diese Erhöhung der ß-Cyclase-Aktivität mindestens 5 %, weiter bevorzugt mindestens 20 %, weiter bevorzugt mindestens 50 %, weiter bevorzugt mindestens 100 %, bevorzugter mindestens 300 %, noch bevorzugter mindestens 500 %, insbesondere mindestens 600 % der ß-Cyclase-Aktivität des Wildtyps.This increase in the β-cyclase activity is preferably at least 5%, more preferably at least 20%, more preferably at least 50%, more preferably at least 100%, more preferably at least 300%, even more preferably at least 500%, in particular at least 600% of the β- Wild-type cyclase activity.
Unter dem Begriff "Wildtyp" wird erfindungsgemäß die entsprechende nicht genetisch veränderte Ausgangspflanze verstanden.According to the invention, the term “wild type” is understood to mean the corresponding non-genetically modified starting plant.
Vorzugsweise und insbesondere in Fällen, in denen die Pflanze oder der Wildtyp nicht eindeutig zugeordnet werden kann, wird unter "Wildtyp" für die Erhöhung der Hydroxylase-Aktivität, für die Erhöhung der ß-Cyclase-Aktivität und für die Erhöhung des Gehalts an Ketocarotinoiden jeweils eine Referenzpflanze verstanden.Preferably and in particular in cases in which the plant or the wild type cannot be clearly assigned, “wild type” is used to increase the hydroxylase activity, to increase the β-cyclase activity and to increase the ketocarotenoid content in each case understood a reference plant.
Diese Referenzpflanze ist vorzugsweise Lycopersicon esculentum.This reference plant is preferably Lycopersicon esculentum.
Die Bestimmung der Hydroxylase-Aktivität in erfindungsgemäßen genetisch veränderten Pflanzen und in Wildtyp- bzw. Referenzpflan- zen erfolgt vorzugsweise unter folgenden Bedingungen:The hydroxylase activity in genetically modified plants according to the invention and in wild-type or reference plants is preferably determined under the following conditions:
Die Aktivität der Hydroxylase wird nach Bouvier et al . (Biochim. Biophys. Acta 1391 (1998), 320-328) in vi tro bestimmt. Es wird zu einer bestimmten Menge an Pflanzenextrakt Ferredoxin, Ferredoxin- NADP Oxidoreductase, Katalase, NADPH sowie beta-Carotin mit Mono- und Digalaktpsylglyzeriden zugegeben. Besonders bevorzugt erfolgt die Bestimmung der Hydroxylase-Aktivität unter folgenden Bedingungen nach Bouvier, Keller, d'Harlin- gue und Camara (Xanthophyll biosynthesis : molecular and functio- nal characterization of carotenoid hydroxylases from pepper 5 fruits (Capsicum annuum L.; Biochim. Biophys . Acta 1391 (1998), 320-328) :The activity of the hydroxylase is according to Bouvier et al. (Biochim. Biophys. Acta 1391 (1998), 320-328) in vi tro. Ferredoxin, ferredoxin-NADP oxidoreductase, catalase, NADPH and beta-carotene with mono- and digalact psylglycerides are added to a certain amount of plant extract. The hydroxylase activity is particularly preferably determined under the following conditions according to Bouvier, Keller, d'Harginue and Camara (xanthophyll biosynthesis: molecular and functional characterization of carotenoid hydroxylases from pepper 5 fruits (Capsicum annuum L .; Biochim. Biophys Acta 1391 (1998) 320-328):
Der in-vitro Assay wird in einem Volumen von 0.250 ml Volumen durchgeführt. Der Ansatz enthält 50 mM Kaliumphosphat (pH 7.6),The in vitro assay is carried out in a volume of 0.250 ml volume. The batch contains 50 mM potassium phosphate (pH 7.6),
10 0.025 mg Ferredoxin von Spinat, 0.5 Einheiten Ferredoxin-NADP-t- Oxidoreduktase von Spinat, 0.25 mM NADPH, 0.010 mg beta-Carotin (in 0.1 mg Tween 80 emulgiert) , 0.05 mM einer Mischung von Mono- und Digalaktosylglyzeriden (1:1), 1 Einheit Katalyse, 200 Mono- und Digalaktosylglyzeriden, (1:1), 0.2 mg Rinderserumalbumin und10 0.025 mg ferredoxin from spinach, 0.5 units ferredoxin-NADP-t oxidoreductase from spinach, 0.25 mM NADPH, 0.010 mg beta-carotene (emulsified in 0.1 mg Tween 80), 0.05 mM a mixture of mono- and digalactosylglycerides (1: 1 ), 1 unit of catalysis, 200 mono- and digalactosylglycerides, (1: 1), 0.2 mg bovine serum albumin and
15 Pflanzenextrakt in unterschiedlichem Volumen. Die Reaktionsmischung wird 2 Stunden bei 30C inkubiert. Die Reaktionsprodukte werden mit organischem Lösungsmittel wie Aceton oder Chloroform/ Methanol (2:1) extrahiert und mittels HPLC bestimmt.15 plant extract in different volumes. The reaction mixture is incubated for 2 hours at 30C. The reaction products are extracted with organic solvent such as acetone or chloroform / methanol (2: 1) and determined by means of HPLC.
20 Die Bestimmung der ß-Cyclase-Aktivität in erfindungsgemäßen genetisch veränderten Pflanzen und in Wildtyp- bzw. Referenzpflanzen erfolgt vorzugsweise unter folgenden Bedingungen:The determination of the β-cyclase activity in genetically modified plants according to the invention and in wild-type or reference plants is preferably carried out under the following conditions:
Die Aktivität der ß-Cyclase wird nach Fräser und Sandmann (Bio- 25 ehem. Biophys. Res . Comm. 185(1) (1992) 9-15) in vitro bestimmt. Es werden zu einer bestimmten Menge an Pflanzenextrakt Kalium- phosphat als Puffer (ph 7.6), Lycopin als Substrat, Stromaprotein von Paprika, NADP+, NADPH und ATP zugegeben.The activity of the β-cyclase is determined in vitro according to Fräser and Sandmann (Bio-25 formerly Biophys. Res. Comm. 185 (1) (1992) 9-15). Potassium phosphate as a buffer (pH 7.6), lycopene as a substrate, paprika stromal protein, NADP +, NADPH and ATP are added to a certain amount of plant extract.
30 Besonders bevorzugt erfolgt die Bestimmung der Hydroxylase-Aktivität unter folgenden Bedingungen nach Bouvier, d'Harlingue und Camara (Molecular Analysis of carotenoid cyclae inhibition; Aren. Biochem. Biophys. 346(1) (1997) 53-64):30 The hydroxylase activity is particularly preferably determined under the following conditions according to Bouvier, d'Harlingue and Camara (Molecular Analysis of carotenoid cyclae inhibition; Aren. Biochem. Biophys. 346 (1) (1997) 53-64):
35 Der in-vitro Assay wird in einem Volumen von 250 °=1 Volumen durchgeführt. Der Ansatz enthält 50 mM Kaliumphosphat (pH 7.6) »unterschiedliche Mengen an Pflanzenextrakt, 20 nM Lycopin, 250 °=g an chromoplastidärem Stromaprotein aus Paprika, 0.2 mM NADP+, 0.2 mM NADPH und 1 mM ATP. NADP/NADPH und ATP werden in35 The in vitro assay is carried out in a volume of 250 ° = 1 volume. The mixture contains 50 mM potassium phosphate (pH 7.6) » different amounts of plant extract, 20 nM lycopene, 250 ° = g of chromoplastidic stromal protein from paprika, 0.2 mM NADP +, 0.2 mM NADPH and 1 mM ATP. NADP / NADPH and ATP are in
40 10 ml Ethanol mit 1 mg Tween 80 unmittelbar vor der Zugabe zum Inkubationsmedium gelöst. Nach einer Reaktionszeit von 60 Minuten bei 30C wird die Reaktion durch Zugabe von Chloroform/Methanol (2:1) beendet. Die in Chloroform extrahierten Reaktionsprodukte werden mittels HPLC analysiert.40 10 ml ethanol dissolved with 1 mg Tween 80 immediately before adding to the incubation medium. After a reaction time of 60 minutes at 30C, the reaction is ended by adding chloroform / methanol (2: 1). The reaction products extracted in chloroform are analyzed by HPLC.
45 Ein alternativer Assay mit radioaktivem Substrat ist beschrieben in Fräser und Sandmann (Biochem. Biophys. Res . Comm. 185(1) (1992) 9-15) .45 An alternative assay with a radioactive substrate is described in Fräser and Sandmann (Biochem. Biophys. Res. Comm. 185 (1) (1992) 9-15).
Die Erhöhung der Hydroxylase-Aktivität und/oder ß-Cyclase-Aktivität kann durch verschiedene Wege erfolgen, beispielsweise durch Ausschalten von hemmenden Regulationsmechanismen auf Expressionsund Proteinebene oder durch Erhöhung der Genexpression von Nukleinsäuren kodierend eine Hydroxylase und/oder von Nukleinsäuren kodierend eine ß-Cyclase gegenüber dem Wildtyp.The hydroxylase activity and / or β-cyclase activity can be increased in various ways, for example by switching off inhibitory regulatory mechanisms at the expression and protein level or by increasing the gene expression of nucleic acids encoding a hydroxylase and / or of nucleic acids encoding a β-cyclase the wild type.
Die Erhöhung der Genexpression der Nukleinsäuren kodierend eine Hydroxylase und/oder die Erhöhung der Genexpression der Nukleinsäure kodierend eine ß-Cyclase gegenüber dem Wildtyp kann eben- falls durch verschiedene Wege erfolgen, beispielsweise durch Induzierung des Hydroxylase-Gens und/oder ß-Cyclase-Gens durch Aktivatoren oder durch Einbringen von einer oder mehrerer Hydroxy- lase-Genkopien und/oder ß-Cyclase-Genkopien, also durch Einbringen mindestens einer Nukleinsäure kodierend eine Hydroxylase und/oder mindestens einer Nukleinsäure kodierend' eine ε-Cyclase in die Pflanze.The increase in the gene expression of the nucleic acids encoding a hydroxylase and / or the increase in the gene expression of the nucleic acid encoding a β-cyclase compared to the wild type can likewise be carried out in various ways, for example by inducing the hydroxylase gene and / or β-cyclase gene by activators or by introducing one or more hydroxylase gene copies and / or β-cyclase gene copies, ie by introducing at least one nucleic acid encoding a hydroxylase and / or at least one nucleic acid encoding an ε-cyclase into the plant.
Unter Erhöhung der Genexpression einer Nukleinsäure codierend eine Hydroxylase und/oder ß-Cyclase wird erfiridungsgemäß auch die Manipulation der Expression der Pflanzen eigenen, endogenen Hydroxylase und/oder ß-Cyclase verstanden.Increasing the gene expression of a nucleic acid encoding a hydroxylase and / or β-cyclase is also understood according to the invention to mean the manipulation of the expression of the plants' own endogenous hydroxylase and / or β-cyclase.
Dies kann beispielsweise durch Veränderung der Promotor DNA-Sequenz für Hydroxylasen und/oder ß-Cyclasen kodierende Gene er- reicht werden. Eine solche Veränderung, die eine erhöhte Expressionsrate des Gens zur Folge hat, kann beispielsweise durch Deletion oder Insertion von DNA Sequenzen erfolgen.This can be achieved, for example, by changing the promoter DNA sequence for genes encoding hydroxylases and / or β-cyclases. Such a change, which results in an increased expression rate of the gene, can take place, for example, by deleting or inserting DNA sequences.
Es ist, wie vorstehend beschrieben, möglich, die Expression der endogenen Hydroxylase und/oder ß-Cyclase durch die Applikation exogener Stimuli zu verändern. Dies kann durch besondere physiologische Bedingungen, also durch die Applikation von Fremdsubstanzen erfolgen.As described above, it is possible to change the expression of the endogenous hydroxylase and / or β-cyclase by applying exogenous stimuli. This can take place through special physiological conditions, ie through the application of foreign substances.
Des weiteren kann eine veränderte bzw. erhöhte Expression eines endogenen Hydroxylase- und/oder ß-Cyclase-Gens dadurch erzielt werden, dass ein in der nicht transformierten Pflanze nicht vorkommendes Regulator-Protein mit dem Promotor dieses Gens in Wechselwirkung tritt. Solch ein Regulator kann ein chimäres Protein darstellen, welches aus einer DNA-Bindedomäne und einer Transkriptionsaktivator-Domäne besteht, wie beispielsweise in WO 96/06166 beschrieben.Furthermore, an altered or increased expression of an endogenous hydroxylase and / or β-cyclase gene can be achieved in that a regulator protein which does not occur in the non-transformed plant interacts with the promoter of this gene. Such a regulator can represent a chimeric protein which consists of a DNA binding domain and a transcription activator domain, as described for example in WO 96/06166.
In einer bevorzugten Ausführungsform erfolgt die Erhöhung der Genexpression einer Nukleinsäure kodierend eine Hydroxylase und/ oder die Erhöhung der Genexpression einer Nukleinsäure kodierend eine ß-Cyclase durch Einbringen von mindestens einer Nukleinsäure kodierend eine Hydroxylase und/oder durch Einbringen von minde- stens einer Nukleinsäure kodierend eine ß-Cyclase in die Pflanze.In a preferred embodiment, the gene expression of a nucleic acid encoding a hydroxylase is increased and / or the gene expression of a nucleic acid encoding a β-cyclase is increased by introducing at least one nucleic acid encoding a hydroxylase and / or by introducing at least one nucleic acid encoding one ß-cyclase into the plant.
Dazu kann prinzipiell jedes Hydroxylase-Gen bzw. jedes ß-Cyclase- Gen, also jede Nukleinsäure, die eine Hydroxylase und jede Nukleinsäure, die eine ß-Cyclase codiert, verwendet werden.In principle, any hydroxylase gene or each β-cyclase gene, that is to say any nucleic acid which codes for a hydroxylase and any nucleic acid which codes for a β-cyclase, can be used for this purpose.
Bei genomischen Hydroxylase-bzw. ß-Cyclase-Nukleinsäure-Sequenzen aus eukaryontischen Quellen, die Introns enthalten, sind für den Fall das die Wirtspflanze nicht in der Lage ist oder nicht in die Lage versetzt werden kann, die entsprechende Hydroxylase bzw. ß-Cyclase zu exprimieren, bevorzugt bereits prozessierte Nuklein- säuresequenzen, wie die entsprechenden cDNAs zu verwenden. xWith genomic hydroxylase or. β-cyclase nucleic acid sequences from eukaryotic sources which contain introns are preferably already processed in the event that the host plant is unable or cannot be able to express the corresponding hydroxylase or β-cyclase Nucleic acid sequences, how to use the corresponding cDNAs. x
Beispiele für Hydroxylase-Gene sind Nukleinsäuren,Examples of hydroxylase genes are nucleic acids,
kodierend eine Hydroxylase aus Haematococcus pluvialis, Accession AX038729, WO 0061764); (Nukleinsäure: SEQ ID NO: 51, Protein: SEQ ID NO: 52) ,encoding a hydroxylase from Haematococcus pluvialis, accession AX038729, WO 0061764); (Nucleic acid: SEQ ID NO: 51, protein: SEQ ID NO: 52),
sowie Hydroxylasegene der folgenden Accession Nummern:and hydroxylase genes of the following accession numbers:
|emb|CAB55626.1, CAA70427.1, CAA70888.1, CAB55625.1, AF499108_1, AF315289_1, AF296158_1, AAC49443.1, NP_194300.1, NP_200070.1, AAG10430.1, CAC06712.1, AAM88619.1, CAC95130.1, AAL80006.1, AF162276_1, AA053295.1, AAN85601.1, CRTZ_ERWHE, CRTZ_PANAN, BAB79605.1, CRTZ_ALCSP, CRTZ_AGRAU, CAB56060.1, ZP_00094836.1, AAC44852.1, BAC77670.1, NP_745389.1, NP_344225.1, NP_849490.1, ZP_00087019.1, NP_503072.1, NP_852012.1, NP_115929.1, ZP_00013255.1| emb | CAB55626.1, CAA70427.1, CAA70888.1, CAB55625.1, AF499108_1, AF315289_1, AF296158_1, AAC49443.1, NP_194300.1, NP_200070.1, AAG10430.1, CAC06712.1, AAM889519.1 .1, AAL80006.1, AF162276_1, AA053295.1, AAN85601.1, CRTZ_ERWHE, CRTZ_PANAN, BAB79605.1, CRTZ_ALCSP, CRTZ_AGRAU, CAB56060.1, ZP_00094836.1, AAC4483852.1, NPAC745370.144, NPAC745370.144 .1, NP_849490.1, ZP_00087019.1, NP_503072.1, NP_852012.1, NP_115929.1, ZP_00013255.1
Eine besonders bevorzugte Hydroxylase ist weiterhin die Hydroxylase aus Tomate) (Nukleinsäure: SEQ. ID. No . 55; Protein: SEQ. ID. No. 56) Beispiele für b-Cyclase-Gene sind Nukleinsäuren, codierend eine b-Cyclase aus Tomate (Accession X86452) . (Nukleinsäure: SEQ ID NO; 53, Protein: SEQ ID NO: 54), sowie b-Cyclase-Gene der folgenden Accession Nummern:Another particularly preferred hydroxylase is the hydroxylase from tomato) (nucleic acid: SEQ. ID. No. 55; protein: SEQ. ID. No. 56) Examples of b-cyclase genes are nucleic acids encoding a b-cyclase from tomato (Accession X86452). (Nucleic acid: SEQ ID NO; 53, protein: SEQ ID NO: 54), and b-cyclase genes of the following accession numbers:
S66350 lycopene beta-cyclase (EC 5.5.1.-) - tomatoS66350 lycopene beta-cyclase (EC 5.5.1.-) - tomato
CAA60119 lycopene synthase [Capsicum annuum]CAA60119 lycopene synthase [Capsicum annuum]
S66349 lycopene beta-cyclase (EC 5.5.1.-) - common tobacco CAA57386 lycopene cyclase [Nicotiana tabacum] AAM21152 lycopene beta-cyclase [Citrus sinensis] AAD38049 lycopene cyclase [Citrus x paradisi] AAN86060 lycopene cyclase [Citrus unshiu] AAF44700 lycopene beta-cyclase [Citrus sinensis] AAK07430 lycopene beta-cyclase [Adonis palaestina] AAG10429 beta cyclase [Tagetes erecta] AAA81880 lycopene cyclase AAB53337 Lycopene beta cyclase AAL92175 beta-lycopene cyclase [Sandersonia aurantiaca] CAA67331 lycopene cyclase [Narcissus pseudonarcissus] AAM45381 beta cyclase [Tagetes erecta] AA018661 lycopene beta-cyclase [Zea mays] AAG21133 chromoplast-specific lycopene beta-cyclaseS66349 lycopene beta-cyclase (EC 5.5.1.-) - common tobacco CAA57386 lycopene cyclase [Nicotiana tabacum] AAM21152 lycopene beta-cyclase [Citrus sinensis] AAD38049 lycopene cyclase [Citrus x paradisi] AAN86060 lycopene cyclase [Citrus unshiuuene] AAF44 -cyclase [Citrus sinensis] AAK07430 lycopene beta-cyclase [Adonis palaestina] AAG10429 beta cyclase [Tagetes erecta] AAA81880 lycopene cyclase AAB53337 Lycopene beta cyclase AAL92175 beta-lycopene cyclase [Sandersonia aurantiaca] CAA6733on lyissene] CAA67331 lycopene erecta] AA018661 lycopene beta-cyclase [Zea mays] AAG21133 chromoplast-specific lycopene beta-cyclase
[Lycopersicon esculentum][Lycopersicon esculentum]
AAF18989 lycopene beta-cyclase [Daucus carota] ZP_001140 hypothetical protein [Prochlorococcus marinus str.AAF18989 lycopene beta-cyclase [Daucus carota] ZP_001140 hypothetical protein [Prochlorococcus marinus str.
MIT9313]MIT9313]
ZP_001050 hypothetical protein [Prochlorococcus marinus subsp. pastoris str. CCMP1378]ZP_001050 hypothetical protein [Prochlorococcus marinus subsp. pastoris str. CCMP1378]
ZP_001046 hypothetical protein [Prochlorococcus marinus subsp. pastoris str. CCMP1378]ZP_001046 hypothetical protein [Prochlorococcus marinus subsp. pastoris str. CCMP1378]
ZP_001134 hypothetical protein [Prochlorococcus marinus str.ZP_001134 hypothetical protein [Prochlorococcus marinus str.
MIT9313]MIT9313]
ZP_001150 hypothetical protein [Synechococcus sp. WH 8102] AAF10377 lycopene cyclase [Deinococcus radiodurans] BAA29250 393aa long hypothetical protein [Pyrococcus horikoshii]ZP_001150 hypothetical protein [Synechococcus sp. WH 8102] AAF10377 lycopene cyclase [Deinococcus radiodurans] BAA29250 393aa long hypothetical protein [Pyrococcus horikoshii]
BAC77673 lycopene beta-monocyclase [marine bacterium P99-3] AAL01999 lycopene cyclase [Xanthobacter sp. Py2] ZP_000190 hypothetical protein [Chloroflexus aurantiacus] ZP_000941 hypothetical protein [Novosphingobium aromaticivorans ]BAC77673 lycopene beta-monocyclase [marine bacterium P99-3] AAL01999 lycopene cyclase [Xanthobacter sp. Py2] ZP_000190 hypothetical protein [Chloroflexus aurantiacus] ZP_000941 hypothetical protein [Novosphingobium aromaticivorans]
AAF78200 lycopene cyclase [Bradyrhizobium sp. ORS278] BAB79602 crtY [Pantoea agglomerans pv. milletiae] CAA64855 lycopene cyclase [Streptomyces griseus] AAA21262 dycopene cyclase [Pantoea agglomerans] C37802 crtY protein - Erwinia uredovora BAB79602 crtY [Pantoea agglomerans pv. milletiae] AAA64980 lycopene cyclase [Pantoea agglomerans]AAF78200 lycopene cyclase [Bradyrhizobium sp. ORS278] BAB79602 crtY [Pantoea agglomerans pv. Milletiae] CAA64855 lycopene cyclase [Streptomyces griseus] AAA21262 dycopene cyclase [Pantoea agglomerans] C37802 crtY protein - Erwinia uredovora BAB79602 crtYans [Pantoea millglomer. AAA64980 lycopene cyclase [Pantoea agglomerans]
AAC44851 lycopene cyclaseAAC44851 lycopene cyclase
BAA09593 Lycopene cyclase [Paracoccus sp. MBIC1143]BAA09593 Lycopene cyclase [Paracoccus sp. MBIC1143]
ZP_000941 hypothetical protein [Novosphingobium aromaticivorans]ZP_000941 hypothetical protein [Novosphingobium aromaticivorans]
CAB56061 lycopene beta-cyclase [Paracoccus marcusii]CAB56061 lycopene beta-cyclase [Paracoccus marcusii]
BAA20275 lycopene cyclase [Erythrobacter longus]BAA20275 lycopene cyclase [Erythrobacter longus]
ZP_000570 hypothetical protein [Thermobifida fusca]ZP_000570 hypothetical protein [Thermobifida fusca]
ZP_000190 hypothetical protein [Chloroflexus aurantiacus] AAK07430 lycopene beta-cyclase [Adonis palaestina]ZP_000190 hypothetical protein [Chloroflexus aurantiacus] AAK07430 lycopene beta-cyclase [Adonis palaestina]
CAA67331 lycopene cyclase [Narcissus pseudonarcissus]CAA67331 lycopene cyclase [Narcissus pseudonarcissus]
AAB53337 Lycopene beta cyclaseAAB53337 Lycopene beta cyclase
BAC77673 lycopene beta-monocyclase [marine bacterium P99-3]BAC77673 lycopene beta-monocyclase [marine bacterium P99-3]
Eine besonders bevorzugte ß-Cyclase ist weiterhin die chromopla- stenspezifische b-Cyclase aus Tomate (AAG21133) (Nukleinsäure: SEQ. ID. No. 57; Protein: SEQ. ID. No. 58)A particularly preferred β-cyclase is also the chromoplast-specific b-cyclase from tomato (AAG21133) (nucleic acid: SEQ. ID. No. 57; protein: SEQ. ID. No. 58)
In den erfindungsgemäßen bevorzugten transgenen Pflanzen liegt also in dieser bevorzugten Ausführungsform gegenüber dem Wildtyp mindestens ein weiteres Hydroxylase-Gen und/oder ß-Cyclase-Gen vor .In this preferred embodiment, the preferred transgenic plants according to the invention therefore have at least one further hydroxylase gene and / or β-cyclase gene compared to the wild type.
In dieser bevorzugten Ausführungsform weist die genetisch verän- derte Pflanze beispielsweise mindestens eine exogene Nukleinsäure, kodierend eine Hydroxylase oder mindestens zwei endogene Nukleinsäuren, kodierend eine Hydroxylase und/oder mindestens eine exogene Nukleinsäure, kodierend eine ß-Cyclase oder mindestens zwei endogene Nukleinsäuren, kodierend eine ß-Cyclase auf.In this preferred embodiment, the genetically modified plant has, for example, at least one exogenous nucleic acid, coding for a hydroxylase or at least two endogenous nucleic acids, coding for a hydroxylase and / or at least one exogenous nucleic acid, coding for a β-cyclase or at least two endogenous nucleic acids, coding for one β-cyclase.
Bevorzugt verwendet man in vorstehend beschriebener bevorzugter Ausführungsform als Hydroxylase-Gene Nukleinsäuren, die Proteine kodieren, enthaltend die Aminosäuresequenz SEQ ID NO: 52 oder eine von dieser Sequenz durch Substitution, Insertion oder Dele- tion von Aminosäuren abgeleitete Sequenz, die eine Identität von mindestens 30 %, vorzugsweise mindestens 50 %, bevorzugter mindestens 70%, noch bevorzugter mindestens 90 %, am bevorzugtesten mindestens 95 % auf Aminosäureebene mit der Sequenz SEQ. ID. NO: 52, und die die enzymatische Eigenschaft einer Hydroxylase aufweisen.In the preferred embodiment described above, nucleic acids encoding proteins are preferably used which contain the amino acid sequence SEQ ID NO: 52 or a sequence derived from this sequence by substitution, insertion or deletion of amino acids and having an identity of at least 30 %, preferably at least 50%, more preferably at least 70%, even more preferably at least 90%, most preferably at least 95% at the amino acid level with the sequence SEQ. ID. NO: 52, and which have the enzymatic property of a hydroxylase.
Weitere Beispiele für Hydroxylasen und Hydroxylase-Gene lassen sich beispielsweise aus verschiedenen Organismen, deren genomische Sequenz bekannt ist, wie vorstehend beschrieben, durch Ho- mologievergleiche der Aminosäuresequenzen oder der entsprechenden rückübersetzten Nukleinsäuresequenzen aus Datenbanken mit der SeQ ID. NO: 52 leicht auffinden.Further examples of hydroxylases and hydroxylase genes can be obtained, for example, from various organisms whose genomic sequence is known, as described above, by comparing the amino acids or the corresponding ones with homology back-translated nucleic acid sequences from databases with the SeQ ID. NO: 52 easy to find.
Weitere Beispiele für Hydroxylasen und Hydroxylase-Gene lassen 5 sich weiterhin beispielsweise ausgehend von der SequenzFurther examples of hydroxylases and hydroxylase genes can also be found, for example, based on the sequence
SEQ ID NO: 51 aus verschiedenen Organismen deren genomische Sequenz nicht bekannt ist, wie vorstehend beschrieben, durch Hybri- disierungs- und PCR-Techniken in an sich bekannter Weise leicht auffinden.SEQ ID NO: 51 from various organisms whose genomic sequence is not known, as described above, can easily be found by hybridization and PCR techniques in a manner known per se.
1010
In einer weiter besonders bevorzugten Ausführungsform werden zur Erhöhung der Hydroxylase-Aktivität Nukleinsäuren in Organismen eingebracht, die Proteine kodieren, enthaltend die Aminosäuresequenz der Hydroxylase der Sequenz SEQ ID NO: 52.In a further particularly preferred embodiment, to increase the hydroxylase activity, nucleic acids are introduced into organisms which encode proteins containing the amino acid sequence of the hydroxylase of the sequence SEQ ID NO: 52.
1515
Geeignete Nukleinsäuresequenzen sind beispielsweise durch Rückübersetzung der Polypeptidsequenz gemäß dem genetischen Code erhältlich.Suitable nucleic acid sequences can be obtained, for example, by back-translating the polypeptide sequence in accordance with the genetic code.
20 Bevorzugt werden dafür solche Codons verwendet, die entsprechend der pflanzenspezifischen codon usage häufig verwendet werden. Die codon usage lässt sich anhand von Computerauswertungen anderer, bekannter Gene der betreffenden Organismen leicht ermitteln.Those codons that are frequently used in accordance with the plant-specific codon usage are preferably used for this. The codon usage can easily be determined on the basis of computer evaluations of other, known genes of the organisms in question.
25 In einer besonders bevorzugten Ausführungsform bringt man eine Nukleinsäure, enthaltend die Sequenz SEQ. ID. NO: 51 in den Organismus ein.In a particularly preferred embodiment, a nucleic acid containing the sequence SEQ is brought. ID. NO: 51 in the organism.
Bevorzugt verwendet man in vorstehend beschriebener bevorzugter 30 Ausführungsform als ß-Cyclase-Gene Nukleinsäuren, die Proteine kodieren, enthaltend die AminosäureSequenz SEQ ID NO: 54 oder eine von dieser Sequenz durch Substitution, Insertion oder Deletion von Aminosäuren abgeleitete Sequenz, die eine Identität von mindestens 30 %, vorzugsweise mindestens 50 %, bevorzugter minde- 35 stens 70 %, noch bevorzugter mindestens 90 %, am bevorzugtesten mindestens 95 % auf Aminosäureebene mit der Sequenz SEQ ID NO: 54, und die die enzymatische Eigenschaft einer ß-Cyclase aufweisen.In the preferred embodiment described above, the β-cyclase genes used are preferably nucleic acids which encode proteins containing the amino acid sequence SEQ ID NO: 54 or a sequence derived from this sequence by substitution, insertion or deletion of amino acids and which have an identity of at least 30%, preferably at least 50%, more preferably at least 35 at least 70%, even more preferably at least 90%, most preferably at least 95% at the amino acid level with the sequence SEQ ID NO: 54, and which have the enzymatic property of a β-cyclase.
40 Weitere Beispiele für ß-Cyclasen und ß-Cyclase-Gene lassen sich beispielsweise aus verschiedenen Organismen, deren genomische Sequenz bekannt ist, wie vorstehend beschrieben durch Homologievergleiche der Aminosäuresequenzen oder der entsprechenden rückübersetzten Nukleinsäuresequenzen aus Datenbanken mit der SEQ ID NO:40 Further examples of β-cyclases and β-cyclase genes can be obtained, for example, from various organisms whose genomic sequence is known, as described above, by comparing the homology of the amino acid sequences or the corresponding back-translated nucleic acid sequences from databases with the SEQ ID NO:
45 54 leicht auffinden. Weitere Beispiele für ß-Cyclasen und ß-Cyclase-Gene lassen sich weiterhin beispielsweise ausgehend von der Sequenz SEQ ID NO: 53 aus verschiedenen Organismen deren genomische Sequenz nicht bekannt ist, durch Hybridisierungs- und PCR-Techniken in an sich bekannter Weise leicht auffinden.45 54 easy to find. Further examples of β-cyclases and β-cyclase genes can also be easily found, for example, starting from the sequence SEQ ID NO: 53 from various organisms whose genomic sequence is not known, using hybridization and PCR techniques in a manner known per se.
In einer weiter besonders bevorzugten Ausführungsform werden zur Erhöhung der ß-Cyclase-Aktivität Nukleinsäuren in Organismen eingebracht, die Proteine kodieren, enthaltend die Aminosäuresequenz der ß-Cyclase der Sequenz SEQ. ID. NO: 54.In a further particularly preferred embodiment, to increase the β-cyclase activity, nucleic acids are introduced into organisms which encode proteins containing the amino acid sequence of the β-cyclase of the sequence SEQ. ID. NO: 54.
Geeignete Nukleinsäuresequenzen sind beispielsweise durch Rückübersetzung der Polypeptidsequenz gemäß dem genetischen Code erhältlich.Suitable nucleic acid sequences can be obtained, for example, by back-translating the polypeptide sequence in accordance with the genetic code.
Bevorzugt werden dafür solche Codons verwendet, die entsprechend der pflanzenspezifischen codon usage häufig verwendet werden. Die codon usage lässt sich anhand von Computerauswertungen anderer, bekannter Gene der betreffenden Organismen leicht ermitteln.Those codons that are frequently used in accordance with the plant-specific codon usage are preferably used for this. The codon usage can easily be determined on the basis of computer evaluations of other, known genes of the organisms in question.
In einer besonders bevorzugten Ausführungsform bringt man eine Nukleinsäure, enthaltend die Sequenz SEQ. ID. NO: 53 in den Organismus ein.In a particularly preferred embodiment, a nucleic acid containing the sequence SEQ is brought. ID. NO: 53 in the organism.
Alle vorstehend erwähnten Hydroxylase-Gene oder ß-Cyclase-Gene sind weiterhin in an sich bekannter Weise durch chemische Synthese aus den Nukleotidbausteinen wie beispielsweise durch Fragmentkondensation einzelner überlappender, komplementärer Nuklein- säurebausteine der Doppelhelix herstellbar. Die chemische Syn- these von Oligonukleotiden kann beispielsweise, in bekannterAll of the above-mentioned hydroxylase genes or β-cyclase genes can also be produced in a manner known per se by chemical synthesis from the nucleotide building blocks, for example by fragment condensation of individual overlapping, complementary nucleic acid building blocks of the double helix. The chemical synthesis of oligonucleotides can, for example, be known
Weise, nach der Phosphoamiditmethode (Voet, Voet, 2. Auflage, Wi- ley Press New York, Seite 896-897) erfolgen. Die Anlagerung synthetischer Oligonukleotide und Auffüllen von Lücken mithilfe des Klenow-Fragmentes der DNA-Polymerase und Ligationsreaktionen so- wie allgemeine Klonierungsverfahren werden in Sambrook et al.Way, according to the phosphoamidite method (Voet, Voet, 2nd edition, Willey Press New York, page 896-897). The addition of synthetic oligonucleotides and the filling of gaps using the Klenow fragment of DNA polymerase and ligation reactions as well as general cloning methods are described in Sambrook et al.
(1989), Molecular cloning: A laboratory manual, Cold Spring Har- bor Laboratory Press, beschrieben.(1989), Molecular cloning: A laboratory manual, Cold Spring Harbor Laboratory Press.
Besonders bevorzugte Pflanzen sind Pflanzen, ausgewählt aus den Pflanzengattungen Actinophloeus , Aglaeonema, Ananas, Arbutus , Archontophoenix, Area, Aronia, Asparagus , Attalea, Berberis, Bixia, Brachychilum, Bryonia, Caliptocalix, Capsicum, Carica, Celastrus, Citrullus, Citrus, Convallaria, Cotoneaster, Crataegus, Cucumis, Cucurbita, Cuscuta, Cycas, Cyphomandra, Dioscorea, Diospyrus, Dura, Elaeagnus, Elaeis, Erythroxylon, Euonymus, Ficus, Fortunella, Fragaria, Gardinia, Gonocaryum, Gossypium, Guava, Guilielma, Hibiscus, Hippophaea, Iris, Lathy- rus, Lonicera, Luffa, Lyciu , Lycopersicum, Malpighia, Mangifera, Mormodica, Murraya, Musa, Nenga, Palisota, Pandanus, Passiflora, Persea, Physalis, Prunus , Ptychandra, Punica, Pyracantha, Pyrus, Ribes, Rosa, Rubus, Sabal, Sambucus, Seaforita, Shepherdia, Sola- num, Sorbus, Synaspadix, Tabernae, Ta us , Taxus, Trichosanthes , Triphasia, Vaccinium, Viburnum, Vignia oder Vitis.Particularly preferred plants are plants selected from the plant genera Actinophloeus, Aglaeonema, pineapple, Arbutus, Archontophoenix, Area, Aronia, Asparagus, Attalea, Berberis, Bixia, Brachychilum, Bryonia, Caliptocalix, Capsicum, Carica, Celastrus, Citrullus, Citrus, Convallaria Cotoneaster, Crataegus, Cucumis, Cucurbita, Cuscuta, Cycas, Cyphomandra, Dioscorea, Diospyrus, Dura, Elaeagnus, Elaeis, Erythroxylon, Euonymus, Ficus, Fortunella, Fragaria, Gardinia, Gonocaryum, Gossypium, Guava, Guilielma, Guilielma, Guilielma, Guilielma, Guilielma, Guilielma, Guilielma, Guilielma, Guilielma, Guilielma, Guilielma, Guilielma, Guilielma, Guilielma, Guilielma, Guilielma, Guilielma, Guilielma, Guilielma Lathy- rus, Lonicera, Luffa, Lyciu, Lycopersicum, Malpighia, Mangifera, Mormodica, Murraya, Musa, Nenga, Palisota, Pandanus, Passiflora, Persea, Physalis, Prunus, Ptychandra, Punica, Pyracantha, Pyrus, Ribes, Rosa, Rubus, Sabal, Sambucus, Seaforita, Shepherdia, Solanum, Sorbus, Synaspadix, Tabernae, Ta us, Taxus, Trichosanthes, Triphasia, Vaccinium, Viburnum, Vignia or Vitis.
Die Bestimmung der Ketolase-Aktivität in erfindungsgemäßen genetisch veränderten Pflanzen erfolgt in Anlehnung an die Methode von Frazer et al . , (J. Biol. Chem. 272(10): 6128-6135, 1997). Die Ketolase-Aktivität in pflanzlichen Extrakten wird mit den Substraten beta-Carotin und Canthaxanthin in Gegenwart von Lipid (Sojalecithin) und Detergens (Natriumcholat) bestimmt. Substrat/ Produkt-Verhältnisse aus den Ketolase-Assays werden mittels HPLC ermittelt.The ketolase activity in genetically modified plants according to the invention is determined in accordance with the method of Frazer et al. , (J. Biol. Chem. 272 (10): 6128-6135, 1997). The ketolase activity in plant extracts is determined with the substrates beta-carotene and canthaxanthin in the presence of lipid (soy lecithin) and detergent (sodium cholate). Substrate / product ratios from the ketolase assays are determined by means of HPLC.
Im erfindungsgemäßen Verfahren zur Herstellung von Ketocarotinoiden wird vorzugsweise dem Kultivierungsschritt der genetisch veränderten Pflanzen, im folgenden auch transgene Pflanzen bezeich- net, ein Ernten der Pflanzen und ein Isolieren von Ketocarotinoiden aus den Früchten der Pflanzen angeschlossen. xIn the process according to the invention for producing ketocarotenoids, the cultivation step of the genetically modified plants, hereinafter also referred to as transgenic plants, is preferably followed by harvesting the plants and isolating ketocarotenoids from the fruits of the plants. x
Die transgenen Pflanzen werden in an sich bekannter Weise aufThe transgenic plants are raised in a manner known per se
Nährböden gezogen und entsprechend geerntet.Culture media are grown and harvested accordingly.
Die Isolierung von Ketocarotinoiden aus den geernteten Früchten erfolgt in an sich bekannter Weise, beispielsweise durch Trocknung und anschließender Extraktion und gegebenenfalls weiterer chemischer oder physikalischer Reinigungsprozesse, wie beispiels- weise Fällungsmethoden, Kristallographie, thermische Trennverfahren, wie Rektifizierverfahren oder physikalische Trennverfahren, wie beispielsweise Chromatographie. Die Isolierung von Ketocarotinoiden aus den Früchten erfolgt beispielsweise bevorzugt durch organische Lösungsmittel wie Aceton, Hexan, Ether oder tert . -Methylbutylether .Ketocarotenoids are isolated from the harvested fruits in a manner known per se, for example by drying and subsequent extraction and, if appropriate, further chemical or physical purification processes, such as, for example, precipitation methods, crystallography, thermal separation processes, such as rectification processes or physical separation processes, such as chromatography. Ketocarotenoids are isolated from the fruit, for example, preferably by organic solvents such as acetone, hexane, ether or tert. Methyl butyl ether.
Weitere Isolierverfahren von Ketocarotinoiden sind beispielsweise in Egger und Kleinig (Phytochemistry (1967) 6, 437-440) und Egger (Phytochemistry (1965) 4, 609-618) beschrieben.Further isolation methods of ketocarotenoids are described, for example, in Egger and Kleinig (Phytochemistry (1967) 6, 437-440) and Egger (Phytochemistry (1965) 4, 609-618).
Vorzugsweise sind die Ketocarotinoide ausgewählt aus der Gruppe Astaxanthin, Canthaxanthin, Echinenon, 3-Hydroxyechinenon, 3 ' -Hydroxyechinenon, Adonirubin und Adonixanthin.The ketocarotenoids are preferably selected from the group astaxanthin, canthaxanthin, echinenone, 3-hydroxyechinenone, 3'-hydroxyechinenone, adonirubin and adonixanthin.
Ein besonders bevorzugtes Ketocarotinoid ist Astaxanthin. Die Herstellung der transgenen Pflanzen erfolgt vorzugsweise durch Transformation der Ausgangspflanzen, mit einem Nuklein- säurekonstrukt, das mindestens eine, vorzugsweise auch mehrere der vorstehend beschriebenen Nukleinsäuren enthält, die mit einem 5 oder mehreren RegulationsSignalen funktionell verknüpft sind, die die Transkription und Translation in Pflanzen gewährleisten.A particularly preferred ketocarotenoid is astaxanthin. The transgenic plants are preferably produced by transforming the starting plants, using a nucleic acid construct which contains at least one, preferably also more than one of the above-described nucleic acids which are functionally linked to one or more regulatory signals which ensure transcription and translation in plants ,
Diese Nukleinsäurekonstrukte, in denen die kodierende Nuklein- säuresequenz mit einem oder mehreren Regulationssignalen funktio- 10 nell verknüpft sind, die die Transkription und Translation in Pflanzen gewährleisten, werden im folgenden auch Expressionskassetten genannt .These nucleic acid constructs, in which the coding nucleic acid sequence is functionally linked to one or more regulatory signals which ensure transcription and translation in plants, are also called expression cassettes below.
Vorzugsweise enthalten die Regulationssignale einen oder mehrere 15 Promotoren, die die Transkription und Translation in Pflanzen gewährleisten.The regulation signals preferably contain one or more 15 promoters which ensure transcription and translation in plants.
Die Expressionskassetten beinhalten Regulationssignale, also regulative Nukleinsäuresequenzen, welche die Expression derThe expression cassettes contain regulatory signals, that is, regulatory nucleic acid sequences which express the expression of the
20 kodierenden Sequenz in der Wirtszelle steuern. Gemäß einer bevorzugten Ausführungsform umfasst eine Expressionskassette stromaufwärts, d.h. am 5 ' -Ende der kodierenden Sequenz, einen Promotor und stromabwärts, d.h. am 3 '-Ende, ein Polyadenylierungssignal und gegebenenfalls weitere regulatorische Elemente, welche mitControl 20 coding sequence in the host cell. According to a preferred embodiment, an expression cassette comprises upstream, i.e. at the 5 'end of the coding sequence, a promoter and downstream, i.e. at the 3 'end, a polyadenylation signal and optionally further regulatory elements which are associated with
25 der dazwischenliegenden kodierenden Sequenz für mindestens eines der vorstehend beschriebenen Gene operativ verknüpft sind. Unter einer operativen Verknüpfung versteht man die sequenzielle Anordnung von Promotor, kodierender Sequenz, Terminator und ggf. weiterer regulativer Elemente derart, dass jedes der regulativen25 of the intermediate coding sequence for at least one of the genes described above are operatively linked. An operative link is understood to mean the sequential arrangement of promoter, coding sequence, terminator and possibly other regulatory elements such that each of the regulatory
30 Elemente seine Funktion bei der Expression der kodierenden Sequenz bestimmungsgemäß erfüllen kann.30 elements can perform its function as intended in the expression of the coding sequence.
Im folgenden werden beispielhaft die bevorzugten Nukleinsäurekonstrukte, Expressionskassetten und Vektoren für Pflanzen und Ver- 35 fahren zur Herstellung von transgenen Pflanzen, sowie die transgenen Pflanzen selbst beschrieben.The preferred nucleic acid constructs, expression cassettes and vectors for plants and methods for producing transgenic plants and the transgenic plants themselves are described below by way of example.
Die zur operativen Verknüpfung bevorzugten aber nicht darauf beschränkten Sequenzen sind Targeting-Sequenzen zur Gewährlei-The sequences preferred but not limited to the operative linkage are targeting sequences to ensure
40 stung der subzellulären Lokalisation im Apoplasten, in der Vaku- ole, in Piastiden, im Mitochondrium, im Endoplasmatischen Retiku- lum (ER) , im Zellkern, in Ölkörperchen oder anderen Kompartimen- ten und Translationsverstärker wie die 5 ' -Führungssequenz aus dem Tabak-Mosaik-Virus (Gallie et al . , Nucl. Acids Res . 15 (1987),40 improvement of the subcellular localization in the apoplast, in the vacuole, in plastids, in the mitochondrion, in the endoplasmic reticulum (ER), in the cell nucleus, in oil corpuscles or other compartments and translation enhancers like the 5 'guiding sequence from tobacco Mosaic virus (Gallie et al., Nucl. Acids Res. 15 (1987),
45 8693-8711) . Als Promotoren der Expressionskassette ist grundsätzlich jeder Promotor geeignet, der die Expression von Fremdgenen in Pflanzen steuern kann.45 8693-8711). In principle, any promoter which can control the expression of foreign genes in plants is suitable as promoters of the expression cassette.
"Konstitutiver" Promotor meint solche Promotoren, die eine"Constitutive" promoter means those promoters that have a
Expression in zahlreichen, bevorzugt allen, Geweben über einen größeren Zeitraum der Pflanzenentwicklung, bevorzugt zu allen Zeitpunkten der Pflanzenentwicklung, gewährleisten.Ensure expression in numerous, preferably all, tissues over a longer period of plant development, preferably at all times during plant development.
Vorzugsweise verwendet man insbesondere einen pflanzlichenIn particular, a vegetable one is preferably used
Promotor oder einen Promotor, der einem Pflanzenvirus entstammt. Insbesondere bevorzugt ist der Promotor des 35S-Transkriptes des CaMV Blumenkohlmosaikvirus (Franck et al . (1980) Cell 21:285-294; Odell et al . (1985) Nature 313:810-812; Shewmaker et al . (1985) Virology 140:281-288; Gardner et al . (1986) Plant Mol BiolPromoter or a promoter derived from a plant virus. Particularly preferred is the promoter of the 35S transcript of the CaMV cauliflower mosaic virus (Franck et al. (1980) Cell 21: 285-294; Odell et al. (1985) Nature 313: 810-812; Shewmaker et al. (1985) Virology 140 : 281-288; Gardner et al. (1986) Plant Mol Biol
6:221-228) oder der 19S CaMV Promotor (US 5,352,605; WO 84/02913; Benfey et al . (1989) EMBO J 8:2195-2202).6: 221-228) or the 19S CaMV promoter (US 5,352,605; WO 84/02913; Benfey et al. (1989) EMBO J 8: 2195-2202).
Ein weiterer geeigneter konstitutiver Promotor ist der pds Pro o- ter (Pecker et al . (1992) Proc. Natl. Acad. Sei USA 89: 4962-4966) oder der "Rubisco small subunit (SSU) "-Promotor (US 4,962,028), der LeguminB-Promotor (GenBank Acc.-Nr. X0S677), der Promotor der Nopalinsynthase aus Agrobacterium, der TR-Doppelpromotor, der OCS (Octopin Synthase) Promόlior aus Agrobacter- ium, der Ubiquitin Promotor (Holtorf S et al . (1995) Plant Mol Biol 29:637-649), den Ubiquitin 1 Promotor (Christensen et al . (1992) Plant Mol Biol 18:675-689; Bruce et al . (1989) Proc Natl Acad Sei USA 86:9692-9696), den Smas Promotor, den Cinnamylalko- holdehydrogenase-Promotor (US 5,683,439), die Promotoren der va- kuolärer ATPase Untereinheiten oder der Promotor eines prolinrei- chen Proteins aus Weizen (WO 91/13991) , der Pnit-Promoter (Y07648.L, Hillebrand et al . (1998), Plant. Mol. Biol. 36, 89-99, Hillebrand et al. (1996), Gene, 170, 197-200, der Ferredoxin- NADPH-Oxidoreductase Promotor (Datenbankeintrag AB011474, Posi- tion 70127 bis 69493), der TPT-Promoter (WO 03006660), der „Superpromotor" (US-Patent 5955646), der 34S-Promotor (US-Patent 6051753) sowie weitere Promotoren von Genen, deren konstitutive Expression in Pflanzen dem Fachmann bekannt ist.Another suitable constitutive promoter is the pds Prooter (Pecker et al. (1992) Proc. Natl. Acad. Be USA 89: 4962-4966) or the "Rubisco small subunit (SSU)" promoter (US 4,962,028) , the LeguminB promoter (GenBank Acc.No. X0S677), the promoter of nopaline synthase from Agrobacterium, the TR double promoter, the OCS (octopine synthase) promoter from Agrobacterium, the ubiquitin promoter (Holtorf S et al. (1995 ) Plant Mol Biol 29: 637-649), the Ubiquitin 1 promoter (Christensen et al. (1992) Plant Mol Biol 18: 675-689; Bruce et al. (1989) Proc Natl Acad Sei USA 86: 9692-9696) , the Smas promoter, the cinnamyl alcohol holdehydrogenase promoter (US 5,683,439), the promoters of the vacuolar ATPase subunits or the promoter of a proline-rich protein from wheat (WO 91/13991), the Pnit promoter (Y07648.L, Hillebrand et al. (1998), Plant. Mol. Biol. 36, 89-99, Hillebrand et al. (1996), Gene, 170, 197-200, the ferredoxin NADPH oxidoreductase promoter (database entry ag AB011474, positions 70127 to 69493), the TPT promoter (WO 03006660), the "super promoter" (US patent 5955646), the 34S promoter (US patent 6051753) and further promoters of genes, their constitutive expression in plants is known to the expert.
Die Expressionskassetten können auch einen chemisch induzierbaren Promotor enthalten (Übersichtsartikel : Gatz et al . (1997) Annu Rev Plant Physiol Plant Mol Biol 48:89-108), durch den die Expression des Ketolase-Gens in der Pflanze zu einem bestimmten Zeitpunkt gesteuert werden kann. Derartige Promotoren, wie z.B. der PRPl Promotor (Ward et al . (1993) Plant Mol Biol 22:361-366), durch Salicylsäure induzierbarer Promotor (WO 95/19443), ein durch Benzolsulfonamid-induzierbarer Promotor (EP 0 388 186) , ein durch Tetrazyklin-induzierbarer Promotor (Gatz et al . (1992) Plant J 2:397-404), ein durch Abscisinsäure induzierbarer Promotor (EP 0 335 528) bzw. ein durch Ethanol- oder Cyclohexa- non-induzierbarer Promotor (WO 93/21334) können ebenfalls verwendet werden.The expression cassettes can also contain a chemically inducible promoter (review article: Gatz et al. (1997) Annu Rev Plant Physiol Plant Mol Biol 48: 89-108), by means of which the expression of the ketolase gene in the plant is controlled at a specific point in time can. Such promoters, such as the PRPl promoter (Ward et al. (1993) Plant Mol Biol 22: 361-366), salicylic acid-inducible promoter (WO 95/19443), a benzenesulfonamide-inducible promoter (EP 0 388 186), a promoter inducible by tetracycline (Gatz et al. (1992) Plant J 2: 397-404), a promoter inducible by abscisic acid (EP 0 335 528) or a promoter inducible by ethanol or cyclohexanone (WO 93 / 21334) can also be used.
Ferner sind Promotoren bevorzugt, die durch biotischen oder abio- tischen Stress induziert werden wie beispielsweise der pathogen- induzierbare Promotor des PRPl-Gens (Ward et al. (1993) Plant Mol Biol 22:361-366), der hitzeinduzierbare hsp70- oder hsp80-Promo- ter aus Tomate (US 5,187,267), der kälteinduzierbare alpha-Amy- lase Promoter aus der Kartoffel (WO 96/12814) , der licht-induzierbare PPDK Promotor oder der verwundungsinduzierte pinll-Pro- oter (EP375091) .Promoters which are induced by biotic or abiotic stress are also preferred, for example the pathogen-inducible promoter of the PRPL gene (Ward et al. (1993) Plant Mol Biol 22: 361-366), the heat-inducible hsp70 or hsp80 Promoter from tomato (US Pat. No. 5,187,267), the cold-inducible alpha-amylase promoter from the potato (WO 96/12814), the light-inducible PPDK promoter or the wound-induced pinII promoter (EP375091).
Pathogen-induzierbare Promotoren umfassen die von Genen, die infolge eines Pathogenbefalls induziert werden wie beispielsweise Gene von PR-Proteinen, SAR-Proteinen, b-1, 3-Glucanase, Chitinase usw. (beispielsweise Redolfi et al . (1983) Neth J Plant Pathol 89:245-254; Uknes, et al . (1992) The PlantPathogen-inducible promoters include those of genes induced by pathogen attack such as genes from PR proteins, SAR proteins, b-1, 3-glucanase, chitinase etc. (e.g. Redolfi et al. (1983) Neth J Plant Pathol 89: 245-254; Uknes, et al. (1992) The Plant
Cell4: 645-656; Van Loon (1985) Plant Mol Viral 4:111-116; Mari- neau et al . (1987) Plant Mol Biol 9:335-342; Matton et al.x(1987) Molecular Plant-Microbe Interactions 2:325-342; Somssich et al . (1986) Proc Natl Acad Sei USA 83:2427-2430; SÖmssich et al . (1988) Mol Gen Genetics 2:93-98; Chen et al . (1996) Plant J 10:955-966; Zhang and Sing (1994) Proc Natl Acad Sei USA 91:2507-2511; Warner, et al . (1993) Plant J 3:191-201; Siebertz et al. (1989) Plant Cell 1:961-968(1989).Cell4: 645-656; Van Loon (1985) Plant Mol Viral 4: 111-116; Marineau et al. (1987) Plant Mol Biol 9: 335-342; Matton et al. x (1987) Molecular Plant-Microbe Interactions 2: 325-342; Somssich et al. (1986) Proc Natl Acad Sei USA 83: 2427-2430; SÖmssich et al. (1988) Mol Gen Genetics 2: 93-98; Chen et al. (1996) Plant J 10: 955-966; Zhang and Sing (1994) Proc Natl Acad Sei USA 91: 2507-2511; Warner, et al. (1993) Plant J 3: 191-201; Siebertz et al. (1989) Plant Cell 1: 961-968 (1989).
Umfasst sind auch verwundungs-induzierbare Promotoren wie der des pinll Gens (Ryan (1990) Ann Rev Phytopath 28:425-449; Duan et al. (1996) Nat Biotech 14:494-498), des wunl und wun2-Gens (US 5,428,148), des winl- und win2-Gens (Stanford et al . (1989) Mol Gen Genet 215:200-208), des Systemin (McGurl et al . (1992) Science 225:1570-1573), des WIPl-Gens (Rohmeier et al . (1993) Plant Mol Biol 22:783-792; Ekelkamp et al . (1993) FEBS Letters 323:73-76), des MPI-Gens (Corderok et al . (1994) The Plant J 6(2) :141-150) und dergleichen.Also included are wound-inducible promoters such as that of the pinll gene (Ryan (1990) Ann Rev Phytopath 28: 425-449; Duan et al. (1996) Nat Biotech 14: 494-498), the wunl and wun2 gene (US 5,428,148), the winl and win2 genes (Stanford et al. (1989) Mol Gen Genet 215: 200-208), the systemin (McGurl et al. (1992) Science 225: 1570-1573), the WIPl gene (Rohmeier et al. (1993) Plant Mol Biol 22: 783-792; Ekelkamp et al. (1993) FEBS Letters 323: 73-76), the MPI gene (Corderok et al. (1994) The Plant J 6 ( 2): 141-150) and the like.
Weitere geeignete Promotoren sind beispielsweise fruchtreifung- spezifische Promotoren, wie beispielsweise der fruchtreifung-spe- zifische Promotor aus Tomate (WO 94/21794, EP 409 625). Entwicklungsabhängige Promotoren schließen zum Teil die gewebespezifischen Promotoren ein, da die Ausbildung einzelner Gewebe natur- gemäß entwicklungsabhängig erfolgt. Weiterhin sind insbesondere solche Promotoren bevorzugt, die die Expression in Geweben oder Pflanzenteilen sicherstellen, in denen beispielsweise die Biosynthese von Ketocarotinoiden bzw. dessen Vorstufen stattfindet. Bevorzugt sind beispielsweise Promotoren mit Spezifitäten für die Antheren, Ovarien, Petalen, Sepalen, Blüten, Blätter, Stengel, Wurzeln und Früchte und Kombinationen hieraus .Further suitable promoters are, for example, fruit ripening-specific promoters, such as, for example, the fruit ripening-specific promoter from tomato (WO 94/21794, EP 409 625). Development-dependent promoters partly include the tissue-specific promoters, since the formation of individual tissues is naturally development-dependent. Furthermore, promoters are particularly preferred which ensure expression in tissues or parts of plants in which, for example, the biosynthesis of ketocarotenoids or their precursors takes place. For example, promoters with specificities for the anthers, ovaries, petals, sepals, flowers, leaves, stems, roots and fruits and combinations thereof are preferred.
Knollen-, Speicherwurzel- oder Wurzel-spezifische Promotoren sind beispielsweise der Patatin Promotor Klasse I (B33) oder der Promotor des Cathepsin D Inhibitors aus Kartoffel.Tuber-, storage root- or root-specific promoters are, for example, the patatin class I promoter (B33) or the potato cathepsin D inhibitor promoter.
Blattspezifische Promotoren sind beispielsweise der Promotor der cytosolischen FBPase aus Kartoffel (WO 97/05900), der SSU Promotor (small subunit) der Rubisco (Ribulose-1, 5-bisphosphat- carboxylase) oder der ST-LSI Promotor aus Kartoffel (Stockhaus et al. (1989) EMBO J 8:2445-2451).Leaf-specific promoters are, for example, the promoter of the cytosolic FBPase from potato (WO 97/05900), the SSU promoter (small subunit) of Rubisco (ribulose-1, 5-bisphosphate carboxylase) or the ST-LSI promoter from potato (Stockhaus et al (1989) EMBO J 8: 2445-2451).
Blütenspezifische Promotoren sind beispielsweise der Phytoen Syn- thase Promotor (WO 92/16635) oder der Promotor des P-rr Gens (WOFlower-specific promoters are, for example, the phytoene synthesis promoter (WO 92/16635) or the promoter of the P-rr gene (WO
98/22593) . x98/22593). x
Antheren-spezifisc e Promotoren sind beispielsweise der 5126- Promotor (US 5,689,049, US 5,689,051), der glόb-1 Promotor oder der g-Zein Promotor.Anther-specific promoters are, for example, the 5126 promoter (US 5,689,049, US 5,689,051), the glόb-1 promoter or the g-zein promoter.
Fruchtspezifische Promotoren sind beispielsweiseFruit-specific promoters are, for example
der Pds-Promoter aus Tomate (Genbank-ACCESSION U46919; Corona, V., Aracri, B., Kosturkova, G. , Bartley, G.E., Pitto, L.,Gior- getti, L., Scolnik, P.A. and Giuliano, G. , Regulation of a carotenoid biosynthesis gene Promoter during plant development Plant J. 9 (4), 505-512 (1996)), SEQ ID N0.17,the Pds promoter from tomato (Genbank ACCESSION U46919; Corona, V., Aracri, B., Kosturkova, G., Bartley, GE, Pitto, L., Giorgetti, L., Scolnik, PA and Giuliano, G ., Regulation of a carotenoid biosynthesis gene promoter during plant development Plant J. 9 (4), 505-512 (1996)), SEQ ID N0.17,
der 2A11 Promoter aus Tomate (Pear, J.R., Ridge, N. , Rasmussen, R. , Rose, R.E. and Houck, CM. Isolation and characterization of a fruit-specific cDNA and the corresponding genomic clone from tomatoPlant Mol. Biol. 13 (6), 639-651 (1989), SEQ ID NO. 18,the 2A11 promoter from tomato (Pear, JR, Ridge, N., Rasmussen, R., Rose, RE and Houck, CM. Isolation and characterization of a fruit-specific cDNA and the corresponding genomic clone from tomatoPlant Mol. Biol. 13 ( 6), 639-651 (1989), SEQ ID NO. 18,
der Cucumisin Promoter (Yamagata, H., Yonesu, K., Hirata, A. and Aizono, Y. , TGTCACA Motif Is a Novel cis-Regulatory Enhancer Element Involved in Fruit-specific Expression of the cucumisin GeneJ. Biol. Chem. 277 (13), 11582-11590 (2002), SEQ ID NO. 19, der Promoter des Endogalacturonasegens (Redondo-Nevado, J. , Me- dina-Escobar, N., Caballero-Repullo, J.L. and Munoz-Blanco, J.the cucumisin promoter (Yamagata, H., Yonesu, K., Hirata, A. and Aizono, Y., TGTCACA Motif Is a Novel cis-Regulatory Enhancer Element Involved in Fruit-specific Expression of the cucumisin Gene J. Biol. Chem. 277 (13), 11582-11590 (2002), SEQ ID NO. 19, the promoter of the endogalacturonase gene (Redondo-Nevado, J., Medina-Escobar, N., Caballero-Repullo, JL and Munoz-Blanco, J.
A fruit-specific and developmentally regulated endo-polygalactu- ronase gene from strawberry (Fragaria x ananassa c.v. Chandler) , J Experimental Botany 52 (362) 1941-1945 (2001), SEQ ID NO. 20,A fruit-specific and developmentally regulated endo-polygalacturonase gene from strawberry (Fragaria x ananassa c.v. Chandler), J Experimental Botany 52 (362) 1941-1945 (2001), SEQ ID NO. 20
der Polygalacturonase Promoter aus Tomate (Nicholass, F.J., Smith, C.J., Schuch, W. , Bird, C.R. and Grierson, D., High levels of ripening-specific reporter gene expression directed by tomato fruit polygalacturonase gene-flanking regions, Plant Mol. Biol. 28 (3), 423-435 (1995)), SEQ ID NO . 21,the polygalacturonase promoter from tomato (Nicholass, FJ, Smith, CJ, Schuch, W., Bird, CR and Grierson, D., High levels of ripening-specific reporter gene expression directed by tomato fruit polygalacturonase gene-flanking regions, Plant Mol. Biol. 28 (3), 423-435 (1995)), SEQ ID NO. 21
die TMF7 und TMF9 Promotoren (US 5608150),the TMF7 and TMF9 promoters (US 5608150),
der Promotor E4 (Cordes S. Deikman J. Margossian LJ. Fischer RL. Interaction of a developmentally regulated DNA-binding factor with sites flanking two different fruit-ripening genes from tomato (1989), Plant Cell 1, 1025-1034) undthe promoter E4 (Cordes S. Deikman J. Margossian LJ. Fischer RL. Interaction of a developmentally regulated DNA-binding factor with sites flanking two different fruit-ripening genes from tomato (1989), Plant Cell 1, 1025-1034) and
der Promotor E8 (Deikman and Fisher, Interaction of a DNA binding factor with the 5 '-flanking region of an ethylene-responsive fruit ripening gene from tomato (1988), EMBO J. 7, 3315-3320). Weitere zur Expression in Pflanzen geeignete Promotoren sind be- schrieben (Rogers et al . (1987) Meth in Enzymol 153:253-277; Schardl et al . (1987) Gene 61:1-11; Berger et al . (1989) Proc Natl Acad Sei USA 86:8402-8406)the promoter E8 (Deikman and Fisher, Interaction of a DNA binding factor with the 5 '-flanking region of an ethylene-responsive fruit ripening gene from tomato (1988), EMBO J. 7, 3315-3320). Further promoters suitable for expression in plants are described (Rogers et al. (1987) Meth in Enzymol 153: 253-277; Schardl et al. (1987) Gene 61: 1-11; Berger et al. (1989) Proc Natl Acad Sei USA 86: 8402-8406)
Alle in der vorliegenden Anmeldung beschriebenen Promotoren er- möglichen in der Regel die Expression der Ketolase in Früchten der erfindungsgemäßen Pflanzen.All promoters described in the present application generally enable expression of the ketolase in fruits of the plants according to the invention.
Besonders bevorzugt im erfindungsgemäßen Verfahren sind konstitu- tive sowie insbesondere fruchtspezifische Promotoren.In the method according to the invention, constitutive and in particular fruit-specific promoters are particularly preferred.
Die vorliegende Erfindung betrifft daher insbesondere ein Nukleinsäurekonstrukt, enthaltend funktionell verknüpft einen fruchtspezifischen Promotor, besonders bevorzugt einen oben beschriebenen fruchtspezifischen Promotor, und eine Nukleinsäure, kodierend eine Ketolase.The present invention therefore relates in particular to a nucleic acid construct containing functionally linked a fruit-specific promoter, particularly preferably a fruit-specific promoter described above, and a nucleic acid encoding a ketolase.
Die Herstellung einer Expressionskassette erfolgt vorzugsweise durch Fusion eines geeigneten Promotors mit einer vorstehend beschriebenen Nukleinsäure kodierend eine Ketolase und vorzugs- weise einer zwischen Promotor und Nukleinsäure-Sequenz inserierten Nukleinsäure, die für ein plastidenspezifisches Transitpeptid kodiert, sowie einem Polyadenylierungssignal nach gängigen Rekombinations- und Klonierungstechniken, wie sie beispielsweise in T. Maniatis, E.F. Fritsch und J. Sambrook, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1989) sowie in T.J. Silhavy, M.L. Berman und L.W. En- quist, Experiments with Gene Fusions, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1984) und in Ausubel , F.M. et al . , Current Protocols in Molecular Biology, Greene Publishing Assoc. and Wiley-Interscience (1987) beschrieben sind.An expression cassette is preferably produced by fusing a suitable promoter with a nucleic acid described above, encoding a ketolase and preferably a nucleic acid inserted between promoter and nucleic acid sequence, which codes for a plastid-specific transit peptide, and a polyadenylation signal in accordance with current standards Recombination and cloning techniques, as described, for example, in T. Maniatis, EF Fritsch and J. Sambrook, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1989) and in TJ Silhavy, ML Berman and LW En - quist, Experiments with Gene Fusions, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1984) and in Ausubel, FM et al. , Current Protocols in Molecular Biology, Greene Publishing Assoc. and Wiley-Interscience (1987).
Die vorzugsweise insertierte Nukleinsäuren, kodierend ein plasti- däres Transitpeptid, gewährleisten die Lokalisation in Piastiden und insbesondere in Chromoplasten.The preferably inserted nucleic acids encoding a plastic transit peptide ensure localization in plastids and in particular in chromoplasts.
Es können auch Expressionskassetten verwendet werden, deren Nukleinsäure-Sequenz für ein Ketolase-Fusionsprotein kodiert, wobei ein Teil des Fusionsproteins ein Transitpeptid ist, das die Translokation des Polypeptides steuert. Bevorzugt sind für die Chromoplasten spezifische Transitpeptide, welche nach Translokation der Ketolase in die Chromoplasten vom Ketolase-Teil enzymatisch abgespalten werden.Expression cassettes, the nucleic acid sequence of which codes for a ketolase fusion protein, can also be used, part of the fusion protein being a transit peptide which controls the translocation of the polypeptide. Preferred transit peptides are preferred for the chromoplasts, which are cleaved enzymatically from the ketolase part after translocation of the ketolase into the chromoplasts.
Insbesondere bevorzugt ist das Transitpeptid, das von der plasti- dären Nicotiana tabacum Transketolase oder einem anderen Transitpeptid (z.B. dem Transitpeptid der kleinen Untereinheit der Rubisco (rbcS) oder der Ferredoxin NADP Oxidoreduktase als auch der Isopentenylpyrophosphat Isomerase-2) oder dessen funktionel- lem Äquivalent abgeleitet ist.The transit peptide which is derived from the plastic Nicotiana tabacum Transketolase or another transit peptide (for example the transit peptide of the small subunit of Rubisco (rbcS) or the ferredoxin NADP oxidoreductase and also the isopentenyl pyrophosphate isomerase-2) or its functional equivalent is particularly preferred is derived.
Besonders bevorzugt sind Nukleinsäure-Sequenzen von drei Kassetten des Plastiden-Transitpeptids der plastidären Transketolase aus Tabak in drei Leserastern als Kpnl/BamHI Fragmente mit einem ATG-Kodon in der Ncol Schnittstelle:Nucleic acid sequences of three cassettes of the plastid transit peptide of plastid transketolase from tobacco in three reading frames are particularly preferred as Kpnl / BamHI fragments with an ATG codon in the Ncol interface:
pTP09pTP09
KpnI_GGTACCATGGCGTCTTCTTCTTCTCTCACTCTCTCTCAAGCTATCCTCTCTCGTTCTGTC CCTCGCCATGGCTCTGCCTCTTCTTCTCAACTTTCCCCTTCTTCTCTCACTTTTTCCGGCCTTAA ATCCAATCCCAATATCACCACCTCCCGCCGCCGTACTCCTTCCTCCGCCGCCGCCGCCGCCGTCG TAAGGTCACCGGCGATTCGTGCCTCAGCTGCAACCGAAACCATAGAGAAAACTGAGACTGCGGGA TCC_BamHIKpnI_GGTACCATGGCGTCTTCTTCTTCTCTCACTCTCTCTCAAGCTATCCTCTCTCGTTCTGTC CCTCGCCATGGCTCTGCCTCTTCTTCTCAACTTTCCCCTTCTTCTCTCACTTTTTCCGGCCTTAA ATCCAATCCCAATATCACCACCTCCCGCCGCCGTACTCCTTCCTCCGCCGCCGCCGCCGCCGTCG TAAGGTCACCGGCGATTCGTGCCTCAGCTGCAACCGAAACCATAGAGAAAACTGAGACTGCGGGA TCC_BamHI
pTPlOpTPlO
KpnI_GGTACCATGGCGTCTTCTTCTTCTCTCACTCTCTCTCAAGCTATCCTCTCTCGTTCTGTC CCTCGCCATGGCTCTGCCTCTTCTTCTCAACTTTCCCCTTCTTCTCTCACTTTTTCCGGCCTTAAKpnI_GGTACCATGGCGTCTTCTTCTTCTCTCACTCTCTCTCAAGCTATCCTCTCTCGTTCTGTC CCTCGCCATGGCTCTGCCTCTTCTTCTCAACTTTCCCCTTCTTCTCTCACTTTTTCCGGCCTTAA
ATCCAATCCCAATATCACCACCTCCCGCCGCCGTACTCCTTCCTCCGCCGCCGCCGCCGCCGTCG TAAGGTCACCGGCGATTCGTGCCTCAGCTGCAACCGAAACCATAGAGAAAACTGAGACTGCGCTG GATCC_BamHIATCCAATCCCAATATCACCACCTCCCGCCGCCGTACTCCTTCCTCCGCCGCCGCCGCCGCCGTCG TAAGGTCACCGGCGATTCGTGCCTCAGCTGCAACCGAAACCATAGAGAAAACTGAGACTGCGCTG GATCC_BamHI
pTPllpTPll
KpnI_GGTACCATGGCGTCTTCTTCTTCTCTCACTCTCTCTCAAGCTATCCTCTCTCGTTCTGTC CCTCGCCATGGCTCTGCCTCTTCTTCTCAACTTTCCCCTTCTTCTCTCACTTTTTCCGGCCTTAA ATCCAATCCCAATATCACCACCTCCCGCCGCCGTACTCCTTCCTCCGCCGCCGCCGCCGCCGTCG TAAGGTCACCGGCGATTCGTGCCTCAGCTGCAACCGAAACCATAGAGAAAACTGAGACTGCGGGG ATCC_BamHIKpnI_GGTACCATGGCGTCTTCTTCTTCTCTCACTCTCTCTCAAGCTATCCTCTCTCGTTCTGTC CCTCGCCATGGCTCTGCCTCTTCTTCTCAACTTTCCCCTTCTTCTCTCACTTTTTCCGGCCTTAA ATCCAATCCCAATATCACCACCTCCCGCCGCCGTACTCCTTCCTCCGCCGCCGCCGCCGCCGTCG TAAGGTCACCGGCGATTCGTGCCTCAGCTGCAACCGAAACCATAGAGAAAACTGAGACTGCGGGG ATCC_BamHI
Weitere Beispiele für ein plastidäres Transitpeptid sind das Transitpeptid der plastidären Isopentenyl-pyrophosphat Isome- rase-2 (IPP-2) aus Arabisopsis thaliana und das Transitpeptid der kleinen Untereinheit der Ribulosebisphospaht Carboxylase (rbcS) aus Erbse (Guerineau, F, Woolston, S, Brooks, L, Mullineaux, P (1988) An expression cassette for targeting foreign proteins into the chloroplstas. Nucl. Acids Res . 16: 11380).Further examples of a plastid transit peptide are the transit peptide of the plastid isopentenyl pyrophosphate isomerase-2 (IPP-2) from Arabisopsis thaliana and the transit peptide of the small subunit of the ribulose bisphosphate carboxylase (rbcS) from pea (Guerineau, F, Woolston, S Brooks, L, Mullineaux, P (1988) An expression cassette for targeting foreign proteins into the chloroplstas. Nucl. Acids Res. 16: 11380).
Die erfindungsgemäßen Nukleinsäuren können synthetisch hergestellt oder natürlich gewonnen sein oder eine Mischung aus synthetischen und natürlichen Nukleinsäure-Bestandteilen enthalten, sowie aus verschiedenen heterologen Genabschnitten verschiedener Organismen bestehen.The nucleic acids according to the invention can be produced synthetically or obtained naturally or contain a mixture of synthetic and natural nucleic acid constituents, and can consist of different heterologous gene segments from different organisms.
Bevorzugt sind, wie vorstehend beschrieben, synthetische Nukleo- tid-Sequenzen mit Kodons, die von Pflanzen bevorzugt werden. Diese von Pflanzen bevorzugten Kodons können aus Kodons mit der höchsten Proteinhäufigkeit bestimmt werden, die in den meisten interessanten Pflanzenspezies exprimiert werden.As described above, preference is given to synthetic nucleotide sequences with codons which are preferred by plants. These plant-preferred codons can be determined from the highest protein frequency codons expressed in most interesting plant species.
Bei der Präparation einer Expressionskassette können verschiedene DNA-Fragmente manipuliert werden, um eine Nukleotid-Sequenz zu erhalten, die zweckmäßigerweise in der korrekten Richtung liest und die mit einem korrekten Leseraster ausgestattet ist. Für die Verbindung der DNA-Fragmente miteinander können an die Fragmente Adaptoren oder Linker angesetzt werden.When preparing an expression cassette, various DNA fragments can be manipulated in order to obtain a nucleotide sequence which expediently reads in the correct direction and which is equipped with a correct reading frame. To connect the DNA fragments to one another, adapters or linkers can be attached to the fragments.
Zweckmäßigerweise können die Promotor- und die Terminator-Regio- nen in Transkriptionsrichtung mit einem Linker oder Polylinker, der eine oder mehrere Restriktionsstellen für die Insertion dieser Sequenz enthält, versehen werden. In der Regel hat der Linker 1 bis 10, meistens 1 bis 8, vorzugsweise 2 bis 6 Restriktionsstellen. Im allgemeinen hat der Linker innerhalb der regulatori- sehen Bereiche eine Größe von weniger als 100 bp, häufig weniger als 60 bp, mindestens jedoch 5 bp. Der Promotor kann sowohl nativ bzw. homolog als auch fremdartig bzw. heterolog zur Wirtspflanze sein. Die Expressionskassette beinhaltet vorzugsweise in der 5 ' -3 ' -Transkriptionsrichtung den Promotor, eine kodierende Nukleinsäuresequenz oder ein Nukleinsäurekonstrukt und eine Region für die transkriptionale Termination. Verschiedene Ter- minationsbereiche sind gegeneinander beliebig austauschbar.The promoter and terminator regions can expediently be provided in the transcription direction with a linker or polylinker which contains one or more restriction sites for the insertion of this sequence. As a rule, the linker has 1 to 10, usually 1 to 8, preferably 2 to 6, restriction sites. In general, the linker has a size of less than 100 bp within the regulatory areas, often less than 60 bp, but at least 5 bp. The promoter can be native or homologous as well as foreign or heterologous to the host plant his. The expression cassette preferably contains in the 5 '-3' transcription direction the promoter, a coding nucleic acid sequence or a nucleic acid construct and a region for the transcriptional termination. Different termination areas are interchangeable.
Ein Beispiel für einen Terminator ist der 35S-Terminator (Guerineau et al. (1988) Nucl Acids Res . 16: 11380), der nos Terminator (Depicker A, Stachel S, Dhaese P, Zambryski P, Goodman HM. Nopaline synthase: transcript mapping and DNA sequence. J Mol Appl Genet. 1982 ; 1 (6) : 561-73) oder der ocs Terminator (Gielen, J, de Beuckeleer, M, Seurinck, J, Debroek, H, de Greve, H, Lemmers, M, van Montagu, M, Schell, J (1984) The complete sequence of the TL-DNA of the Agrobacterium tumefaciens plasmid pTiAch5. EMBO J. 3: 835-846).An example of a terminator is the 35S terminator (Guerineau et al. (1988) Nucl Acids Res. 16: 11380), the nos terminator (Depicker A, Stachel S, Dhaese P, Zambryski P, Goodman HM. Nopaline synthase: transcript mapping and DNA sequence. J Mol Appl Genet. 1982; 1 (6): 561-73) or the ocs terminator (Gielen, J, de Beuckeleer, M, Seurinck, J, Debroek, H, de Greve, H, Lemmers, M, van Montagu, M, Schell, J (1984) The complete sequence of the TL-DNA of the Agrobacterium tumefaciens plasmid pTiAch5. EMBO J. 3: 835-846).
Ferner können Manipulationen, die passende Restriktionsschnittstellen bereitstellen oder die überflüssige DNA oder Restriktionsschnittstellen entfernen, eingesetzt werden. Wo Insertionen, Deletionen oder Substitutionen wie z.B. Transitionen und Transversionen in Frage kommen, können in v ro-Mutagenese, "primer- repair", Restriktion oder Ligation verwendet werden.Manipulations which provide suitable restriction sites or which remove superfluous DNA or restriction sites can also be used. Where insertions, deletions or substitutions such as Transitions and transversions can be used in v ro mutagenesis, "primer repair", restriction or ligation.
Bei geeigneten Manipulationen, wie z.B. Restriktion, "chewing- back" oder Auffüllen von Überhängen für "bluntends", können komplementäre Enden der Fragmente für die Ligation zur Verfügung gestellt werden.With suitable manipulations, e.g. Restriction, "chewing-back" or filling of overhangs for "bluntends", complementary ends of the fragments can be made available for the ligation.
Bevorzugte Polyadenylierungssignale sind pflanzliche Polyadeny- lierungssignale, vorzugsweise solche, die im wesentlichen T-DNA- Polyadenylierungssignale aus Agrobacterium tumefaciens, insbesondere des Gens 3 der T-DNA (Octopin Synthase) des Ti-Plasmids pTiACH5 entsprechen (Gielen et al . , EMBO J. 3 (1984), 835 ff) oder funktionelle Äquivalente.Preferred polyadenylation signals are plant polyadenylation signals, preferably those which essentially correspond to T-DNA polyadenylation signals from Agrobacterium tumefaciens, in particular gene 3 of T-DNA (octopine synthase) of the Ti plasmid pTiACH5 (Gielen et al., EMBO J. 3 (1984), 835 ff) or functional equivalents.
Die Übertragung von Fremdgenen in das Genom einer Pflanze wird als Transformation bezeichnet.The transfer of foreign genes into the genome of a plant is called transformation.
Dazu können an sich bekannte Methoden zur Transformation und Regeneration von Pflanzen aus Pflanzengeweben oder Pflanzenzellen zur transienten oder stabilen Transformation genutzt werden.Methods known per se for the transformation and regeneration of plants from plant tissues or plant cells for transient or stable transformation can be used for this purpose.
Geeignete Methoden zur Transformation von Pflanzen sind die Pro- toplastentransformation durch Polyethylenglykol-induzierte DNA- Aufnahme, das biolistische Verfahren mit der Genkanone - die sogenannte particle bombardment Methode, die Elektroporation, die Inkubation trockener Embryonen in DNA-haltiger Lösung, die Mikro- injektion und der, vorstehend beschriebene, durch Agrobacterium vermittelte Gentransfer. Die genannten Verfahren sind beispielsweise in B. Jenes et al., Techniques for Gene Transfer, in: Transgenic Plants, Vol. 1, Engineering and Utilization, herausge- geben von S.D. Kung und R. Wu, Academic Press (1993), 128-143 sowie in Potrykus, Annu. Rev. Plant Physiol . Plant Molec. Biol. 42 (1991), 205-225) beschrieben.Suitable methods for the transformation of plants are the protoplast transformation by polyethylene glycol-induced DNA uptake, the biolistic method with the gene gun - the so-called particle bombardment method, the electroporation, the incubation of dry embryos in DNA-containing solution, the micro- injection and Agrobacterium-mediated gene transfer described above. The methods mentioned are described, for example, in B. Jenes et al., Techniques for Gene Transfer, in: Transgenic Plants, Vol. 1, Engineering and Utilization, edited by SD Kung and R. Wu, Academic Press (1993), 128- 143 and in Potrykus, Annu. Rev. Plant Physiol. Plant Molec. Biol. 42 (1991), 205-225).
Vorzugsweise wird das zu exprimierende Konstrukt in einen Vektor kloniert, der geeignet ist, Agrobacterium tumefaciens zu transformieren, beispielsweise pBinl9 (Bevan et al . , Nucl. Acids Res . 12 (1984), 8711) oder besonders bevorzugt pSUN2 , pSUN3 , pSUN4 oder pSUN5 (WO 02/00900) .The construct to be expressed is preferably cloned into a vector which is suitable for transforming Agrobacterium tumefaciens, for example pBin19 (Bevan et al., Nucl. Acids Res. 12 (1984), 8711) or particularly preferably pSUN2, pSUN3, pSUN4 or pSUN5 (WO 02/00900).
Mit einem Expressionsplasmid transformierte Agrobakterien können in bekannter Weise zur Transformation von Pflanzen verwendet werden, z.B. indem verwundete Blätter oder Blattstücke in einer Agrobakterienlösung gebadet und anschließend in geeigneten Medien kultiviert werden.Agrobacteria transformed with an expression plasmid can be used in a known manner to transform plants, e.g. by bathing wounded leaves or leaf pieces in an agrobacterial solution and then cultivating them in suitable media.
Zur bevorzugten Herstellung von genetisch veränderten Pflanzen, im folgenden auch transgene Pflanzen bezeichnet, wird die fusionierte Expressionskassette, die eine Ketolase exprimiert, in einen Vektor, beispielsweise pBinl9 oder insbesondere pSUN2 klo- niert, der geeignet ist, in Agrobacterium tumefaciens transformiert zu werdenFor the preferred production of genetically modified plants, hereinafter also referred to as transgenic plants, the fused expression cassette, which expresses a ketolase, is cloned into a vector, for example pBin19 or in particular pSUN2, which is suitable for being transformed into Agrobacterium tumefaciens
Mit einem solchen Vektor transformierte Agrobakterien können dann in bekannter Weise zur Transformation von Pflanzen, insbesondere von Kulturpflanzen verwendet werden, indem beispielsweise verwundete Blätter oder Blattstücke in einer Agrobakterienlösung gebadet und anschließend in geeigneten Medien kultiviert werden.Agrobacteria transformed with such a vector can then be used in a known manner to transform plants, in particular crop plants, for example by bathing wounded leaves or leaf pieces in an agrobacterial solution and then cultivating them in suitable media.
Die Transformation von Pflanzen durch Agrobakterien ist unter anderem bekannt aus F.F. White, Vectors for Gene Transfer inThe transformation of plants by agrobacteria is known, among other things, from F.F. White, Vectors for Gene Transfer in
Higher Plants; in Transgenic Plants, Vol. 1, Engineering and Utilization, herausgegeben von S.D. Kung und R. Wu, Academic Press, 1993, S. 15-38. Aus den transformierten Zellen der verwundeten Blätter bzw. Blattstücke können in bekannter Weise transgene Pflanzen regeneriert werden, die ein in die Expressionskassette integriertes Gen für die Expression einer Nukleinsäure codierend eine Ketolase enthalten.Higher plants; in Transgenic Plants, Vol. 1, Engineering and Utilization, edited by S.D. Kung and R. Wu, Academic Press, 1993, pp. 15-38. From the transformed cells of the wounded leaves or leaf pieces, transgenic plants can be regenerated in a known manner, which plants contain a gene encoding the expression cassette for the expression of a nucleic acid encoding a ketolase.
Zur Transformation einer Wirtspflanze mit einer für eine Ketolase kodierenden Nukleinsäure wird eine Expressionskassette als Insertion in einen rekombinanten Vektor eingebaut, dessen Vektor-DNA zusätzliche funktioneile Regulationssignale, beispielsweise Sequenzen für Replikation oder Integration enthält . Geeignete Vektoren sind unter anderem in "Methods in Plant Molecular Bio- logy and Biotechnology" (CRC Press), Kap. 6/7, S. 71-119 (1993) beschrieben.To transform a host plant with a nucleic acid coding for a ketolase, an expression cassette is inserted as an insert into a recombinant vector whose vector DNA contains additional functional regulatory signals, for example Contains sequences for replication or integration. Suitable vectors are described in "Methods in Plant Molecular Biology and Biotechnology" (CRC Press), Chap. 6/7, pp. 71-119 (1993).
Unter Verwendung der oben zitierten Rekombinations- und Klonie- rungstechniken können die Expressionskassetten in geeignete Vektoren kloniert werden, die ihre Vermehrung, beispielsweise in E. coli , ermöglichen. Geeignete Klonierungsvektoren sind u.a. pJITH7 (Guerineau et al . (1988) Nucl. Acids Res.16 :11380), pBR332, pUC-Serien, Ml3mp-Serien ,pACYC184, pMC1210, pMcl 210 und pCLl920. Besonders geeignet sind binäre Vektoren, die sowohl in E. coli als auch in Agrobakterien replizieren können.Using the recombination and cloning techniques cited above, the expression cassettes can be cloned into suitable vectors which enable their multiplication, for example in E. coli. Suitable cloning vectors include pJITH7 (Guerineau et al. (1988) Nucl. Acids Res. 16: 11380), pBR332, pUC series, Ml3mp series, pACYC184, pMC1210, pMcl 210 and pCLl920. Binary vectors which can replicate both in E. coli and in agrobacteria are particularly suitable.
Dabei kann je nach Wahl des Promotors die Expression konstitutiv oder vorzugsweise spezifisch in den Früchten erfolgen.Depending on the choice of the promoter, the expression can be constitutive or preferably specific in the fruit.
Dementsprechend betrifft die Erfindung ferner ein Verfahren zur Herstellung von genetisch veränderten Pflanzen, dadurch gekenn- zeichnet, dass man ein Nukleinsäurekonstrukt, enthaltend funktionell verknüpft einen fruchtspezifischen Promotor und Nukleinsäuren kodierend eine Ketolase in das Genom der Ausgangspfϊanze einführt .Accordingly, the invention further relates to a method for producing genetically modified plants, characterized in that a nucleic acid construct containing functionally linked, a fruit-specific promoter and nucleic acids encoding a ketolase is introduced into the genome of the starting plant.
Die Erfindung betrifft ferner die genetisch veränderten Pflanzen, die im Vergleich zur Ausgangspflanze in Früchten eine Ketolase- Aktivität aufweist.The invention further relates to the genetically modified plants which have a ketolase activity in fruits compared to the starting plant.
Die Ketolaseaktivität wird in einer bevorzugten Ausführungsform dadurch erreicht, dass die genetisch veränderte Pflanze in den Früchten eine Ketolase exprimiert .In a preferred embodiment, the ketolase activity is achieved in that the genetically modified plant expresses a ketolase in the fruit.
Die bevorzugten, genetisch veränderten Pflanzen enthalten daher in Früchten mindestens eine Nukleinsäure, kodierend eine Keto- läse.The preferred, genetically modified plants therefore contain at least one nucleic acid encoding a keto-glass in fruits.
In einer weiter bevorzugten Ausführungsform erfolgt, wie vorstehend ausgeführt, die Verursachung der Genexpression einer Nukleinsäure, kodierend eine Ketolase, durch Einbringen von Nukleinsäuren, kodierend eine Ketolase, in die Ausgangspflanze.In a further preferred embodiment, as explained above, the gene expression of a nucleic acid, coding for a ketolase, is caused by introducing nucleic acids, coding for a ketolase, into the starting plant.
Der Erfindung betrifft daher besonders bevorzugt eine vorstehend beschriebene genetisch veränderte Pflanze, dadurch gekennzeichnet, dass man in die Pflanze ausgehend von einer Ausgangspflanze mindestens eine Nukleinsäure, kodierend eine Ketolase eingebracht hat. Die Erfindung betrifft insbesondere genetisch veränderte Pflanzen, ausgewählt aus den Pflanzengattungen Actinophloeus, Aglaeo- nema, Ananas, Arbutus, Archontophoenix, Area, Aronia, Asparagus, Attalea, Berberis, Bixia, Brachychilum, Bryonia, Caliptocalix, Capsicum, Carica, Celastrus, Citrullus, Citrus, Convallaria, Cotoneaster, Crataegus, Cucumis, Cucurbita, Cuscuta, Cycas, Cyphomandra, Dioscorea, Diospyrus, Dura, Elaeagnus, Elaeis, Erythroxylon, Euonymus, Ficus, Fortunella, Fragaria, Gardinia, Gonocaryum, Gossypium, Guava, Guilielma, Hibiscus, Hippophaea, Iris, Lathyrus, Lonicera, Luffa, Lycium, Lycopersicum, Malpighia, Mangifera, Mormodica, Murraya, Musa, Nenga, Palisota, Pandanus , Passiflora, Persea, Physalis, Prunus, Ptychandra, Punica, Pyra- cantha, Pyrus, Ribes, Rosa, Rubus, Sabal, Sambucus, Seaforita, Shepherdia, Solanum, Sorbus, Synaspadix, Tabernae, Tamus , Taxus, Trichosanthes, Triphasia, Vaccinium, Viburnum, Vignia oder Vitis, enthaltend mindestens eine Nukleinsäure, kodierend eine Ketolase.The invention therefore particularly preferably relates to a genetically modified plant described above, characterized in that, starting from a starting plant, at least one nucleic acid coding for a ketolase has been introduced into the plant. The invention relates in particular to genetically modified plants selected from the plant genera Actinophloeus, Aglaeo-nema, pineapple, Arbutus, Archontophoenix, Area, Aronia, Asparagus, Attalea, Berberis, Bixia, Brachychilum, Bryonia, Caliptocalix, Capsicum, Carica, Celastrus, Citrullus, Citrus, Convallaria, Cotoneaster, Crataegus, Cucumis, Cucurbita, Cuscuta, Cycas, Cyphomandra, Dioscorea, Diospyrus, Dura, Elaeagnus, Elaeis, Erythroxylon, Euonymus, Ficus, Fortunella, Fragaria, Gardinia, Gonocaryum, Gossypilma, Gossypilma, Guossilium, Guossypium, Guossypium, Gu Hippophaea, Iris, Lathyrus, Lonicera, Luffa, Lycium, Lycopersicum, Malpighia, Mangifera, Mormodica, Murraya, Musa, Nenga, Palisota, Pandanus, Passiflora, Persea, Physalis, Prunus, Ptychandra, Punica, Pyra- cantha, Pyrus, Ribes Rosa, Rubus, Sabal, Sambucus, Seaforita, Shepherdia, Solanum, Sorbus, Synaspadix, Tabernae, Tamus, Taxus, Trichosanthes, Triphasia, Vaccinium, Viburnum, Vignia or Vitis, containing at least one nucleic acid, kodi a ketolase.
Ganz besonders bevorzugte Pflanzengattungen sind Ananas, Asparagus, Capsicum, Citrus, Cucumis, Cucurbita, Citrullus, Lycopersicum, Passiflora, Prunus, Physalis, Solanum, Vaccinium und Vitis, enthaltend mindestens eine transgene Nukleinsäure, kodierend eine Ketolase.Very particularly preferred plant genera are pineapple, asparagus, capsicum, citrus, cucumis, cucurbita, citrullus, lycopersicum, passiflora, prunus, physalis, solanum, vaccinium and vitis, containing at least one transgenic nucleic acid, encoding a ketolase.
Wie vorstehend erwähnt wird in bevorzugten transgenen Pflanzen die Ketolase in den Früchten exprimiert, besonderes bevorzugt ist die Expression der Ketolase in den Früchten am höchsten.As mentioned above, the ketolase is expressed in the fruits in preferred transgenic plants, particularly preferably the expression of the ketolase is highest in the fruits.
Besonders bevorzugte, genetisch veränderte Pflanzen weisen, wie vorstehend erwähnt, zusätzlich eine erhöhte Hydroxylase-Aktivität und/oder ß-Cyclase-Aktivität gegenüber einer Wildpflanze auf. Weiter bevorzugte Ausführungsformen sind vorstehend im erfindungsgemäßen Verfahren beschrieben.As mentioned above, particularly preferred, genetically modified plants additionally have an increased hydroxylase activity and / or β-cyclase activity compared to a wild plant. Further preferred embodiments are described above in the method according to the invention.
Die transgenen Pflanzen, deren Vermehrungsgut, sowie deren Pflan- zenzellen, -gewebe oder -teile, insbesondere deren Früchte sind ein weiterer Gegenstand der vorliegenden Erfindung.The present invention further relates to the transgenic plants, their propagation material, and their plant cells, tissue or parts, in particular their fruits.
Die genetisch veränderten Pflanzen können, wie vorstehend beschrieben, zur Herstellung von Ketocarotinoiden, insbesondere Astaxanthin, verwendet werden.The genetically modified plants can, as described above, be used to produce ketocarotenoids, in particular astaxanthin.
Von Menschen und Tieren verzehrbare erfindungsgemäße, genetisch veränderte Pflanzen mit erhöhtem Gehalt an Ketocarotinoiden können auch beispielsweise direkt oder nach an sich bekannter Pro- zessierung als Nahrungsmittel oder Futtermittel oder als Futter- und Nahrungsergänzungsmittel verwendet werden. Ferner können die genetisch veränderten Pflanzen zur Herstellung von Ketocaroti- noid-haltigen Extrakten der Pflanzen und/oder zur Herstellung von Futter- und Nahrungsergänzungsmitteln verwendet werden.Genetically modified plants according to the invention with an increased content of ketocarotenoids which can be consumed by humans and animals can also be used, for example, directly or after processing known per se as food or feed or as feed and food supplements. Furthermore, the genetically modified plants for the production of ketocarotenoids extracts of the plants containing noid and / or for the production of feed and food supplements.
Die genetisch veränderten Pflanzen weisen im Vergleich zum Wild- 5 typ einen erhöhten Gehalt an Ketocarotinoiden auf.The genetically modified plants have an increased ketocarotenoid content compared to the wild type.
Unter einem erhöhten Gehalt an Ketocarotinoiden wird in der Regel ein erhöhter Gehalt an Gesamt-Ketocarotinoid verstanden.An increased ketocarotenoid content is generally understood to mean an increased total ketocarotenoid content.
10 Unter einem erhöhten Gehalt an Ketocarotinoiden wird aber auch insbesondere ein veränderter Gehalt der bevorzugten Ketocarotinoide verstanden, ohne dass zwangsläufig der Gesamt-Carotinoidge- halt erhöht sein muss.10 An increased content of ketocarotenoids is also understood to mean, in particular, a changed content of the preferred ketocarotenoids, without the total carotenoid content necessarily having to be increased.
15 In einer besonders bevorzugten Ausführungsform weisen die erfindungsgemäßen, genetisch veränderten Pflanzen im Vergleich zum Wildtyp einen erhöhten Gehalt an Astaxanthin auf.In a particularly preferred embodiment, the genetically modified plants according to the invention have an increased astaxanthin content compared to the wild type.
Unter einem erhöhten Gehalt wird in diesem Fall insbesondereIn this case, an increased salary is particularly
20 ein verursachter Gehalt an Ketocarotinoiden, bzw. Astaxanthin verstanden. x20 understood a caused content of ketocarotenoids or astaxanthin. x
Die Erfindung wird durch die nun folgenden Beispiele erläutert, ist aber nicht auf diese beschränkt: 25The invention is illustrated by the following examples, but is not limited to these: 25
Allgemeine Experimentelle Bedingungen: Sequenzanalyse rekombinanter DNAGeneral experimental conditions: Sequence analysis of recombinant DNA
Die Sequenzierung rekombinanter DNA-Moleküle erfolgte mit einem 30 Laserfluoreszenz-DNA-Sequenzierer der Firma Licor (Vertrieb durch MWG Biotech, Ebersbach) nach der Methode von Sanger (Sanger et al., Proc. Natl. Acad. Sei. USA 74 (1977), 5463-5467).The sequencing of recombinant DNA molecules was carried out with a laser fluorescence DNA sequencer from Licor (sales by MWG Biotech, Ebersbach) according to the method of Sanger (Sanger et al., Proc. Natl. Acad. Sci. USA 74 (1977) , 5463-5467).
Beispiel 1: Amplifikation einer cDNA, die die gesamte Primär- 35 sequenz der Ketolase aus Haematococcus pluvialis Flo- tow em. Wille kodiertExample 1: Amplification of a cDNA which contains the entire primary sequence of the ketolase from Haematococcus pluvialis Floow em. Will encodes
Die cDNA, die für die Ketolase aus Haematococcus pluvialis kodiert, wurde mittels PCR aus Haematococcus pluvialis .(Stamm 40 192.80 der "Sammlung von Algenkulturen der Universität Göttingen") Suspensionskultur amplifiziert .The cDNA coding for the ketolase from Haematococcus pluvialis was amplified by PCR from Haematococcus pluvialis (strain 40 192.80 from the "Collection of algal cultures of the University of Göttingen") suspension culture.
Für die Präparation von Total-RNA aus einer Suspensionskultur von Haematococcus pluvialis (Stamm 192.80), die 2 Wochen mit in- 45 direktem Tageslicht bei Raumtemperatur in Haerπatococcus-_Medium (1-.2 g/1 Natriu acetat, 2 g/1 Hefeextrakt, 0.2 g/1 MgC12x6H20, 0.02 CaCl2x2H20; pH 6.8; nach Autoklavieren Zugabe von 400 mg/1 L-Asparagin, 10 mg/1 FeS04xH20) gewachsen war, wurden die Zellen geerntet, in flüssigem Stickstoff eingefroren und im Mörser pulverisiert. Anschließend wurden 100 mg der gefrorenen, pulverisierten Algenzellen in ein Reaktionsgefäß überführt und in 0,8 ml Trizol-Puffer (Life Technologies) aufgenommen. Die Suspension wurde mit 0,2 ml Chloroform extrahiert. Nach 15minütiger Zentri- fugation bei 12000 g wurde der wässrige Überstand abgenommen und in ein neues Reaktionsgefäß überführt und mit einem Volumen Ethanol extrahiert . Die RNA wurde mit einem Volumen Isopropanol gefällt, mit 75 % Ethanol gewaschen und das Pellet in DEPC Wasser (über Nacht Inkubation von Wasser mit 1/1000 Volumen Diethylpyro- carbonat bei Raumtemperatur, anschließend autoklaviert) gelöst. Die RNA-Konzentration wurde photometrisch bestimmt.For the preparation of total RNA from a suspension culture of Haematococcus pluvialis (strain 192.80), which has been used for 2 weeks with direct sunlight at room temperature in Haerπatococcus medium (1 - .2 g / 1 sodium acetate, 2 g / 1 yeast extract, 0.2 g / 1 MgC12x6H20, 0.02 CaCl2x2H20; pH 6.8; after autoclaving, add 400 mg / 1 L-asparagine, 10 mg / 1 FeS04xH20), the cells were harvested, frozen in liquid nitrogen and pulverized in a mortar. Then 100 mg of the frozen, pulverized algal cells were transferred to a reaction vessel and taken up in 0.8 ml of Trizol buffer (Life Technologies). The suspension was extracted with 0.2 ml of chloroform. After centrifugation at 12,000 g for 15 minutes, the aqueous supernatant was removed and transferred to a new reaction vessel and extracted with a volume of ethanol. The RNA was precipitated with a volume of isopropanol, washed with 75% ethanol and the pellet dissolved in DEPC water (overnight incubation of water with 1/1000 volume of diethyl pyrocarbonate at room temperature, then autoclaved). The RNA concentration was determined photometrically.
Für die cDNA-Synthese wurden 2.5 μg Gesamt-RNA für 10 min bei 60°C denaturiert, für 2 min auf Eis abgekühlt und mittels eines cDNA-Kits (Ready-to-go-you-prime-beads, Pharmacia Biotech) nach Herstellerangaben unter Verwendung eines antisense spezifischen Primers (PRl SEQ ID No . 29) in cDNA umgeschrieben.For the cDNA synthesis, 2.5 μg of total RNA were denatured for 10 min at 60 ° C., cooled on ice for 2 min and using a cDNA kit (ready-to-go-you-prime beads, Pharmacia Biotech) according to the manufacturer's instructions rewritten into cDNA using an antisense specific primer (PRI SEQ ID No. 29).
Die Nukleinsäure codierend eine Ketolase aus Haematococcus x pluvialis (Stamm 192.80) wurde mittels polymerase chain reactionThe nucleic acid encoding a ketolase from Haematococcus x pluvialis (strain 192.80) was determined using the polymerase chain reaction
(PCR) aus Haematococcus pluvialis unter Verwendung eines sense spezifischen Primers (PR2 SEQ ID No . 30) und eines antisense spezifischen Primers (PRl SEQ ID No . 29) amplifiziert .(PCR) from Haematococcus pluvialis using a sense-specific primer (PR2 SEQ ID No. 30) and an antisense-specific primer (PRI SEQ ID No. 29).
Die PCR-Bedingungen waren die folgenden:The PCR conditions were as follows:
Die PCR zur Amplifikation der cDNA, die für ein Ketolase Protein bestehend aus der gesamten Primärsequenz kodiert, erfolgte in einem 50 μl Reaktionsansatz, in dem enthalten war:The PCR for the amplification of the cDNA, which codes for a ketolase protein consisting of the entire primary sequence, was carried out in a 50 μl reaction mixture which contained:
- 4 μl einer Haematococcus pluvialis cDNA (hergestellt wie oben beschrieben) - 0,25 mM dNTPs- 4 ul of a Haematococcus pluvialis cDNA (prepared as described above) - 0.25 mM dNTPs
0,2 mM PRl (SEQ ID No . 29) 0,2 mM PR2 (SEQ ID No. 30)0.2 mM PRI (SEQ ID No. 29) 0.2 mM PR2 (SEQ ID No. 30)
- 5 μl 10X PCR-Puffer (TAKARA) 0,25 μl R Taq Polymerase (TAKARA) - 25,8 μl Aq. Dest.- 5 μl 10X PCR buffer (TAKARA) 0.25 μl R Taq polymerase (TAKARA) - 25.8 μl Aq. Least.
Die PCR wurde unter folgenden Zyklusbedingungen durchgeführt:The PCR was carried out under the following cycle conditions:
IX 94°C 2 MinutenIX 94 ° C 2 minutes
35X 94°C 1 Minute35X 94 ° C 1 minute
53°C 2 Minuten53 ° C for 2 minutes
72°C 3 Minuten IX 72°C 10 Minuten72 ° C for 3 minutes IX 72 ° C 10 minutes
Die PCR-Amplifikation mit SEQ ID No. 29 und SEQ ID No . 30 resultierte in einem 1155 Bp-Fragment, das für ein Protein bestehend aus der gesamten Primärsequenz kodiert (SEQ ID No. 22). Unter Verwendung von Standardmethoden wurde das Amplifikat in den PCR- Klonierungsvektor pGEM-Teasy (Promega) kloniert und der Klon pGKET02 erhalten.PCR amplification with SEQ ID No. 29 and SEQ ID No. 30 resulted in an 1155 bp fragment coding for a protein consisting of the entire primary sequence (SEQ ID No. 22). Using standard methods, the amplificate was cloned into the PCR cloning vector pGEM-Teasy (Promega) and the clone pGKET02 was obtained.
Sequenzierung des Klons pGKET02 mit dem T7- und dem SP6-Primer bestätigte eine Sequenz, die sich lediglich in den drei Kodons 73, 114 und 119 in je einer Base von der publizierten Sequenz X86782 unterscheidet. Diese Nukleotidaustausche wurden in einem unabhängigem Amplifikationsexperiment reproduziert und repräsentieren somit die Nukleotidsequenz im verwendeten Haematococcus pluvialis Stamm 192.80 (Abbildung 3 und 4, Sequenzvergleiche) .Sequencing of the clone pGKET02 with the T7 and the SP6 primer confirmed a sequence which differs from the published sequence X86782 only in the three codons 73, 114 and 119 in one base each. These nucleotide changes were reproduced in an independent amplification experiment and thus represent the nucleotide sequence in the Haematococcus pluvialis strain 192.80 used (Figures 3 and 4, sequence comparisons).
Dieser Klon wurde daher für die Klonierung in den Expressionsvek- tor pJITH7 (Guerineau et al . 1988, Nucl. Acids Res . 16: 11380) verwendet. Die Klonierung erfolgte durch Isolierung des 1027 Bp SpHI-Fragmentes aus pGKET02 und Ligierung in den SpHI geschnittenen Vektor pJIT117. Der Klon, der das Haematococcus pluvialis Ke- tolasegen in der korrekten Orientierung als N-terminale transla- tionale Fusion mit der rbcs Transitpeptidsequenz enthält, heißt pJKET02.This clone was therefore used for cloning into the expression vector pJITH7 (Guerineau et al. 1988, Nucl. Acids Res. 16: 11380). The cloning was carried out by isolating the 1027 bp SpHI fragment from pGKET02 and ligation into the SpHI-cut vector pJIT117. The clone that contains the Haematococcus pluvialis ketola gene in the correct orientation as an N-terminal translational fusion with the rbcs transit peptide sequence is called pJKET02.
Beispiel 2: Amplifikation einer cDNA, die die Ketolase aus Haematococcus pluvialis Flotow em. Wille mit einem um 14 Aminosäuren verkürztem N-terminus kodiertExample 2: Amplification of a cDNA which contains the ketolase from Haematococcus pluvialis Flotow em. Will encoded with an N-terminus shortened by 14 amino acids
Die cDNA, die für die Ketolase aus Haematococcus pluvialis (Stamm 192.80) mit einem um 14 Aminosäuren verkürztem N-Termi- nus kodiert, wurde mittels PCR aus Haematococcus pluvialis Sus- pensionskultur (Stamm 192.80 der "Sammlung von Algenkulturen der Universität Göttingen") amplifiziert .The cDNA, which codes for the ketolase from Haematococcus pluvialis (strain 192.80) with an N-terminus shortened by 14 amino acids, was amplified by PCR from Haematococcus pluvialis suspension culture (strain 192.80 from the "Collection of algal cultures of the University of Göttingen") ,
Die Präparation von Total-RNA aus einer Suspensionskultur von Haematococcus pluvialis (Stamm 192.80) erfolgte wie in Beispiel 1 beschrieben.Total RNA was prepared from a suspension culture of Haematococcus pluvialis (strain 192.80) as described in Example 1.
Die cDNA-Synthese erfolgte wie unter Beispiel 1 beschrieben.The cDNA synthesis was carried out as described in Example 1.
Die Nukleinsäure, kodierend eine Ketolase, aus Haema tococcus pluvialis (Stamm 192.80) mit einem um 14 Aminosäuren verkürztem N-Terminus wurde mittels polymerase chain reaction (PCR) ausThe nucleic acid encoding a ketolase from Haema tococcus pluvialis (strain 192.80) with an N-terminus shortened by 14 amino acids was extracted by means of polymerase chain reaction (PCR)
Haematococcus pluvialis unter Verwendung eines sense spezifischen Primers (PR3 SEQ ID No. 31) und eines antisense spezifischen Primers (PRl SEQ ID No. 29) amplifiziert.Haematococcus pluvialis using a sense specific Primers (PR3 SEQ ID No. 31) and an antisense specific primer (PRI SEQ ID No. 29) amplified.
Die PCR-Bedingungen waren die folgenden:The PCR conditions were as follows:
55
Die PCR zur Amplifikation der cDNA, die für ein Ketolase Protein mit um 14 Aminosäuren verkürztem N-Terminus kodiert, erfolgte in einem 50 μl Reaktionsansatz, in dem enthalten war:The PCR for the amplification of the cDNA, which codes for a ketolase protein with an N-terminus shortened by 14 amino acids, was carried out in a 50 μl reaction mixture which contained:
10 - 4 μl einer Haema tococcus pluvialis cDNA (hergestellt wie oben beschrieben)10 - 4 μl of a Haema tococcus pluvialis cDNA (prepared as described above)
0,25 mM dNTPs0.25 mM dNTPs
0,2 mM PRl (SEQ ID No. 29)0.2 mM PRI (SEQ ID No. 29)
0,2 mM PR3 (SEQ ID No . 31)0.2 mM PR3 (SEQ ID No. 31)
15 - 5 μl 10X PCR-Puffer (TAKARA)15 - 5 μl 10X PCR buffer (TAKARA)
0,25 μl R Taq Polymerase (TAKARA)0.25 μl R Taq polymerase (TAKARA)
25,8 μl Aq. Dest.25.8 ul Aq. Least.
Die PCR wurde unter folgenden Zyklusbedingungen durchgeführt;The PCR was carried out under the following cycle conditions;
2020
IX 94°C 2 Minuten 35X 94°C 1 Minute 53°C 2 Minuten 72°C 3 MinutenIX 94 ° C 2 minutes 35X 94 ° C 1 minute 53 ° C 2 minutes 72 ° C 3 minutes
25 IX 72°C 10 Minuten25 IX 72 ° C 10 minutes
Die PCR-Amplifikation mit SEQ ID No.29 und SEQ ID No. 31 resultierte in einem 1111 Bp Fragment, das für ein Ketolase Protein kodiert, bei dem N-terminalen Aminosäuren (Position 2-16) durch 30 eine einzige Aminosäure (Leucin) ersetzt sind.PCR amplification with SEQ ID No.29 and SEQ ID No. 31 resulted in an 1111 bp fragment coding for a ketolase protein in which the N-terminal amino acids (position 2-16) are replaced by 30 a single amino acid (leucine).
Das Amplifikat wurde unter Verwendung von Standardmethoden in den PCR-Klonierungsvektor pGEM-Teasy (Promega) kloniert und der Klon pGKET03 erhalten. Sequenzierungen mit den Primern T7- undThe amplificate was cloned into the PCR cloning vector pGEM-Teasy (Promega) using standard methods and the clone pGKET03 was obtained. Sequencing with the primers T7 and
35 SP6 bestätigten eine zur Sequenz SEQ ID No. 22 identische35 SP6 confirmed a sequence SEQ ID No. 22 identical
Sequenz, wobei die 5'Region (Position 1-53) der SEQ ID No. 22 im Amplikikat SEQ ID No . 24 durch eine in der Sequenz abweichende Nonamersequenz ersetzt wurde. Dieser Klon wurde daher für die Klonierung in den Expressionsvektor pJITH7 (Guerineau et al.Sequence, the 5 'region (position 1-53) of SEQ ID No. 22 in the SEQ ID No. 24 has been replaced by a nonamer sequence differing in sequence. This clone was therefore used for cloning into the expression vector pJITH7 (Guerineau et al.
40 1988, Nucl. Acids Res . 16: 11380) verwendet.40 1988, Nucl. Acids Res. 16: 11380) is used.
Die Klonierung erfolgte durch Isolierung des 985 Bp SpHI Fragmentes aus pGKET03 und Ligierung mit dem SpHI geschnittenen Vektor pJITH7. Der Klon, der die Haematococcus pluvialis Ketolase mit 45 einem um 14 Aminosäuren verkürztem N-Terminus in der korrekten Orientierung als N-terminale translationale Fusion mit dem rbcs Transitpeptid enthält, heißt pJKET03.The cloning was carried out by isolating the 985 bp SpHI fragment from pGKET03 and ligation with the SpHI-cut vector pJITH7. The clone that contains the correct Haematococcus pluvialis ketolase with 45 N-terminus shortened by 14 amino acids Containing orientation as an N-terminal translational fusion with the rbcs transit peptide is called pJKET03.
Beispiel 3 : Amplifikation einer cDNA, die die Ketolase aus Haema- 5 tococcus pluvialis Flotow em. Wille (Stamm 192.80 derExample 3: Amplification of a cDNA which contains the ketolase from Haema-5 tococcus pluvialis Flotow em. Will (tribe 192.80 the
"Sammlung von Algenkulturen der Universität Göttingen" ) bestehend aus der gesamten Primärsequenz und fusioniertem C-terminalem myc-Tag kodiert"Collection of algal cultures from the University of Göttingen") consisting of the entire primary sequence and fused C-terminal myc tag
10 Die cDNA, die für die Ketolase aus Haematococcus pluvialis (Stamm 192.80) bestehend aus der gesamten Primärsequenz und fusioniertem C-terminalem myc-Tag kodiert, wurde mittels PCR unter Verwendung des Plasmids pGKET02 (in Beispiel 1 beschrieben) und des Primers PR15 (SEQ ID No. 32) hergestellt. Der Primer PR15 setzt sich zu-10 The cDNA coding for the ketolase from Haematococcus pluvialis (strain 192.80) consisting of the entire primary sequence and fused C-terminal myc tag was PCR-analyzed using the plasmid pGKET02 (described in Example 1) and the primer PR15 (SEQ ID No. 32). The PR15 primer
15 sammen aus einer antisense spezifischen 3 'Region (Nucleotide15 come from an antisense specific 3 'region (nucleotides
40-59) und einer myc-Tag kodierenden 5 'Region (Nucleotide 1-39).40-59) and a 5 'region encoding myc-tag (nucleotides 1-39).
Die Denaturierung (5 min bei 95°C) und Annealing (langsame Abkühlung bei Raumtemperatur auf 40°C) von pGKET02 und PR15 erfolgte in 20 einem 11,5 μl Reaktionsansatz, in dem enthalten war:The denaturation (5 min at 95 ° C.) and annealing (slow cooling at room temperature to 40 ° C.) of pGKET02 and PR15 was carried out in an 11.5 μl reaction mixture which contained:
1 μg pGKET02 PlasmidDNA 0,1 μg PR15 (SEQ ID No . 32;1 μg pGKET02 plasmid DNA 0.1 μg PR15 (SEQ ID No. 32;
25 Das Auffüllen der 3 'Enden (30 min bei 30°C) erfolgte in einem 20 μl Reaktionsansatz, in dem enthalten war:25 The 3 'ends were filled in (30 min at 30 ° C.) in a 20 μl reaction mixture which contained:
11,5 μl pGKET02/PR15-Annealingsreaktion (hergestellt wie oben beschrieben)11.5 μl pGKET02 / PR15 annealing reaction (prepared as described above)
30 - 50 μM dNTPs30-50 µM dNTPs
2 μl IX Klenow Puffer2 ul IX Klenow buffer
2U Klenow Enzym2U Klenow enzyme
Die Nukleinsäure kodierend eine Ketolase aus Haematococcus 35 pluvialis (Stamm 192.80) bestehend aus der gesamten Primärsequenz und fusioniertem C-terminalem myc-Tag wurde mittels polymerase chain reaction (PCR) aus Haematococcus pluvialis unter Verwendung eines sense spezifischen Primers (PR2 SEQ ID No . 30) und eines antisense spezifischen Primers (PR15 SEQ ID No . 32) amplifiziert .The nucleic acid encoding a ketolase from Haematococcus 35 pluvialis (strain 192.80) consisting of the entire primary sequence and fused C-terminal myc tag was determined by means of polymerase chain reaction (PCR) from Haematococcus pluvialis using a sense-specific primer (PR2 SEQ ID No. 30 ) and an antisense-specific primer (PR15 SEQ ID No. 32).
4040
Die PCR-Bedingungen waren die folgenden:The PCR conditions were as follows:
Die PCR zur Amplifikation der cDNA, die für ein Ketolase Protein mit fusioniertem C-terminalem myc-Tag kodiert, erfolgte in einem 45 50 μl Reaktionsansatz, in dem enthalten war: - 1 μl einer Annealingsreaktion (hergestellt wie oben beschrieben) 0,25 mM dNTPsThe PCR for the amplification of the cDNA, which codes for a ketolase protein with a fused C-terminal myc tag, was carried out in a 45 50 μl reaction mixture which contained: - 1 ul of an annealing reaction (prepared as described above) 0.25 mM dNTPs
0,2 μM PR15 (SEQ ID No . 32) - 0,2 μM PR2 (SEQ ID No . 30)0.2 μM PR15 (SEQ ID No. 32) - 0.2 μM PR2 (SEQ ID No. 30)
5 μl 10X PCR-Puffer (TAKARA) 0,25 μl R Taq Polymerase (TAKARA) 28,8 μl Aq. Dest .5 ul 10X PCR buffer (TAKARA) 0.25 ul R Taq polymerase (TAKARA) 28.8 ul Aq. Dest.
Die PCR wurde unter folgenden Zyklusbedingungen durchgeführt :The PCR was carried out under the following cycle conditions:
IX 94°C 2 MinutenIX 94 ° C 2 minutes
35X 94°C 1 Minute35X 94 ° C 1 minute
53°C 1 Minute 72°C 1 Minute53 ° C for 1 minute 72 ° C for 1 minute
IX 72°C 10 MinutenIX 72 ° C 10 minutes
Die PCR-Amplifikation mit SEQ ID No. 32 und SEQ ID No. 30 resultierte in einem 1032 Bp-Fragment, das für ein Protein kodiert, bestehend aus der gesamten Primärsequenz der Ketolase aus Haematococcus pluvialis als zweifache translationale Fusion mit dem rbcS Transitpeptide am N-Terminus und dem myc-Tag am C-Terminus .PCR amplification with SEQ ID No. 32 and SEQ ID No. 30 resulted in a 1032 bp fragment coding for a protein consisting of the entire primary sequence of the ketolase from Haematococcus pluvialis as a double translational fusion with the rbcS transit peptide at the N-terminus and the myc tag at the C-terminus.
Das Amplifikat wurde unter Verwendung von Standardmethoden in den PCR-Klonierungsvektor pGEM-Teasy (Promega) kloniert und der Klon pGKET04 erhalten. Sequenzierungen mit den Primern T7- und SP6 bestätigten eine zur Sequenz SEQ ID No. 22 identische Sequenz, wobei die 3 'Region (Position 993-1155) der SEQ ID No . 22 im Amplifikat SEQ ID No . 26 durch eine in der abweichende Sequenz aus 39 Bp ersetzt wurde. Dieser Klon wurde daher für dieThe amplificate was cloned into the PCR cloning vector pGEM-Teasy (Promega) using standard methods and the clone pGKET04 was obtained. Sequencing with the primers T7 and SP6 confirmed a sequence SEQ ID no. 22 identical sequence, the 3 'region (position 993-1155) of SEQ ID No. 22 in the amplificate SEQ ID No. 26 was replaced by one in the different sequence from 39 bp. This clone was therefore made for
Klonierung in den Expressionsvektor pJITH7 (Guerineau et al . 1988, Nucl. Acids Res . 16: 11380) verwendet.Cloning in the expression vector pJITH7 (Guerineau et al. 1988, Nucl. Acids Res. 16: 11380) was used.
Die Klonierung erfolgte durch Isolierung des 1038 Bp EcoRI-SpHI Fragmentes aus pGKET04 und Ligierung mit dem EcoRI-SpHI geschnittenen Vektor pJITH7. Durch die Ligation entsteht eine translationale Fusion zwischen dem C-Terminus der rbcS Transitpeptidsequenz und dem N-Terminus der Ketolase Sequenz. Der Klon, der die Haematococcus pluvialis Ketolase mit fusioniertem C-termina- lern myc-Tag in der korrekten Orientierung als translationale N-terminale Fusion mit dem rbcs Transitpeptid enthält, heißt pJKET4.The cloning was carried out by isolating the 1038 bp EcoRI-SpHI fragment from pGKET04 and ligation with the EcoRI-SpHI cut vector pJITH7. The ligation creates a translational fusion between the C-terminus of the rbcS transit peptide sequence and the N-terminus of the ketolase sequence. The clone which contains the Haematococcus pluvialis ketolase with fused C-terminal myc tag in the correct orientation as a translational N-terminal fusion with the rbcs transit peptide is called pJKET4.
Beispiel 4 : Herstellung von Expressionsvektoren zur konstitutiven Expression der Haematococcus pluvialis Ketolase inExample 4: Production of expression vectors for the constitutive expression of the Haematococcus pluvialis ketolase in
Lycopersicon esculentum Die Expression der Ketolase aus Haematococcus pluvialis in . esculentum erfolgte unter Kontrolle des konstitutiven Promoters d35S aus CaMV (Franck et al . 1980, Cell 21: 285-294). Die Expression erfolgte mit dem Transitpeptid rbcS aus Erbse (Ander- son et al . 1986, Biochem J. 240:709-715). Lycopersicon esculentum Expression of Haematococcus pluvialis ketolase in. esculentum took place under the control of the constitutive promoter d35S from CaMV (Franck et al. 1980, Cell 21: 285-294). Expression was carried out using the pea transit peptide rbcS (Andersson et al. 1986, Biochem J. 240: 709-715).
Die Herstellung eines Expressionsplasmides für die Agrobacterium- vermittelte Transformation der Ketolase aus Haematococcus pluvialis in L . esculentum erfolgte unter der Verwendung des binären Vektors pSUN3 (WO02/00900) .The production of an expression plasmid for the Agrobacterium -mediated transformation of ketolase from Haematococcus pluvialis in L. esculentum was carried out using the binary vector pSUN3 (WO02 / 00900).
- Zur Herstellung des Expressionsvektors pS3KET02 wurde das 2.8 Kb Sacl-Xhol Fragment aus pJKET02 mit dem Sacl-Xhol geschnittenen Vektor pSUN3 ligiert (Abbildung 5, Konstruktkarte) . In der Abbildung 5 beinhaltet Fragment d35S den duplizierten- To produce the expression vector pS3KET02, the 2.8 Kb Sacl-Xhol fragment from pJKET02 was ligated with the Sacl-Xhol cut vector pSUN3 (Figure 5, construct map). In Figure 5, fragment d35S contains the duplicate
35S Promoter (747 bp) , Fragment rbcS das rbcS Transitpeptid aus Erbse (204 bp) , Fragment KET02 (1027 bp) die gesamte Primärsequenz kodierend für die Haema tococcus pluvialis Ketolase, Fragment term (761 bp) das Polyadenylierungssignal von CaMV.35S promoter (747 bp), fragment rbcS the rbcS transit peptide from pea (204 bp), fragment KET02 (1027 bp) the entire primary sequence coding for the Haema tococcus pluvialis ketolase, fragment term (761 bp) the polyadenylation signal from CaMV.
Zur Herstellung des Expressionsvektors pS3KET03 wurde dasThis was used to produce the expression vector pS3KET03
2.7 Kb bp Sacl-Xhol Fragment aus pJKET03 mit dem Sacl-Xhol geschnittenen Vektor pSUN3 ligiert. (Abbildung 6, Konstruktkarte) . In der Abbildung 6 beinhaltet Fragment d35S den dupli- zierten 35S Promoter (747 bp) , Fragment rbcS das rbcS Transitpeptid aus Erbse (204 bp) , Fragment KET03 (985 bp) die um 14 N- terminale Aminosäuren verkürzte Primärsequenz kodierend für die Haematococcus pluvialis Ketolase, Fragment term (761 bp) das Polyadenylierungssignal von CaMV.2.7 Kb bp Sacl-Xhol fragment from pJKET03 ligated with the Sacl-Xhol cut vector pSUN3. (Figure 6, construct card). In Figure 6, fragment d35S contains the duplicated 35S promoter (747 bp), fragment rbcS the rbcS transit peptide from pea (204 bp), fragment KET03 (985 bp) the primary sequence shortened by 14 N-terminal amino acids coding for the Haematococcus pluvialis Ketolase, fragment term (761 bp) the polyadenylation signal of CaMV.
Zur Herstellung des Expressionsvektors pS3KET04 wurde das 2.8 Kb Sacl-Xhol Fragment aus pJKET04 mit dem Sacl-Xhol geschnittenen Vektor pSUN3 ligiert. (Abbildung 7, Konstruktkarte). In der Abbildung 7 beinhaltet Fragment d35S den duplizierten 35S Promoter ((747 bp) , Fragment rbcS das rbcS Transitpeptid aus Erbse (204 bp) , Fragment KET04 (1038 bp) die gesamte Primärsequenz codierend für die Haematococcus pluvialis Ketolase mit C-terminalem myc- Tag, Fragment term (761 bp) das Polyadenylierungssignal von CaMV.To produce the expression vector pS3KET04, the 2.8 Kb Sacl-Xhol fragment from pJKET04 was ligated with the Sacl-Xhol cut vector pSUN3. (Figure 7, construct card). In Figure 7, fragment d35S contains the duplicated 35S promoter ((747 bp), fragment rbcS the rbcS transit peptide from pea (204 bp), fragment KET04 (1038 bp) the entire primary sequence coding for the Haematococcus pluvialis ketolase with C-terminal myc- Day, fragment term (761 bp) the polyadenylation signal of CaMV.
Beispiel 5 : Herstellung von Expressionsvektoren zur Expression der Haematococcus pluvialis Ketolase in Lycopersicon esculentumExample 5: Production of expression vectors for the expression of Haematococcus pluvialis ketolase in Lycopersicon esculentum
Die Expression der Ketolase aus Haematococcus pluvialis in L . esculentum erfolgte mit dem Transitpeptid rbcS aus ErbseExpression of Haematococcus pluvialis ketolase in L. esculentum occurred with the transit peptide rbcS from pea
(Anderson et • al . 1986, Biochem J. 240:709-715). Die Expression erfolgte unter Kontrolle einer modifizierten Version AP3P des Promoters AP3 aus Arabidopsis thaliana (AL132971: Nukleotidregion 9298-10200; Hill et al . (1998) Development 125: 1711-1721).(Anderson et al. 1986, Biochem J. 240: 709-715). The expression was carried out under the control of a modified version of AP3P Arabidopsis thaliana AP3 promoter (AL132971: nucleotide region 9298-10200; Hill et al. (1998) Development 125: 1711-1721).
Das DNA Fragment, das die AP3 Promoterregion -902 bis +15 aus Arabidopsis thaliana beinhaltet, wurde mittels PCR unterThe DNA fragment, which contains the AP3 promoter region -902 to +15 from Arabidopsis thaliana, was analyzed by means of PCR
Verwendung genomischer DNA (nach Standardmethoden aus Arabidopsis thaliana isoliert) sowie der Primer PR7 (SEQ ID No . 33) und PR10 (SEQ ID No. 36) hergestellt.Using genomic DNA (isolated from Arabidopsis thaliana according to standard methods) and the primers PR7 (SEQ ID No. 33) and PR10 (SEQ ID No. 36).
Die PCR-Bedingungen waren die folgenden:The PCR conditions were as follows:
Die PCR zur Amplifikation der DNA, die das AP3-Promoterfragment (-902 bis +15) beinhaltet, erfolgte in einem 50 μl Reaktionsansatz, in dem enthalten war:The PCR for the amplification of the DNA, which contains the AP3 promoter fragment (-902 to +15), was carried out in a 50 μl reaction mixture, which contained:
100 ng genomischer DNA aus A . thaliana 0,25 mM dNTPs100 ng of genomic DNA from A. thaliana 0.25 mM dNTPs
0,2 mM PR7 (SEQ ID No. 33) 0,2 mM PR10 (SEQ ID No. 36) - 5 μl 10X PCR-Puffer (Stratagene) - 0,25 μl Pfu Polymerase (Stratagene) 28,8 μl Aq. Dest.0.2 mM PR7 (SEQ ID No. 33) 0.2 mM PR10 (SEQ ID No. 36) - 5 μl 10X PCR buffer (Stratagene) - 0.25 μl Pfu polymerase (Stratagene) 28.8 μl Aq. Least.
Die PCR wurde unter folgenden Zyklusbedingungen durchgeführt:The PCR was carried out under the following cycle conditions:
IX 94°C 2 MinutenIX 94 ° C 2 minutes
35X 94°C 1 Minute35X 94 ° C 1 minute
50°C 1 Minute50 ° C for 1 minute
72°C 1 Minute72 ° C for 1 minute
IX 72°C 10 MinutenIX 72 ° C 10 minutes
Das 922 Bp Amplifikat wurde unter Verwendung von Standardmethoden in den PCR-Klonierungsvektor pCR 2.1 (Invitrogen) kloniert und das Plasmid pTAP3 erhalten.The 922 bp amplificate was cloned into the PCR cloning vector pCR 2.1 (Invitrogen) using standard methods and the plasmid pTAP3 was obtained.
Sequenzierung des Klons pTAP3 bestätigte eine Sequenz, die sich lediglich in durch eine Insertion (ein G in Position 9765 der Sequenz AL132971) und einen Basenaustausch (ein G statt ein A in Position 9726 der Sequenz AL132971) von der publizierten AP3 Sequenz (AL132971, Nukleotidregion 9298-10200) unterscheidet. Diese Nukleotidunterschiede wurden in einem unabhängigen Ampli- fikationsexperiment reproduziert und repräsentieren somit die tatsächliche Nukleotidsequenz in den verwendeten Arabidopsis thaliana Pflanzen. Die modifizierte Version AP3P wurde mittels rekombinanter PCR unter Verwendung des Plasmids pTAP3 hergestellt . Die Region 10200-9771 wurde mit den Primern PR7 (SEQ ID No. 33) und Primern PR9 (SEQ ID No. 35) amplifiziert (Amplifikat A7/9) , die Region 9526-9285 wurde mit den PR8 (SEQ ID No. 34) und PR10 (SEQ ID No. 36) amplifiziert (Amplifikat A8/10) .Sequencing of the clone pTAP3 confirmed a sequence consisting only of an insertion (a G in position 9765 of the sequence AL132971) and a base exchange (a G instead of an A in position 9726 of the sequence AL132971) from the published AP3 sequence (AL132971, nucleotide region 9298-10200) differs. These nucleotide differences were reproduced in an independent amplification experiment and thus represent the actual nucleotide sequence in the Arabidopsis thaliana plants used. The modified version AP3P was produced by recombinant PCR using the plasmid pTAP3. The region 10200-9771 was amplified with the primers PR7 (SEQ ID No. 33) and primers PR9 (SEQ ID No. 35) (amplificate A7 / 9), the region 9526-9285 with the PR8 (SEQ ID No. 34 ) and PR10 (SEQ ID No. 36) amplified (amplificate A8 / 10).
Die PCR-Bedingungen waren die folgenden:The PCR conditions were as follows:
Die PCR-Reaktionen zur Amplifikation der DNA-Fragmente, die die Regionen Region 10200-9771 und Region 9526-9285 des AP3 Promoters beinhalten, erfolgte in 50 μl Reaktionsansätzen, in denen enthalten war:The PCR reactions for the amplification of the DNA fragments, which contain the regions region 10200-9771 and region 9526-9285 of the AP3 promoter, were carried out in 50 μl reaction batches which contained:
- 100 ng AP3 Amplifikat (oben beschrieben)- 100 ng AP3 amplificate (described above)
0,25 mM dNTPs0.25 mM dNTPs
0,2 mM sense Primer (PR7 SEQ ID No . 33 bzw. PR80.2 mM sense primer (PR7 SEQ ID No. 33 or PR8
SEQ ID No. 35)SEQ ID No. 35)
0,2 mM antisense Primer (PR9 SEQ ID No . 35 bzw. PR10 SEQ ID No. 36)0.2 mM antisense primer (PR9 SEQ ID No. 35 or PR10 SEQ ID No. 36)
5 μl 10X PCR-Puffer (Stratagene)5 μl 10X PCR buffer (Stratagene)
0,25 μl Pfu Taq Polymerase (Stratagene)0.25 μl Pfu Taq polymerase (Stratagene)
28,8 μl Aq. Dest.28.8 ul Aq. Least.
Die PCR wurde unter folgenden Zyklusbedingungen durchgeführt:The PCR was carried out under the following cycle conditions:
IX 94°C 2 Minute:IX 94 ° C 2 minutes:
35X 94°C 1 Minute35X 94 ° C 1 minute
50°C 1 Minute50 ° C for 1 minute
72°C 1 Minute72 ° C for 1 minute
IX 72°C 10 Minute:IX 72 ° C 10 minutes:
Die reko binante PCR beinhaltet Annealing der sich über eine Sequenz von 25 Nukleotiden überlappenden Amplifikate A7/9 und A8/10, Vervollständigung zu einem Doppelstrang und anschließende Amplifizierung. Dadurch entsteht eine modifizierte Version des AP3 Promoters, AP3P, in dem die Positionen 9670-9526 deletiert sind. Die Denaturierung (5 min bei 95°C) und Annealing (langsame Abkühlung bei Raumtemperatur auf 40°C) beider Amplifikate A7/9 und A8/10 erfolgte in einem 17.6 «=1 Reaktionsansatz, in dem enthalten war:The recombinant PCR includes annealing of the amplificates A7 / 9 and A8 / 10, which overlap over a sequence of 25 nucleotides, completion into a double strand and subsequent amplification. This creates a modified version of the AP3 promoter, AP3P, in which positions 9670-9526 are deleted. The denaturation (5 min at 95 ° C.) and annealing (slow cooling at room temperature to 40 ° C.) of both amplificates A7 / 9 and A8 / 10 was carried out in a 17.6 1 reaction, which contained:
0,5 μg A7/9 Amplifikat 0,25 μg A8/10 Amplifikat Das Auffüllen der 3 'Enden (30 min bei 30°C) erfolgte in einem 20 °cl Reaktionsansatz, in dem enthalten war:0.5 μg A7 / 9 amplificate 0.25 μg A8 / 10 amplificate The 3 'ends were filled in (30 min at 30 ° C) in a 20 ° cl reaction mixture which contained:
17,6 μl A7/9 und A8/10-Annealingsreaktion (hergestellt wie oben beschrieben)17.6 ul A7 / 9 and A8 / 10 annealing reaction (prepared as described above)
50 μM dNTPs50 µM dNTPs
2 μl IX Klenow Puffer2 ul IX Klenow buffer
- 2U Klenow Enzym- 2U Klenow enzyme
Die Nukleinsäure, kodierend für die modifizierte Promoterversion AP3P, wurde mittels PCR unter Verwendung eines sense spezifischen Primers (PR7 SEQ ID No. 28) und eines antisense spezifischen Primers (PR10 SEQ ID No. 36) amplifiziert.The nucleic acid coding for the modified promoter version AP3P was amplified by means of PCR using a sense-specific primer (PR7 SEQ ID No. 28) and an antisense-specific primer (PR10 SEQ ID No. 36).
Die PCR-Bedingungen waren die folgenden:The PCR conditions were as follows:
Die PCR zur Amplifikation des AP3P Fragmentes erfolgte in einem 50 μl Reaktionsansatz, in dem enthalten war:The PCR for the amplification of the AP3P fragment was carried out in a 50 μl reaction mixture, which contained:
- 1 μl Annealingsreaktion (hergestellt wie oben beschrieben)- 1 μl annealing reaction (prepared as described above)
0,25 mM dNTPs / 0.25 mM dNTPs /
0,2 mM PR7 (SEQ ID No. 33)0.2 mM PR7 (SEQ ID No. 33)
0,2 mM PR10 (SEQ ID No . 36) - 5 μl 10X PCR-Puffer (Stratagene)0.2 mM PR10 (SEQ ID No. 36) - 5 μl 10X PCR buffer (Stratagene)
0,25 μl Pfu Taq Polymerase (Stratagene)0.25 μl Pfu Taq polymerase (Stratagene)
28,8 μl Aq. Dest.28.8 ul Aq. Least.
Die PCR wurde unter folgenden Zyklusbedingungen durchgeführt :The PCR was carried out under the following cycle conditions:
IX 94°C 2 MinutenIX 94 ° C 2 minutes
35X 94°C 1 Minute35X 94 ° C 1 minute
50°C 1 Minute50 ° C for 1 minute
72°C 1 Minute72 ° C for 1 minute
-IX 72°C 10 Minuten-IX 72 ° C 10 minutes
Die PCR-Amplifikation mit SEQ ID No. 33 und SEQ ID No. 36 resultierte in einem 778 Bp Fragment, das für die modifizierte Promoterversion AP3P kodiert. Das Amplifikat wurde in den Klonierungs- vektor pCR .1 (Invitrogen) kloniert und der Klon pTAP3P erhalten. Sequenzierungen mit den Primern T7 und M13 bestätigten eine zur Sequenz AL132971, Region 10200-9298 identische Sequenz, wobei die interne Region 9285-9526 deletiert wurde. Diese Klon wurde daher für die Klonierung in den Expressionsvektor pJIT117 (Guerineau et al. 1988, Nucl. Acids Res . 16: 11380) verwendet. Die Klonierung erfolgte durch Isolierung des 771 Bp Sacl- Hindlll Fragmentes aus pTAP3P und Ligierung in den Sacl-Hindlll geschnittenen Vektor pJITH7. Der Klon, der den Promoter AP3P anstelle des ursprünglichen Promoters d35S enthält, heißt pJAP3P.PCR amplification with SEQ ID No. 33 and SEQ ID No. 36 resulted in a 778 bp fragment coding for the modified promoter version AP3P. The amplificate was cloned into the cloning vector pCR .1 (Invitrogen) and the clone pTAP3P was obtained. Sequencing with the primers T7 and M13 confirmed a sequence identical to the sequence AL132971, region 10200-9298, the internal region 9285-9526 being deleted. This clone was therefore used for the cloning into the expression vector pJIT117 (Guerineau et al. 1988, Nucl. Acids Res. 16: 11380). The cloning was carried out by isolating the 771 bp SacI-HindIII fragment from pTAP3P and ligating into the SacI-HindIII cut vector pJITH7. The clone that contains the AP3P promoter instead of the original d35S promoter is called pJAP3P.
Zur Herstellung einer Expressionskassette pJAP3PKET02 wurde das 1027 Bp SpHI-Fragment KET02 (in Beispiel 1 beschrieben) in den SpHI geschnittenen Vektor pJAP3P kloniert. Der Klon, der das Fragment KET02 in der korrekten Orientierung als N-terminale Fusion mit dem rbcS Transitpeptid enthält, heißt pJAP3PKET02.To produce an expression cassette pJAP3PKET02, the 1027 bp SpHI fragment KET02 (described in Example 1) was cloned into the SpHI-cut vector pJAP3P. The clone that contains the fragment KET02 in the correct orientation as an N-terminal fusion with the rbcS transit peptide is called pJAP3PKET02.
Zur Herstellung einer Expressionskassette pJAP3PKET04 wurde das 1032 Bp SpHI-EcoRI Fragment KET04 (in Beispiel 3 beschrieben) in den SpHI-EcoRI geschnittenen Vektor pJAP3P kloniert. Der Klon, der das Fragment KET04 in der korrekten Orientierung als N-terminale Fusion mit dem rbcS Transitpeptid enthält, heißt pJAP3PKET04.To produce an expression cassette pJAP3PKET04, the 1032 bp SpHI-EcoRI fragment KET04 (described in Example 3) was cloned into the SpHI-EcoRI cut vector pJAP3P. The clone that contains the fragment KET04 in the correct orientation as an N-terminal fusion with the rbcS transit peptide is called pJAP3PKET04.
Die Herstellung eines Expressionsvektors für die Agrobacterium- vermittelte Transformation der AP3P-kontrollierten Ketolase aus Haematococcus pluvialis in L. esculentum erfolgte unter der Verwendung des binären Vektors pSUN3 (WO02/00900) .An expression vector for the Agrobacterium -mediated transformation of the AP3P-controlled ketolase from Haematococcus pluvialis into L. esculentum was produced using the binary vector pSUN3 (WO02 / 00900).
- Zur Herstellung des Expressionsvektors pS3AP3PKET02 wurde das 2.8 KB bp Sacl-Xhol Fragment aus pJAP3KET02 mit dem Sacl-Xhol geschnittenen Vektor pSUN3 ligiert (Abbildung 8, Konstruktkarte) . In der Abbildung 8 beinhaltet Fragment AP3P den modifizierten AP3P Promoter (771 bp) , Fragment rbcS das rbcS Transitpeptid aus Erbse (204 bp) , Fragment KET02 (1027 bp) die gesamte Primärsequenz codierend für die Haematococcus pluvialis Ketolase, Fragment term (761 Bp) das Polyadenylierungssignal von CaMV.- To produce the expression vector pS3AP3PKET02, the 2.8 KB bp Sacl-Xhol fragment from pJAP3KET02 was ligated with the Sacl-Xhol cut vector pSUN3 (Figure 8, construct map). In Figure 8, fragment AP3P contains the modified AP3P promoter (771 bp), fragment rbcS the rbcS transit peptide from pea (204 bp), fragment KET02 (1027 bp) the entire primary sequence coding for the Haematococcus pluvialis ketolase, fragment term (761 Bp) the polyadenylation signal from CaMV.
- Zur Herstellung des Expressionsvektors pS3AP3PKET04 wurde das 2.8 KB Sacl-Xhol Fragment aus pJAP3PKET04 mit dem Sacl-Xhol geschnittenen Vektor pSUN3 ligiert. (Abbildung 9, Konstruktkarte) . In der Abbildung 9 beinhaltet Fragment AP3P den modifizierten AP3P Promoter (771 bp) , Fragment rbcS das rbcS Transitpeptid aus Erbse (204 bp) , Fragment KET04 (1038 bp) die gesamte Primärsequenz codierend für die Haematococcus pluvialis Ketolase mit C-terminalem myc-Tag, Fragment term (761 Bp) das Polyadenylierungssignal von CaMV.- To produce the expression vector pS3AP3PKET04, the 2.8 KB Sacl-Xhol fragment from pJAP3PKET04 was ligated with the Sacl-Xhol cut vector pSUN3. (Figure 9, construct card). In Figure 9, fragment AP3P contains the modified AP3P promoter (771 bp), fragment rbcS the rbcS transit peptide from pea (204 bp), fragment KET04 (1038 bp) the entire primary sequence coding for the Haematococcus pluvialis ketolase with C-terminal myc tag , Fragment term (761 bp) the polyadenylation signal of CaMV.
Beispiel 6: Herstellung transgener Lycopersicon esculentum Pflan- zen Transformation und Regeneration von Tomatenpflanzen erfolgte nach der publizierten Methode von Ling und Mitarbeitern (Plant Cell Reports (1998), 17:843-847). Für die Varietät Microtom wurde mit höherer Kanamycin-Konzentration (lOOmg/L) selektioniert. 5Example 6: Production of transgenic Lycopersicon esculentum plants Transformation and regeneration of tomato plants was carried out according to the published method by Ling and co-workers (Plant Cell Reports (1998), 17: 843-847). For the microtome variety, higher kanamycin concentrations (100 mg / L) were selected. 5
Als Ausgangsexplantat für die Transformation dienten Kotyledonen und Hypokotyle sieben bis zehn Tage alter Keimlinge der Linie Microtom. Für die Keimung wurde das Kulturmedium nach Murashige und Skoog (1962: Murashige and Skoog, 1962, Physiol. Plant 15,The starting explant for the transformation was cotyledons and hypocotyls, seven to ten day old seedlings of the Microtome line. The culture medium according to Murashige and Skoog (1962: Murashige and Skoog, 1962, Physiol. Plant 15,
10 473-) mit 2 % Saccharose, pH 6,1 verwendet. Die Keimung fand bei 21°C bei wenig Licht (20 bis 100 μE) statt. Nach sieben bis zehn Tagen wurden die Kotyledonen quer geteilt und die Hypokotyle in ca. 5 bis 10 mm lange Abschnitte geschnitten und auf das Medium MSBN (MS, pH 6,1, 3 % Saccharose + 1 mg/1 BAP, 0,1 mg/1 NAA)10 473-) with 2% sucrose, pH 6.1. Germination took place at 21 ° C with little light (20 to 100 μE). After seven to ten days, the cotyledons were divided transversely and the hypocotyls were cut into sections about 5 to 10 mm long and placed on the medium MSBN (MS, pH 6.1, 3% sucrose + 1 mg / 1 BAP, 0.1 mg / 1 NAA)
15 gelegt, das am Vortag mit suspensionskultivierten Tabakzellen beschickt wurde. Die Tabakzellen wurden luftblasenfrei mit sterilem Filterpapier abgedeckt. Die Vorkultur der Explantate auf dem beschriebenen Medium erfolgte für drei bis fünf Tage. Zellen des Stammes Agrobakterium tumefaciens LBA4404 wurden einzeln mit den15, which was loaded with suspension-cultivated tobacco cells the day before. The tobacco cells were covered with sterile filter paper without air bubbles. The explants were precultured on the medium described for three to five days. Cells from the Agrobacterium tumefaciens LBA4404 strain were isolated individually with the
20 Plasmiden pS3KET02, pS3KET03 bzw. pS3AP3KET02 transformiert. Von den einzelnen mit den Binaervektoren pS3KET02, pS3KET03 bzw. pS3KET02 transformierten Agrobakterium-Stämmen wurde jeweils eine Übernachtkultur in YEB Medium mit Kanamycin (20 mg/1) bei 28 Grad Celsius kultiviert und die Zellen zentrifugiert . Das Bakterien-20 plasmids pS3KET02, pS3KET03 and pS3AP3KET02 were transformed. From each of the individual Agrobacterium strains transformed with the binary vectors pS3KET02, pS3KET03 or pS3KET02, an overnight culture was cultivated in YEB medium with kanamycin (20 mg / 1) at 28 degrees Celsius and the cells were centrifuged. The bacteria
25 pellet wurde mit flüssigem MS Medium (3 % Saccharose, pH 6,1) resuspendiert und auf eine optische Dichte von 0,3 (bei 600 nm) eingestellt. Die vorkultivierten Explantate wurden in die Suspension überführt und für 30 Minuten bei Zimmertemperatur unter leichtem Schütteln inkubiert. Anschließend wurden die25 pellet was resuspended with liquid MS medium (3% sucrose, pH 6.1) and adjusted to an optical density of 0.3 (at 600 nm). The precultivated explants were transferred to the suspension and incubated for 30 minutes at room temperature with gentle shaking. Then the
30 Explantate mit sterilem Filterpapier getrocknet und für die dreitägige Co-Kultur (21°C) auf ihr Vorkulturmedium zurück gelegt.30 explants dried with sterile filter paper and put back on their preculture medium for the three-day co-culture (21 ° C).
Nach der Co-kultur wurden die Explantate auf MSZ2 Medium (MS pH 6 , 1 + 3 % Saccharose, 2 mg/1 Zeatin, 100 mg/1 Kanamycin,After the co-culture, the explants were placed on MSZ2 medium (MS pH 6, 1 + 3% sucrose, 2 mg / 1 zeatin, 100 mg / 1 kanamycin,
35 160 mg/1 Timentin) transferiert und für die selektive Regeneration bei 21°C unter Schwachlicht Bedingungen (20 bis 100 °=E, Lichtrhythmus 16 h / 8 h) aufbewahrt. Aller zwei bis drei Wochen erfolgte der Transfer der Explantate bis sich Sprosse bildeten. Kleine Sprosse konnten vom Explantat abgetrennt werden und auf MS35 160 mg / 1 timentin) and stored for selective regeneration at 21 ° C under low light conditions (20 to 100 ° = E, light rhythm 16 h / 8 h). The explants were transferred every two to three weeks until shoots formed. Small shoots could be separated from the explant and on MS
40 (pH 6,1 + 3 % Saccharose) 160 mg/1 Timentin, 30 mg/1 Kanamycin, 0,1 mg/1 IAA bewurzelt werden. Bewurzelte Pflanzen wurden ins Gewächshaus überführt .40 (pH 6.1 + 3% sucrose) 160 mg / 1 timentin, 30 mg / 1 kanamycin, 0.1 mg / 1 IAA. Rooted plants were transferred to the greenhouse.
45 Gemäß der oben beschriebenen Transformationsmethode wurden mit folgenden Expressionskonstrukten folgende Linien erhalten:45 According to the transformation method described above, the following lines were obtained with the following expression constructs:
Mit pS3KET02 wurde erhalten: csl3-24, csl3-30, csl3-40.With pS3KET02 it was obtained: csl3-24, csl3-30, csl3-40.
Mit pS3KET03 wurde erhalten: csl4-2, csl4-3, csl4-9, csl4-19.With pS3KET03 it was obtained: csl4-2, csl4-3, csl4-9, csl4-19.
Mit pS3AP3PKET02 wurde erhalten: csl6-15, csl6-34, cslδ-35, csl6-40.With pS3AP3PKET02 was obtained: csl6-15, csl6-34, cslδ-35, csl6-40.
1010
Beispiel 8 : Charakterisierung der transgenen FrüchteExample 8: Characterization of the transgenic fruits
Das Fruchtmaterial der transgenen Pflanzen wurde in flüssigem 15 Stickstoff gemörsert und das Pulver (etwa 250 bis 500 mg) mit 100 % Aceton extrahiert (dreimal je 500 ul) . Das Lösungs-mittel wurde evaporiert und die Carotinoide in 100 ul Aceton resuspendiert .The fruit material of the transgenic plants was ground in liquid nitrogen and the powder (about 250 to 500 mg) extracted with 100% acetone (three times 500 ul each). The solvent was evaporated and the carotenoids resuspended in 100 ul acetone.
20 Mittels einer C30-Reverse phase-Säule konnte zwischen Mono- und Diestern der Carotinoide unterschieden werden HPLC-Laufbe- dingungen wurden modifiziert nach einer publizierten Methode (Frazer et al.(2000), Plant Journal 24(4): 551-55820 A C30 reverse phase column was used to distinguish between mono- and diesters of carotenoids. HPLC running conditions were modified according to a published method (Frazer et al. (2000), Plant Journal 24 (4): 551-558
Folgende HPLC-Bedingungen wurden eingestellt. 25 Trennsäule: Prontosil C30-Säule, 250 x 4,6 mm, (Bischoff , Leon- berg, Germany)The following HPLC conditions were set. 25 separation column: Prontosil C30 column, 250 x 4.6 mm, (Bischoff, Leonberg, Germany)
Flussrate: 1.0 ml/minFlow rate: 1.0 ml / min
Eluenten: Laufmittel A - 100% MethanolEluents: mobile phase A - 100% methanol
Laufmittel B - 80% Methanol, 0.2% Ammoniumacetat Laufmittel C - 100% t-Butyl-methyletherSolvent B - 80% methanol, 0.2% ammonium acetate Solvent C - 100% t-butyl methyl ether
3030
Gradientenprofil ;Gradient profile;
Detektion : 300 530 nmDetection: 300 530 nm
4545
Die Spektren wurden unter Verwendung eines Photodiodenarray-De- tektors bestimmt. Die Carotinoide wurden über ihre Absorptions- Spektren und ihre Retentionszeiten im Vergleich zu Standardproben identifiziert .The spectra were determined using a photodiode array detector. The carotenoids were absorbed through their Spectra and their retention times compared to standard samples identified.
Tabelle 1 zeigt das Carotinoidprofil in Tomatenfrüchten der gemäß der vorstehend beschriebenen Beispiele hergestellten transgenen Tomaten und Kontrolltomatenpflanzen. Im Vergleich zur genetisch nicht veränderten Kontrollpflanze weisen die genetisch veränderten Pflanzen einen Gehalt an Ketocarotinoiden und insbesondere einen Gehalt an Astaxanthin auf.Table 1 shows the carotenoid profile in tomato fruits of the transgenic tomatoes and control tomato plants produced according to the examples described above. Compared to the genetically unmodified control plant, the genetically modified plants have a ketocarotenoid content and in particular astaxanthin content.
Tabelle 1Table 1
+ bedeutet Carotinoid nachweisbar bedeutet Carotinoid nicht detektiert (+) bedeutet Carotinoidkonzentration an der Nachweisgrenze+ means carotenoid detectable means carotenoid not detected (+) means carotenoid concentration at the detection limit
Tabelle 2a zeigt die Carotinoidmengen in reifen Früchten von transgenen Tomaten und Kontrollpflanzen. Die Angaben sind Mittelwerte verschiedener Linine und in Prozent des Gesamtcarotinoidge- ha1t angegeben.Table 2a shows the amounts of carotenoids in ripe fruit of transgenic tomatoes and control plants. The data are mean values of various linines and are given as a percentage of the total carotenoid content.
Tabelle 2b zeigt die Carotinoidmengen in reifenden Früchten von transgenen Tomaten und Kontrollpflanzen. Die Angaben sind Mittelwerte verschiedener Linine und in Prozent des Gesamtcarotinoidge- halt angegeben. Table 2b shows the amounts of carotenoids in ripening fruits of transgenic tomatoes and control plants. The data are mean values of various linines and are given as a percentage of the total carotenoid content.
Beispiel 9 :Example 9:
10 Amplifikation einer DNA, die die gesamte Primärsequenz der NPl96-Ketolase aus Nostoc puncti forme ATCC 29133 kodiert10 Amplification of a DNA encoding the entire primary sequence of the NPl96 ketolase from Nostoc puncti forme ATCC 29133
Die DNA, die für die NP196-Ketolase aus Nostoc punctiforme ATCC 29133 kodiert, wurde mittels PCR aus Nostoc punctiforme ATCC 15 29133 (Stamm der "American Type Culture Collection") amplifiziert.The DNA encoding the NP196 ketolase from Nostoc punctiform ATCC 29133 was amplified by PCR from Nostoc punctiform ATCC 15 29133 (strain of the "American Type Culture Collection").
Für die Präparation von genomischer DNA aus einer Suspensionskultur von Nostoc punctiforme ATCC 29133 , die 1 Woche mit DauerlichtFor the preparation of genomic DNA from a suspension culture of Nostoc punctiforme ATCC 29133, which is 1 week with continuous light
20 und konstantem Schütteln (150 rpm) at 25°C in BG 21-Medium (1.5 g/1 NaN03, 0.04 g/1 K2P04x3H20, 0.075 g/1 MgS04xH20, 0.036 g/1 CaClx2H0, 0.006 g/1 citric acid, 0.006 g/1 Ferric ammonium ci- trate, 0.001 g/1 EDTA disodium magnesium, 0.04 g/1 Na2C03 , 1ml Trace Metal Mix "A5+Co" (2.86 g/1 H3B03 , 1.81' 'g/1 MnCl2x4H2o,20 and constant shaking (150 rpm) at 25 ° C in BG 21 medium (1.5 g / 1 NaN0 3 , 0.04 g / 1 K 2 P0 4 x3H 2 0, 0.075 g / 1 MgS0 4 xH 2 0, 0.036 g / 1 CaClx2H0, 0.006 g / 1 citric acid, 0.006 g / 1 ferric ammonium citrate, 0.001 g / 1 EDTA disodium magnesium, 0.04 g / 1 Na 2 C0 3 , 1 ml trace metal mix "A5 + Co" (2.86 g / 1 H 3 B0 3 , 1.81 '' g / 1 MnCl 2 x4H 2 o,
25 0.222 g/1 ZnSO4x7H20, 0.39 g/1 NaMo04X2H2o, 0.079 g/1 CuS04x5H20, 0.0494 g/1 Co (N03 ) x6H0) gewachsen war, wurden die Zellen durch Zentrifugation geerntet, in flüssigem Stickstoff eingefroren und im Mörser pulverisiert.25 0.222 g / 1 ZnSO 4 x7H 2 0, 0.39 g / 1 NaMo0 4 X2H 2 o, 0.079 g / 1 CuS0 4 x5H 2 0, 0.0494 g / 1 Co (N0 3 ) x6H0), the cells were centrifuged harvested, frozen in liquid nitrogen and pulverized in a mortar.
30 Protokoll für die DNA-Isolation aus Nostoc punctiforme ATCC 29133 :30 Protocol for DNA isolation from Nostoc punctiforme ATCC 29133:
Aus einer 10 ml Flüssigkultur wurden die Bakterienzellen durch 10 minütige Zentrifugation bei 8000 rpm pelletiert. Anschließend wurden die Bakterienzellen in flüssigem Stickstoff mit einem Mör-The bacterial cells were pelleted from a 10 ml liquid culture by centrifugation at 8000 rpm for 10 minutes. The bacterial cells were then washed in liquid nitrogen with a mortar.
35 ser zerstoßen und gemahlen. Das Zellmaterial wurde in 1 ml lOmM Tris_HCl (pH 7.5) resuspendiert und in ein Eppendorf-Reaktionsge- fäß (2ml Volumen) überführt. Nach Zugabe von35 crushed and ground. The cell material was resuspended in 1 ml 10mM Tris_HCl (pH 7.5) and transferred to an Eppendorf reaction vessel (2ml volume). After adding
100 μl Proteinase K (Konzentration: 20 mg/ml) wurde die Zellsuspension für 3 Stunden bei 37°C inkubiert. Anschließend wurdeThe cell suspension was incubated for 3 hours at 37 ° C. in 100 μl proteinase K (concentration: 20 mg / ml). Then was
40 die Suspension mit 500 μl Phenol extrahiert. Nach 5minütiger40 the suspension extracted with 500 ul phenol. After 5 minutes
Zentrifugation bei 13 000 upm wurde die obere, wässrige Phase in ein neues 2 ml-Eppendorf-Reaktionsgefäß überführt . Die Extraktion mit Phenol wurde 3mal wiederholt. Die DNA wurde durch Zugabe von 1/10 Volumen 3 M Natriumacetat (pH 5.2) und 0.6 Volumen Iso-Centrifugation at 13,000 rpm, the upper, aqueous phase was transferred to a new 2 ml Eppendorf reaction vessel. The extraction with phenol was repeated 3 times. The DNA was obtained by adding 1/10 volume of 3 M sodium acetate (pH 5.2) and 0.6 volume of iso-
45 propanol gefällt und anschließend mit 70% Ethanol gewaschen. Das DNA-Pellet wurde bei Raumtemperatur getrocknet, in 25 μl Wasser aufgenommen und unter Erhitzung auf 65°C gelöst.45 propanol precipitated and then washed with 70% ethanol. The DNA pellet was dried at room temperature, taken up in 25 μl of water and dissolved with heating to 65 ° C.
Die Nukleinsäure, kodierend eine Ketolase aus Nostoc punctiforme ATCC 29133 , wurde mittels "polymerase chain reaction" (PCR) aus Nostoc punctiforme ATCC 29133 unter Verwendung eines sense-spezi- fischen Primers (NP196-1, SEQ ID No . 59) und eines antisense-spe- zifischen Primers (NP196-2 SEQ ID No . 60) amplifiziert.The nucleic acid, coding for a ketolase from Nostoc punctiform ATCC 29133, was determined by means of a "polymerase chain reaction" (PCR) from Nostoc punctiform ATCC 29133 using a sense-specific primer (NP196-1, SEQ ID No. 59) and an antisense -specific primer (NP196-2 SEQ ID No. 60) amplified.
Die PCR-Bedingungen waren die folgenden:The PCR conditions were as follows:
Die PCR zur Amplifikation der DNA, die für ein Ketolase Protein bestehend aus der gesamten Primärsequenz kodiert, erfolgte in einem 50 ul Reaktionsansatz, in dem enthalten war:The PCR for the amplification of the DNA, which codes for a ketolase protein consisting of the entire primary sequence, was carried out in a 50 μl reaction mixture which contained:
1 ul einer Nostoc punctiforme ATCC 29133 DNA (hergestellt wie oben beschrieben)1 µl of a Nostoc punctiform ATCC 29133 DNA (prepared as described above)
0.25 mM dNTPs0.25 mM dNTPs
0.2 mM NP196-1 (SEQ ID No . 59) - 0.2 mM NP196-2 (SEQ ID No. 60)0.2 mM NP196-1 (SEQ ID No. 59) - 0.2 mM NP196-2 (SEQ ID No. 60)
5 ul 10X PCR-Puffer (TAKARA)5 ul 10X PCR buffer (TAKARA)
0.25 ul R Taq Polymerase (TAKARA)0.25 ul R Taq polymerase (TAKARA)
25.8 ul Aq. Dest .25.8 ul Aq. Dest.
Die PCR wurde unter folgenden Zyklusbedingungen durchgeführt:The PCR was carried out under the following cycle conditions:
IX 94°C 2 MinutenIX 94 ° C 2 minutes
35X 94°C 1 Minute35X 94 ° C 1 minute
55°C 1 Minuten55 ° C for 1 minute
72°C 3 Minuten72 ° C for 3 minutes
IX 72°C 10 MinutenIX 72 ° C 10 minutes
Die PCR-Amplifikation mit SEQ ID No . 59 und SEQ ID No . 60 resultierte in einem 792 Bp-Fragment, das für ein Protein bestehend aus der gesamten Primärsequenz kodiert (NP196, SEQ ID No . 61) .PCR amplification with SEQ ID No. 59 and SEQ ID No. 60 resulted in a 792 bp fragment which codes for a protein consisting of the entire primary sequence (NP196, SEQ ID No. 61).
Unter Verwendung von Standardmethoden wurde das Amplifikat in den PCR-Klonierungsvektor pCR 2.1 (Invitrogen) kloniert und der Klon pNP196 erhalten.Using standard methods, the amplificate was cloned into the PCR cloning vector pCR 2.1 (Invitrogen) and the clone pNP196 was obtained.
Sequenzierung des Klons pNP196 mit dem M13F- und dem M13R-Primer bestätigte eine Sequenz, welche mit der DNA-Sequenz von 140.571-139.810 des Datenbank-eintrages NZ_AABC01000196 identisch ist (inverse orientiert zum veröffentlichen Datenbankeintrag) mit der Ausnahme, daß G in Position 140.571 durch A ersetzt wurde, um ein Standard-Startkodon ATG zu erzeugen. Diese Nukleotidsequenz wurde in einem unabhängigem Amplifikationsexperiment reproduziert und repräsentiert somit die Nukleotidsequenz im verwendeten Nostoc punctiforme ATCC 29133.Sequencing of the clone pNP196 with the M13F and M13R primers confirmed a sequence which is identical to the DNA sequence from 140.571-139.810 of the database entry NZ_AABC01000196 (inverse oriented to the published database entry) with the exception that G in position 140.571 was replaced by A to create a standard start codon ATG. This nucleotide sequence was reproduced in an independent amplification experiment and thus represents the nucleotide sequence in the Nostoc punctiform ATCC 29133 used.
Dieser Klon pNPl96 wurde daher für die Klonierung in den Expres- 5 sionsvektor pJAP3P (in Beispiel 5 beschrieben) verwendet.This clone pNPl96 was therefore used for cloning into the expression vector pJAP3P (described in Example 5).
PJAP3P wurde modifiziert, indem der 35S-Terminator durch den OCS- Terminator (Octopine Synthase) des Ti-Plasmides pTil5955 von Agrobacterium tumefaciens (Datenbankeintrag X00493 von Position 10 12,541-12,350, Gielen et al . (1984) EMBO J. 3 835-846) ersetzt wurde .PJAP3P was modified by the 35S terminator through the OCS terminator (octopine synthase) of the Ti plasmid pTil5955 from Agrobacterium tumefaciens (database entry X00493 from position 10 12.541-12.350, Gielen et al. (1984) EMBO J. 3 835-846 ) was replaced.
Das DNA-Fragment, das die OCS-Terminatorregion beinhaltet, wurde mittels PCR unter Verwendung des Plasmides pHELLSGATE (Datenban- 15 keintrag AJ311874, Wesley et al . (2001) Plant J. 27 581-590, nach Standardmethoden aus E. coli isoliert) sowie der Primer OCS-1 (SEQ ID No. 63) und OCS-2 (SEQ ID No . 64) hergestellt.The DNA fragment containing the OCS terminator region was isolated by PCR using the plasmid pHELLSGATE (database entry 15 AJ311874, Wesley et al. (2001) Plant J. 27 581-590, isolated from E. coli by standard methods) as well as the primer OCS-1 (SEQ ID No. 63) and OCS-2 (SEQ ID No. 64).
Die PCR-Bedingungen waren die folgenden:The PCR conditions were as follows:
2020
Die PCR zur Amplifikation der DNA, die die Octopin Synthase (OCS) Terminatorregion (SEQ ID 65) beinhaltet, erfolgte in einem'50 ul Reaktionsansatz, in dem enthalten waren:The PCR for the amplification of the DNA, which contains the octopine synthase (OCS) terminator region (SEQ ID 65), was carried out in a 50 μl reaction mixture which contained:
25 - 100 ng pHELLSGATE plasmid DNA25-100ng pHELLSGATE plasmid DNA
0.25 mM dNTPs0.25 mM dNTPs
0.2 mM OCS-1 (SEQ ID No . 63)0.2 mM OCS-1 (SEQ ID No. 63)
0.2 mM OCS-2 (SEQ ID No. 64)0.2 mM OCS-2 (SEQ ID No. 64)
5 ul 10X PCR-Puffer (Stratagene) 30 - 0.25 ul Pfu Polymerase (Stratagene)5 ul 10X PCR buffer (Stratagene) 30-0.25 ul Pfu polymerase (Stratagene)
28.8 ul Aq. Dest.28.8 ul Aq. Least.
Die PCR wurde unter folgenden Zyklusbedingungen durchgeführt :The PCR was carried out under the following cycle conditions:
35 IX 94°C 2 Minuten35 IX 94 ° C 2 minutes
35X 94°C 1 Minute35X 94 ° C 1 minute
50°C 1 Minute50 ° C for 1 minute
72°C 1 Minute72 ° C for 1 minute
IX 72°C 10 MinutenIX 72 ° C 10 minutes
4040
Das 210 bp Amplifikat wurde unter Verwendung von Standardmethoden in den PCR-Klonierungsvektor pCR 2.1 (Invitrogen) kloniert und das Plasmid pOCS erhalten.The 210 bp amplificate was cloned into the PCR cloning vector pCR 2.1 (Invitrogen) using standard methods and the plasmid pOCS was obtained.
45 Sequenzierung des Klons pOCS bestätigte eine Sequenz, die mit einem Sequenzabschnitt auf dem Ti-Plasmid pTil5955 von Agrobacterium tumefaciens (Datenbankeintrag X00493) von Position 12.541 bis 12.350 übereinstimmt.45 Sequencing of the clone pOCS confirmed a sequence which corresponds to a sequence section on the Ti plasmid pTil5955 from Agrobacterium tumefaciens (database entry X00493) from positions 12,541 to 12,350.
Die Klonierung erfolgte durch Isolierung des 210 bp Sall-Xhol Fragmentes aus pOCS und Ligierung in den Sall-Xhol geschnittenen Vektor pJAP3P.The cloning was carried out by isolating the 210 bp Sall-Xhol fragment from pOCS and ligation into the Sall-Xhol cut vector pJAP3P.
Dieser Klon heisst pJOAP und wurde daher für die Klonierung in den Expressionsvektor pJOAP:NP196 verwendet.This clone is called pJOAP and was therefore used for cloning into the expression vector pJOAP: NP196.
Die Klonierung erfolgte durch Isolierung des 782 Bp Sphl-Fragmen- tes aus pNPl96 und Ligierung in den SphI geschnittenen Vektor pJOAP. Der Klon, der die NPl96-Ketolase von Nostoc punctiforme in der korrekten Orientierung als N-terminale translationale Fusion mit dem rbcS Transitpeptid enthält, heisst pJOAP:NPl96.The cloning was carried out by isolating the 782 bp Sphl fragment from pNPl96 and ligating into the SphI cut vector pJOAP. The clone that contains the Nostoc punctiforme NPl96 ketolase in the correct orientation as an N-terminal translational fusion with the rbcS transit peptide is called pJOAP: NPl96.
Beispiel 10;Example 10;
Herstellung von Expressionsvektoren zur fruchtspezifischen Ueber- expression der NP196-Ketolase aus Nostoc punctiforme ATCC 2*9133 (Stamm der "American Type Culture Collection") in Lycopersicon esculentum Die Expression der NP196-Ketolase aus Nostoc punctiforme in . esculentum erfolgte mit dem Transitpeptid rbcS aus Erbse (Anderson et al. 1986, Biochem J. 240:709-715). Die Expression erfolgte unter Kontrolle des Promoters AP3P aus Arabidopsis thaliana (in Beispiel 5 beschrieben) .Production of expression vectors for the fruit-specific overexpression of NP196 ketolase from Nostoc punctiforme ATCC 2 * 9133 (strain of the "American Type Culture Collection") in Lycopersicon esculentum. Expression of NP196 ketolase from Nostoc punctiforme in. Esculentum took place with the transit peptide rbcS from pea (Anderson et al. 1986, Biochem J. 240: 709-715). Expression was carried out under the control of the AP3P promoter from Arabidopsis thaliana (described in Example 5).
Die Herstellung eines Expressionsvektors für die Agrobacterium- ver ittelte Transformation der AP3P-kontrollierten NPl96-Ketolase aus Nostoc punctiforme ATCC 29133 in L. esculentum erfolgte unter der Verwendung des binären Vektors pSUN3 (WO02/00900) .An expression vector for the Agrobacterium -mediated transformation of the AP3P-controlled NPl96 ketolase from Nostoc punctiform ATCC 29133 into L. esculentum was produced using the binary vector pSUN3 (WO02 / 00900).
Zur Herstellung des Expressionsvektors MSP120 wurde das 1.958 KB bp Sacl-Xhol Fragment aus pJOAP:NP196 mit dem Sacl-Xhol geschnittenen Vektor pSUN3 ligiert (Abbildung 10, Konstruktkarte) . In der Abbildung 10 beinhaltet Fragment AP3P PROM den AP3P Promoter (765 bp) , Fragment rbcS TP FRAGMENT das rbcS Transitpeptid aus Erbse (194 bp) , Fragment NP196 KETO CDS (761 bp) , kodierend für die Nos toc punctiforme NPl96-Ketolase, Fragment OCS Terminator (192 bp) das Polyadenylierungssignal von Octopin-Synthase . Beispiel 11 :To produce the expression vector MSP120, the 1,958 KB bp Sacl-Xhol fragment from pJOAP: NP196 was ligated with the Sacl-Xhol cut vector pSUN3 (Figure 10, construct map). In Figure 10 fragment AP3P PROM contains the AP3P promoter (765 bp), fragment rbcS TP FRAGMENT the rbcS transit peptide from pea (194 bp), fragment NP196 KETO CDS (761 bp), coding for the nos toc punctiform NPl96 ketolase, fragment OCS terminator (192 bp) the octopine synthase polyadenylation signal. Example 11:
Amplifikation einer DNA, die die gesamte Primärsequenz der NOST- Ketolase aus Nostoc spp . PCC 7120 codiert 5Amplification of a DNA which contains the entire primary sequence of the NOST ketolase from Nostoc spp. PCC 7120 coded 5
Die DNA, die für die NOST-Ketolase aus Nostoc punctiforme PCC 7120 kodiert, wurde mittels PCR aus Nostoc PCC 7120 (Stamm der "Pasteur Culture Collection of Cyanobacterium" ) amplifiziert.The DNA coding for the NOST ketolase from Nostoc punctiform PCC 7120 was amplified by means of PCR from Nostoc PCC 7120 (strain of the "Pasteur Culture Collection of Cyanobacterium").
10 Für die Präparation von genomischer DNA aus einer Suspensionskultur von aus Nostoc spp . PCC 7120, die 1 Woche mit Dauerlicht und konstantem Schütteln (150 rpm) at 25°C in BG 22-Medium (1.5 g/1 NaN03, 0.04 g/1 K2P04x3H20, 0.075 g/1 MgS04xH20, 0.036 g/1 CaCl x2H0, 0.006 g/1 citric acid, 0.006 g/1 Ferric ammonium ci-10 For the preparation of genomic DNA from a suspension culture of from Nostoc spp. PCC 7120, the 1 week with continuous light and constant shaking (150 rpm) at 25 ° C in BG 22 medium (1.5 g / 1 NaN0 3 , 0.04 g / 1 K 2 P0 4 x3H 2 0, 0.075 g / 1 MgS0 4 xH 2 0, 0.036 g / 1 CaCl x2H0, 0.006 g / 1 citric acid, 0.006 g / 1 Ferric ammonium ci-
15 träte, 0.001 g/1 EDTA disodium magnesium, 0.04 g/1 Na2C03 , 1ml Trace Metal Mix "A5+Co" (2.86 g/1 H3B03, 1.81 g/1 MnCl2x4H2o, 0.222 g/1 ZnSO4x7H20, 0.39 g/1 NaMo04X2H2o, 0.079 g/1 CuS04x5H20, 0.0494 g/1 Co (N03 ) x6H0) gewachsen war, wurden die Zellen durch Zentrifugation geerntet, in flüssigem Stickstoff eingefroren und15 steps, 0.001 g / 1 EDTA disodium magnesium, 0.04 g / 1 Na 2 C0 3 , 1 ml trace metal mix "A5 + Co" (2.86 g / 1 H 3 B0 3 , 1.81 g / 1 MnCl 2 x4H 2 o, 0.222 g / 1 ZnSO 4 x7H 2 0, 0.39 g / 1 NaMo0 4 X2H 2 o, 0.079 g / 1 CuS0 4 x5H 2 0, 0.0494 g / 1 Co (N0 3 ) x6H0), the cells were harvested by centrifugation, frozen in liquid nitrogen and
20 im Mörser pulverisiert.20 powdered in a mortar.
Protokoll für die DNA-Isolation aus aus Nostoc spp . PCC 712O:Protocol for DNA isolation from from Nostoc spp. PCC 712O:
Aus einer 10 ml Flüssigkultur wurden die Bakterienzellen durch 10The bacterial cells were removed from a 10 ml liquid culture by 10
25 minütige Zentrifugation bei 8000 rpm pelletiert. Anschließend wurden die Bakterienzellen in flüssigem Stickstoff mit einem Mörser zerstoßen und gemahlen. Das Zellmaterial wurde in 1 ml lOmM Tris_HCl (pH 7.5) resuspendiert und in ein Eppendorf-Reaktionsge- fäß (2ml Volumen) überführt. Nach Zugabe vonPelleted for 25 minutes at 8000 rpm. The bacterial cells were then crushed and ground in liquid nitrogen using a mortar. The cell material was resuspended in 1 ml 10mM Tris_HCl (pH 7.5) and transferred to an Eppendorf reaction vessel (2ml volume). After adding
30 100 μl Proteinase K (Konzentration: 20 mg/ml) wurde die Zellsuspension für 3 Stunden bei 37°C inkubiert. Anschließend wurde die Suspension mit 500 μl Phenol extrahiert. Nach 5minütiger Zentrifugation bei 13 000 upm wurde die obere, wässrige Phase in ein neues 2 ml-Eppendorf-Reaktionsgefäß überführt. Die ExtraktionThe cell suspension was incubated for 3 hours at 37 ° C. in 30 100 μl proteinase K (concentration: 20 mg / ml). The suspension was then extracted with 500 μl of phenol. After centrifugation at 13,000 rpm for 5 minutes, the upper, aqueous phase was transferred to a new 2 ml Eppendorf reaction vessel. The extraction
35 mit Phenol wurde 3mal wiederholt. Die DNA wurde durch Zugabe von 1/10 Volumen 3 M Natriumacetat (pH 5.2) und 0.6 Volumen Iso- propanol gefällt und anschließend mit 70% Ethanol gewaschen. Das DNA-Pellet wurde bei Raumtemperatur getrocknet, in 25 μl Wasser aufgenommen und unter Erhitzung auf 65°C gelöst.35 with phenol was repeated 3 times. The DNA was precipitated by adding 1/10 volume of 3 M sodium acetate (pH 5.2) and 0.6 volume of isopropanol and then washed with 70% ethanol. The DNA pellet was dried at room temperature, taken up in 25 μl of water and dissolved with heating to 65 ° C.
4040
Die Nukleinsäure, kodierend eine Ketolase aus Nostoc PCC 7120, wurde mittels "polymerase chain reaction" (PCR) aus Nostoc PCC 7120 unter Verwendung eines sense-spezifischen Primers (NOST-1, SEQ ID No. 66) und eines antisense-spezifischen Primers (NOST-2The nucleic acid encoding a ketolase from Nostoc PCC 7120 was determined by means of a "polymerase chain reaction" (PCR) from Nostoc PCC 7120 using a sense-specific primer (NOST-1, SEQ ID No. 66) and an antisense-specific primer NOST-2
45 SEQ ID No. 67) amplifiziert. Die PCR-Bedingungen waren die folgenden:45 SEQ ID No. 67) amplified. The PCR conditions were as follows:
Die PCR zur Amplifikation der DNA, die für ein Ketolase Protein bestehend aus der gesamten Primärsequenz kodiert, erfolgte in einem 50 ul Reaktionsansatz, in dem enthalten war:The PCR for the amplification of the DNA, which codes for a ketolase protein consisting of the entire primary sequence, was carried out in a 50 μl reaction mixture which contained:
1 ul einer Nostoc PCC 7120 DNA (hergestellt wie in Beispiel 9 beschrieben)1 µl of a Nostoc PCC 7120 DNA (prepared as described in Example 9)
0.25 mM dNTPs - 0.2 mM NOST-1 (SEQ ID No . 66)0.25 mM dNTPs - 0.2 mM NOST-1 (SEQ ID No. 66)
0.2 mM NOST-2 (SEQ ID No . 67)0.2 mM NOST-2 (SEQ ID No. 67)
5 ul 10X PCR-Puffer (TAKARA)5 ul 10X PCR buffer (TAKARA)
0.25 ul R Taq Polymerase (TAKARA)0.25 ul R Taq polymerase (TAKARA)
25.8 ul Aq. Dest .25.8 ul Aq. Dest.
Die PCR wurde unter folgenden Zyklusbedingungen durchgeführt :The PCR was carried out under the following cycle conditions:
IX 94°C 2 MinutenIX 94 ° C 2 minutes
35X 94°C 1 Minute35X 94 ° C 1 minute
55°C 1 Minuten55 ° C for 1 minute
72°C 3 Minuten72 ° C for 3 minutes
IX 72°C 10 MinutenIX 72 ° C 10 minutes
Die PCR-A plifikation mit SEQ ID No. 66 und SEQ ID No. 67 resul- tierte in einem 809 Bp-Fragment, das für ein Protein bestehend aus der gesamten Primärsequenz kodiert (SEQ ID No. 68) . Unter Verwendung von Standardmethoden wurde das Amplifikat in den PCR- Klonierungsvektor pGEM-T (Promega) kloniert und der Klon pNOST erhalten.PCR amplification with SEQ ID No. 66 and SEQ ID No. 67 resulted in an 809 bp fragment that codes for a protein consisting of the entire primary sequence (SEQ ID No. 68). Using standard methods, the amplificate was cloned into the PCR cloning vector pGEM-T (Promega) and the clone pNOST was obtained.
Sequenzierung des Klons pNOST mit dem M13F- und dem M13R-Primer bestätigte eine Sequenz, welche mit der DNA-Sequenz des Datenbankeintrages AP003592 identisch ist. Diese Nukleotidsequenz wurde in einem unabhängigem Amplifikationsexperiment reproduziert und repräsentiert somit die Nukleotidsequenz im verwendeten Nostoc PCC 7120.Sequencing of the clone pNOST with the M13F and M13R primers confirmed a sequence which is identical to the DNA sequence of the database entry AP003592. This nucleotide sequence was reproduced in an independent amplification experiment and thus represents the nucleotide sequence in the Nostoc PCC 7120 used.
Dieser Klon pNOST wurde daher für die Klonierung in den Expressionsvektor pJOAP (in Beispiel 9 beschrieben) verwendet.This clone pNOST was therefore used for the cloning into the expression vector pJOAP (described in Example 9).
Die Klonierung erfolgte durch Isolierung des 799 Bp Sphl-Fragmen- tes aus pNOST und Ligierung in den SphI geschnittenen Vektor pJOAP. Der Klon, der die NOST-Ketolase von Nostoc PCC7120 in der korrekten Orientierung als N-terminale translationale Fusion mit dem rbcS Transitpeptid enthält, heisst pJOAP:NOST Beispiel 12 :The cloning was carried out by isolating the 799 bp Sphl fragment from pNOST and ligation into the SphI-cut vector pJOAP. The clone that contains the NOSToc PCC7120 NOST ketolase in the correct orientation as an N-terminal translational fusion with the rbcS transit peptide is called pJOAP: NOST Example 12:
Herstellung von Expressionsvektoren zur fruchtspezifischen Ueber- expression der NOST-Ketolase aus Nostoc spp . PCC 7120 in Lycopersicon esculentum.Production of expression vectors for fruit-specific overexpression of the NOST-Ketolase from Nostoc spp. PCC 7120 in Lycopersicon esculentum.
Die Expression der NOST-Ketolase aus Nostoc spp. PCC 7120 in L . esculentum erfolgte mit dem Transitpeptid rbcS aus Erbse (Anderson et al . 1986, Biochem J. 240:709-715). Die Expression erfolgte unter Kontrolle des Promoters AP3P aus Arabidopsis thaliana (in Beispiel 5 beschrieben) .The expression of the NOST ketolase from Nostoc spp. PCC 7120 in L. Esculentum occurred with the pea transit peptide rbcS (Anderson et al. 1986, Biochem J. 240: 709-715). Expression was carried out under the control of the AP3P promoter from Arabidopsis thaliana (described in Example 5).
Die Herstellung eines Expressionsvektors für die Agrobacterium- vermittelte Transformation der AP3P-kontrollierten NOST-Ketolase aus Nostoc spp . PCC 7120 in L. esculentum erfolgte unter der Verwendung des binären Vektors pSUN3 (WO02/00900) .The production of an expression vector for the Agrobacterium -mediated transformation of the AP3P-controlled NOST ketolase from Nostoc spp. PCC 7120 in L. esculentum was carried out using the binary vector pSUN3 (WO02 / 00900).
Zur Herstellung des Expressionsvektors MSP121 wurde das 1.982 KB bp Sacl-Xhol Fragment aus pJOAP:NOST mit dem Sacl-Xhol geschnit- tenen Vektor pSUN3 ligiert (Abbildung 11, Konstruktkarte) . In der Abbildung 11 beinhaltet Fragment AP3P PROM den AP3P Promoter (765 bp) , Fragment rbcS TP FRAGMENT das rbcS Transitpeptid'aus Erbse (194 bp) , Fragment NOST KETO CDS (774 bp) , kodierend für die Nostoc spp . PCC 7120 NOST-Ketolase, Fragment OCS Terminator (192 bp) das Polyadenylierungssignal von Octopin-Synthase .To produce the expression vector MSP121, the 1,982 KB bp Sacl-Xhol fragment from pJOAP: NOST was ligated to the Sacl-Xhol-cut vector pSUN3 (Figure 11, construct map). In Figure 11 fragment AP3P PROM contains the AP3P promoter (765 bp), fragment rbcS TP FRAGMENT the rbcS transit peptide from pea (194 bp), fragment NOST KETO CDS (774 bp), coding for the Nostoc spp. PCC 7120 NOST-Ketolase, fragment OCS terminator (192 bp) the polyadenylation signal of octopine synthase.
Beispiel 13 :Example 13:
Amplifikation einer DNA, die die gesamte Primärsequenz der NPl95-Ketolase aus Nostoc punctiforme ATCC 29133 codiertAmplification of a DNA encoding the entire primary sequence of the NPl95 ketolase from Nostoc punctiforme ATCC 29133
Die DNA, die für die NPl95-Ketolase aus Nostoc punctiforme ATCC 29133 kodiert, wurde mittels PCR aus Nostoc punctiforme ATCC 29133 (Stamm der "American Type Culture Collection") amplifi- ziert. Die Präparation von genomischer DNA aus einer Suspensionskultur von Nostoc punctiforme ATCC 29133 wurde in Beispiel 9 beschrieben.The DNA which codes for the NPl95 ketolase from Nostoc punctiform ATCC 29133 was amplified by means of PCR from Nostoc punctiform ATCC 29133 (strain of the "American Type Culture Collection"). The preparation of genomic DNA from a suspension culture of Nostoc punctiforme ATCC 29133 was described in Example 9.
Die Nukleinsäure, kodierend eine Ketolase aus Nostoc punctiforme ATCC 29133, wurde mittels "polymerase chain reaction" (PCR) aus Nostoc punctiforme ATCC 29133 unter Verwendung eines sense-spezi- fischen Primers (NP195-1, SEQ ID No . 70) und eines antisense-spe- zifischen Primers (NP195-2 SEQ ID No . 71) amplifiziert.The nucleic acid, coding for a ketolase from Nostoc punctiform ATCC 29133, was determined by means of a "polymerase chain reaction" (PCR) from Nostoc punctiform ATCC 29133 using a sense-specific primer (NP195-1, SEQ ID No. 70) and an antisense -specific primer (NP195-2 SEQ ID No. 71) amplified.
Die PCR-Bedingungen waren die folgenden: Die PCR zur Amplifikation der DNA, die für ein Ketolase Protein bestehend aus der gesamten Primärsequenz kodiert, erfolgte in einem 50 ul Reaktionsansatz, in dem enthalten war:The PCR conditions were as follows: The PCR for the amplification of the DNA, which codes for a ketolase protein consisting of the entire primary sequence, was carried out in a 50 μl reaction mixture which contained:
- 1 ul einer Nostoc punctiforme ATCC 29133 DNA (hergestellt wie in Beispiel 9 beschrieben) 0.25 mM dNTPs1 µl of a Nostoc punctiform ATCC 29133 DNA (prepared as described in Example 9) 0.25 mM dNTPs
0.2 mM NP195-1 (SEQ ID No. 70) 0.2 mM NP195-2 (SEQ ID No . 71) - 5 ul 10X PCR-Puffer (TAKARA)0.2 mM NP195-1 (SEQ ID No. 70) 0.2 mM NP195-2 (SEQ ID No. 71) - 5 ul 10X PCR buffer (TAKARA)
0.25 ul R Taq Polymerase (TAKARA) 25.8 ul Aq. Dest .0.25 ul R Taq Polymerase (TAKARA) 25.8 ul Aq. Dest.
Die PCR wurde unter folgenden Zyklusbedingungen durchgeführt :The PCR was carried out under the following cycle conditions:
IX 94°C 2 MinutenIX 94 ° C 2 minutes
35X 94°C 1 Minute35X 94 ° C 1 minute
55°C 1 Minuten55 ° C for 1 minute
72°C 3 Minuten IX 72°C 10 Minuten72 ° C 3 minutes IX 72 ° C 10 minutes
Die PCR-Amplifikation mit SEQ ID No . 70 und SEQ ID No. 71 Resultierte in einem 819 Bp-Fragment, das für ein Protein bestehend aus der gesamten Primärsequenz kodiert (SEQ ID No . 72). Unter Verwendung von Standardmethoden wurde das Amplifikat in den PCR- Klonierungsvektor pGEM-T (Promega) kloniert und der Klon pNP195 erhalten.PCR amplification with SEQ ID No. 70 and SEQ ID No. 71 Resulted in an 819 bp fragment that codes for a protein consisting of the entire primary sequence (SEQ ID No. 72). Using standard methods, the amplificate was cloned into the PCR cloning vector pGEM-T (Promega) and the clone pNP195 was obtained.
Sequenzierung des Klons pNP195 mit dem M13F- und dem M13R-Primer bestätigte eine Sequenz, welche mit der DNA-Sequenz vonSequencing of the clone pNP195 with the M13F and M13R primers confirmed a sequence which is identical to the DNA sequence of
55,604-56,392 des Datenbank-eintrages NZ_AABC010001965 identisch ist, mit der Ausnahme, daß T in Position 55.604 durch A ersetzt wurde, um ein Standard-Startkodon ATG zu erzeugen. Diese Nukleotidsequenz wurde in einem unabhängigem Amplifikationsexpe- riment reproduziert und repräsentiert somit die Nukleotidsequenz im verwendeten Nostoc punctiforme ATCC 29133 .55,604-56,392 of the database entry NZ_AABC010001965 is identical, with the exception that T in position 55.604 was replaced by A in order to generate a standard start codon ATG. This nucleotide sequence was reproduced in an independent amplification experiment and thus represents the nucleotide sequence in the Nostoc punctiforme ATCC 29133 used.
Dieser Klon pNPl95 wurde daher für die Klonierung in den Expressionsvektor pJOAP (in Beispiel 9 beschrieben) verwendet.This clone pNPl95 was therefore used for the cloning into the expression vector pJOAP (described in Example 9).
Die Klonierung erfolgte durch Isolierung des 709 Bp Sphl-Fragmen- tes aus pNPl95 und Ligierung in den SphI geschnittenen Vektor pJOAP. Der Klon, der die NPl95-Ketolase von Nostoc punctiforme ATCC 29133 in der korrekten Orientierung als N-terminale transla- tionale Fusion mit dem rbcS Transitpeptid enthält, heisst pJOAP:NPl95. Beispiel 14 :The cloning was carried out by isolating the 709 bp Sphl fragment from pNPl95 and ligating into the SphI-cut vector pJOAP. The clone which contains the NPl95 ketolase from Nostoc punctiforme ATCC 29133 in the correct orientation as an N-terminal translational fusion with the rbcS transit peptide is called pJOAP: NPl95. Example 14:
Herstellung von Expressionsvektoren zur fruchtspezifischen Ueber- expression der NP195-Ketolase aus Nostoc punctiforme ATCC 29133 in Lycopersicon esculentumProduction of expression vectors for fruit-specific overexpression of the NP195 ketolase from Nostoc punctiforme ATCC 29133 in Lycopersicon esculentum
Die Expression der NPl95-Ketolase aus Nostoc punctiforme ATCC 29133 (Stamm der "American Type Culture Collection" ) in L. esculentum erfolgte mit dem Transitpeptid rbcS aus Erbse (Anderson et al . 1986, Biochem J. 240:709-715). Die Expression erfolgte unter Kontrolle des Promoters AP3P aus Arabidopsis thaliana (in Beispiel 5 beschrieben) .The expression of the NPl95 ketolase from Nostoc punctiform ATCC 29133 (strain of the "American Type Culture Collection") in L. esculentum was carried out with the transit peptide rbcS from pea (Anderson et al. 1986, Biochem J. 240: 709-715). Expression was carried out under the control of the AP3P promoter from Arabidopsis thaliana (described in Example 5).
Die Herstellung eines Expressionsvektors für die Agrobacterium- vermittelte Transformation der AP3P-kontrollierten NPl95-Ketolase aus Nostoc punctiforme ATCC 29133 in L . esculentum erfolgte unter der Verwendung des binären Vektors pSUN3 (WO02/00900) .The production of an expression vector for the Agrobacterium -mediated transformation of the AP3P-controlled NPl95 ketolase from Nostoc punctiforme ATCC 29133 in L. esculentum was carried out using the binary vector pSUN3 (WO02 / 00900).
Zur Herstellung des Expressionsvektors MSP122 wurde das 1.992 KB bp Sacl-Xhol Fragment aus pJOAP:NPl95 mit dem Sacl-Xhol geschnittenen Vektor pSUN3 ligiert (Abbildung 12, Konstruktkarte). In der Abbildung 12 beinhaltet Fragment AP3P PROM den AP3P Promoter (765 bp) , Fragment rbcS TP FRAGMENT das rbcS Transitpeptid aus Erbse (194 bp) , Fragment NP195 KETO CDS (789 bp) , kodierend für die Nostoc punctiforme ATCC 29133 NP195-Ketolase, Fragment OCS Terminator (192 bp) das Polyadenylierungssignal von Octopin-Syn- thase .To produce the expression vector MSP122, the 1,992 KB bp Sacl-Xhol fragment from pJOAP: NPl95 was ligated with the Sacl-Xhol cut vector pSUN3 (Figure 12, construct map). In Figure 12, fragment AP3P PROM contains the AP3P promoter (765 bp), fragment rbcS TP FRAGMENT the rbcS transit peptide from pea (194 bp), fragment NP195 KETO CDS (789 bp), coding for the nostoc punctiform ATCC 29133 NP195 ketolase, Fragment OCS terminator (192 bp) the polyadenylation signal from octopine synthase.
Beispiel 15 ;Example 15;
Amplifikation einer DNA, die die gesamte Primärsequenz der NODK- Ketolase aus Nodularia spumignea NSOR10 codiert.Amplification of a DNA encoding the entire primary sequence of the NODK ketolase from Nodularia spumignea NSOR10.
Die DNA, die für die Ketolase aus Nodularia spumignea NSOR10 kodiert, wurde mittels PCR aus Nodularia spumignea NSOR10 amplifi- ziert.The DNA encoding the ketolase from Nodularia spumignea NSOR10 was amplified by PCR from Nodularia spumignea NSOR10.
Für die Präparation von genomischer DNA aus einer Suspensionskultur von Nodularia spumignea NSOR10 , die 1 Woche mit Dauerlicht und konstantem Schütteln (150 rpm) at 25°C in BG 12-Medium (1.5 g/1 NaN03, 0.04 g/1 K2P04x3H20, 0.075 g/1 MgS04xH20, 0.036 g/1 CaClx2H20, 0.006 g/1 citric acid, 0.006 g/1 Ferric ammonium ci- trate, 0.001 g/1 EDTA disodium agnesium, 0.04 g/1 Na2C03 , 1ml Trace Metal Mix "A5+Co" (2.86 g/1 H3B03 , 1.81 g/1 MnCl2x4H2o, 0.222 g/1 ZnSO4x7H20, 0.39 g/1 NaMo04X2H2o, 0.079 g/1 CuS04x5H20, 0.0494 g/1 Co (N0 ) x6H0) gewachsen war, wurden die Zellen durch Zentrifugation geerntet, in flüssigem Stickstoff eingefroren und im Mörser pulverisiert.For the preparation of genomic DNA from a suspension culture of Nodularia spumignea NSOR10, which for 1 week with continuous light and constant shaking (150 rpm) at 25 ° C in BG 12 medium (1.5 g / 1 NaN0 3 , 0.04 g / 1 K 2 P0 4 x3H 2 0, 0.075 g / 1 MgS0 4 xH 2 0, 0.036 g / 1 CaClx2H 2 0, 0.006 g / 1 citric acid, 0.006 g / 1 Ferric ammonium citrate, 0.001 g / 1 EDTA disodium agnes, 0.04 g / 1 Na 2 C0 3 , 1ml trace metal mix "A5 + Co" (2.86 g / 1 H 3 B0 3 , 1.81 g / 1 MnCl 2 x4H 2 o, 0.222 g / 1 ZnSO 4 x7H 2 0, 0.39 g / 1 NaMo0 4 X2H 2 o, 0.079 g / 1 CuS0 4 x5H 2 0, 0.0494 g / 1 Co (N0) x6H0), the cells were through Centrifugation harvested, frozen in liquid nitrogen and pulverized in a mortar.
Protokoll für die DNA-Isolation aus Nodularia spumignea NSORIO :Protocol for DNA isolation from Nodularia spumignea NSORIO:
Aus einer 10 ml Flüssigkultur wurden die Bakterienzellen durch 10 minütige Zentrifugation bei 8000 rpm pelletiert. Anschließend wurden die Bakterienzellen in flüssigem Stickstoff mit einem Mörser zerstoßen und gemahlen. Das Zellmaterial wurde in 1 ml lOmM Tris_HCl (pH 7.5) resuspendiert und in ein Eppendorf-Reaktionsge- fäß (2ml Volumen) überführt. Nach Zugabe von 100 μl Proteinase K (Konzentration: 20 mg/ml) wurde die Zellsuspension für 3 Stunden bei 37°C inkubiert. Anschließend wurde die Suspension mit 500 μl Phenol extrahiert. Nach 5minütiger Zentrifugation bei 13 000 upm wurde die obere, wässrige Phase in ein neues 2 ml-Eppendorf-Reaktionsgefäß überführt. Die Extraktion mit Phenol wurde 3mal wiederholt. Die DNA wurde durch Zugabe von 1/10 Volumen 3 M Natrium- acetat (pH 5.2) und 0.6 Volumen Isopropanol gefällt und anschließend mit 70% Ethanol gewaschen. Das DNA-Pellet wurde bei Raumtem- peratur getrocknet, in 25 μl Wasser aufgenommen und unter Erhitzung auf 65°C gelöst. xThe bacterial cells were pelleted from a 10 ml liquid culture by centrifugation at 8000 rpm for 10 minutes. The bacterial cells were then crushed and ground in liquid nitrogen using a mortar. The cell material was resuspended in 1 ml 10mM Tris_HCl (pH 7.5) and transferred to an Eppendorf reaction vessel (2ml volume). After adding 100 μl Proteinase K (concentration: 20 mg / ml), the cell suspension was incubated for 3 hours at 37 ° C. The suspension was then extracted with 500 μl of phenol. After centrifugation at 13,000 rpm for 5 minutes, the upper, aqueous phase was transferred to a new 2 ml Eppendorf reaction vessel. The extraction with phenol was repeated 3 times. The DNA was precipitated by adding 1/10 volume of 3 M sodium acetate (pH 5.2) and 0.6 volume of isopropanol and then washed with 70% ethanol. The DNA pellet was dried at room temperature, taken up in 25 μl of water and dissolved with heating to 65 ° C. x
Die Nukleinsäure, kodierend eine Ketolase aus Nodularia spumignea NSORIO, wurde mittels "polymerase chain reaction" (PCR) aus Nodu- laria spumignea NSORIO unter Verwendung eines sense-spezifischen Primers (NODK-1, SEQ ID No . 74) und eines antisense-spezifischen Primers (NODK-2 SEQ ID No . 75) amplifiziert.The nucleic acid, coding for a ketolase from Nodularia spumignea NSORIO, was determined by means of a "polymerase chain reaction" (PCR) from Nodularia spumignea NSORIO using a sense-specific primer (NODK-1, SEQ ID No. 74) and an antisense-specific one Primers (NODK-2 SEQ ID No. 75) amplified.
Die PCR-Bedingungen waren die folgenden:The PCR conditions were as follows:
Die PCR zur Amplifikation der DNA, die für ein Ketolase Protein bestehend aus der gesamten Primärsequenz kodiert, erfolgte in einem 50 ul Reaktionsansatz, in dem enthalten war:The PCR for the amplification of the DNA, which codes for a ketolase protein consisting of the entire primary sequence, was carried out in a 50 μl reaction mixture which contained:
- 1 ul einer Nodularia spumignea NSORIO DNA (hergestellt wie oben beschrieben)- 1 ul of a Nodularia spumignea NSORIO DNA (prepared as described above)
0.25 mM dNTPs0.25 mM dNTPs
0.2 mM NODK-1 (SEQ ID No. 74)0.2 mM NODK-1 (SEQ ID No. 74)
0.2 mM NODK-2 (SEQ ID No . 75) - 5 ul 10X PCR-Puffer (TAKARA)0.2 mM NODK-2 (SEQ ID No. 75) - 5 ul 10X PCR buffer (TAKARA)
0.25 ul R Taq Polymerase (TAKARA)0.25 ul R Taq polymerase (TAKARA)
25.8 ul Aq. Dest .25.8 ul Aq. Dest.
Die PCR wurde unter folgenden Zyklusbedingungen durchgeführt;The PCR was carried out under the following cycle conditions;
IX 94°C 2 Minuten 35X 94°C 1 Minute 55°C 1 Minuten 72°C 3 Minuten IX 72°C 10 MinutenIX 94 ° C 2 minutes 35X 94 ° C 1 minute 55 ° C 1 minute 72 ° C 3 minutes IX 72 ° C 10 minutes
Die PCR-Amplifikation mit SEQ ID No . 74 und SEQ ID No . 75 resultierte in einem 720 Bp-Fragment, das für ein Protein bestehend aus der gesamten Primärsequenz kodiert (NODK, SEQ ID No. 76) . Unter Verwendung von Standardmethoden wurde das Amplifikat in den PCR-Klonierungsvektor pCR 2.1 (Invitrogen) kloniert und der Klon pNODK erhalten.PCR amplification with SEQ ID No. 74 and SEQ ID No. 75 resulted in a 720 bp fragment coding for a protein consisting of the entire primary sequence (NODK, SEQ ID No. 76). Using standard methods, the amplificate was cloned into the PCR cloning vector pCR 2.1 (Invitrogen) and the clone pNODK was obtained.
Sequenzierung des Klons pNODK mit dem M13F- und dem M13R-Primer bestätigte eine Sequenz, welche mit der DNA-Sequenz von 2130-2819 des Datenbank-eintrages AY210783 identisch ist (inverse orien- tiert zum veröffentlichen Datenbankeintrag) . Diese Nukleotidsequenz wurde in einem unabhängigem Amplifikationsexperiment reproduziert und repräsentiert somit die Nukleotidsequenz im verwendeten Nodularia spumignea NSORIO.Sequencing of the clone pNODK with the M13F and M13R primers confirmed a sequence which is identical to the DNA sequence from 2130-2819 of the database entry AY210783 (inverse to the published database entry). This nucleotide sequence was reproduced in an independent amplification experiment and thus represents the nucleotide sequence in the Nodularia spumignea NSORIO used.
Dieser Klon pNODK wurde daher für die Klonierung in den Expressionsvektor pJOAP (in Beispiel 9 beschrieben) verwendet. xThis clone pNODK was therefore used for the cloning into the expression vector pJOAP (described in Example 9). x
Die Klonierung erfolgte durch Isolierung des 710 Bp Sphl-Fragmen- tes aus pNODK und Ligierung in den SphI geschnittenen Vektor pJOAP. Der Klon, der die NODK-Ketolase von Nodularia spumignea NSORIO in der korrekten Orientierung als N-terminale translationale Fusion mit dem rbcS Transitpeptid enthält, heisst pJOAP:NODK.The cloning was carried out by isolating the 710 bp Sphl fragment from pNODK and ligation into the SphI-cut vector pJOAP. The clone that contains the NODK ketolase from Nodularia spumignea NSORIO in the correct orientation as an N-terminal translational fusion with the rbcS transit peptide is called pJOAP: NODK.
Beispiel 16:Example 16:
Herstellung von Expressionsvektoren zur fruchtspezifischen Ueber- expression der NODK-Ketolase aus Nodularia spumignea NSORIO in Lycopersicon esculentum.Production of expression vectors for fruit-specific overexpression of the NODK ketolase from Nodularia spumignea NSORIO in Lycopersicon esculentum.
Die Expression der NODK-Ketolase aus Nodularia spumignea NSORIO in L. esculentum erfolgte mit dem Transitpeptid rbcS aus Erbse (Anderson et al . 1986, Biochem J. 240:709-715). Die Expression erfolgte unter Kontrolle des Promoters AP3P aus Arabidopsis tha- liana (in Beispiel 5 beschrieben) .The NODK ketolase from Nodularia spumignea NSORIO was expressed in L. esculentum with the transit peptide rbcS from pea (Anderson et al. 1986, Biochem J. 240: 709-715). The expression was carried out under the control of the AP3P promoter from Arabidopsis thaliana (described in Example 5).
Die Herstellung eines Expressionsvektors für die Agrobacterium- vermittelte Transformation der AP3P-kontrollierten NPl95-Ketolase aus Nostoc punctiforme ATCC 29133 in L. esculentum erfolgte unter der Verwendung des binären Vektors pSUN3 (WO02/00900) . Zur Herstellung des Expressionsvektors MSP123 wurde das 1.893 KB bp Sacl-Xhol Fragment aus pJOAP:NODK mit dem Sacl-Xhol geschnittenen Vektor pSUN3 ligiert (Abbildung 13, Konstruktkarte). In der Abbildung 13 beinhaltet Fragment AP3P PROM den AP3P Promoter (765 bp) , Fragment rbcS TP FRAGMENT das rbcS Transitpeptid aus Erbse (194 bp) , Fragment NODK KETO CDS (690 bp) , kodierend für die Nodularia spumignea NSORIO NODK-Ketolase, Fragment OCS Terminator (192 bp) das Polyadenylierungssignal von Octopin-Synthase.An expression vector for the Agrobacterium -mediated transformation of the AP3P-controlled NPl95 ketolase from Nostoc punctiforme ATCC 29133 in L. esculentum was produced using the binary vector pSUN3 (WO02 / 00900). To produce the expression vector MSP123, the 1,893 KB bp Sacl-Xhol fragment from pJOAP: NODK was ligated with the Sacl-Xhol cut vector pSUN3 (Figure 13, construct map). In Figure 13 fragment AP3P PROM contains the AP3P promoter (765 bp), fragment rbcS TP FRAGMENT the rbcS transit peptide from pea (194 bp), fragment NODK KETO CDS (690 bp), coding for the Nodularia spumignea NSORIO NODK ketolase, fragment OCS terminator (192 bp) the octopine synthase polyadenylation signal.
Beispiel 17: Herstellung einer Expressionskassette zur fruchtspezifischen Ueberexpression der chromoplastenspezifischen b-Hydro- xylase aus Lycopersicon esculentum.Example 17: Production of an expression cassette for fruit-specific overexpression of the chromoplast-specific b-hydroxylase from Lycopersicon esculentum.
Die Expression der chromoplastenspezifischen ß-Hydroxylase aus Lycopersicon esculentum in Tomate erfolgt unter Kontrolle des fruchtspezifischen Promoters AP3P aus Arabidopsis (Beispiel 2) . Als Terminatorelement wird LB3 (Datenbank-eintrages AX696005) aus Vicia faba verwendet. Die Sequenz der chromoplastenspezifischen ß-Hydroxylase (Datenbank-eintrages Y14810 & BE354440) wurde durch RNA Isolierung, reverse Transkription und PCR hergestellt.The expression of the chromoplast-specific β-hydroxylase from Lycopersicon esculentum in tomato takes place under the control of the fruit-specific promoter AP3P from Arabidopsis (Example 2). LB3 (database entry AX696005) from Vicia faba is used as the terminator element. The sequence of the chromoplast-specific β-hydroxylase (database entry Y14810 & BE354440) was produced by RNA isolation, reverse transcription and PCR.
Das DNA-Fragment, das die LB3-Terminatorregion beinhaltet, 'wurde mittels PCR isoliert.The DNA fragment containing the LB3 terminator region was isolated by PCR.
Genomische DNA aus Vicia faJba-Gewebe nach Standardmethoden wird isoliert und durch genomische PCR unter Verwendung der Primer PR206 (SEQ ID No. 78) und PR207 (SEQ ID No . 79) eingesetzt. Die PCR zur Amplifikation dieses LB3 DNA-Fragmentes, erfolgt in einem 50 ul Reaktionsansatz, in dem enthalten ist:Genomic DNA from Vicia faJba tissue according to standard methods is isolated and used by genomic PCR using the primers PR206 (SEQ ID No. 78) and PR207 (SEQ ID No. 79). The PCR for the amplification of this LB3 DNA fragment is carried out in a 50 μl reaction mixture which contains:
- 1 ul genomische DNA (hergestellt wie oben beschrieben) 0.25 mM dNTPs- 1 µl genomic DNA (prepared as described above) 0.25 mM dNTPs
0.2 uM PR206 (SEQ ID No . 78) 0.2 uM PR207 (SEQ ID No . 79) - 5 ul 10X PCR-Puffer (TAKARA)0.2 uM PR206 (SEQ ID No. 78) 0.2 uM PR207 (SEQ ID No. 79) - 5 ul 10X PCR buffer (TAKARA)
0.25 ul. R Taq Polymerase (TAKARA) 28.8 ul. Aq. Dest.0.25 ul. R Taq Polymerase (TAKARA) 28.8 ul. Aq. Least.
Die PCR-Amplifikation mit SEQ ID No . 78 und SEQ ID No. 79 resul- tiert in einem 307 bp Fragment (SEQ ID No. 80) das für den LB- Terminator enthaelt . Unter Verwendung von Standardmethoden wurde das Amplifikat in den PCR-Klonierungsvektor pCR 2.1 (Invitrogen) kloniert und der Klon pLB3 erhalten. Sequenzierung des Klons pLB3 mit dem M13F- und dem M13R-Primer bestätigte eine Sequenz, welche mit der DNA-Sequenz von 3-298 des Datenbank-eintrages AX696005 identisch ist. Dieser Klon heisst pLB3 und wird daher für die Klonierung in den Vektor pJAP3P (siehe Beispiel 5) verwendet.PCR amplification with SEQ ID No. 78 and SEQ ID No. 79 results in a 307 bp fragment (SEQ ID No. 80) which contains the LB terminator. Using standard methods, the amplificate was cloned into the PCR cloning vector pCR 2.1 (Invitrogen) and the clone pLB3 was obtained. Sequencing of the clone pLB3 with the M13F and the M13R primer confirmed a sequence which corresponds to the DNA sequence from 3-298 of the database entry AX696005 is identical. This clone is called pLB3 and is therefore used for cloning into the vector pJAP3P (see example 5).
Die Expressionskassette pJAP3P wurde modifiziert, indem der 35S- 5 Terminator durch den Legumin LB3-Terminator des Vicia faba (Datenbankeintrag AX696005; WO03/008596) ersetzt wurde (siehe unten) .The expression cassette pJAP3P was modified by replacing the 35S- 5 terminator with the Legumin LB3 terminator from Vicia faba (database entry AX696005; WO03 / 008596) (see below).
Für die Herstellung der ß-Hydrόxylase-Sequenz wird Total-RNA ausTotal RNA is used to produce the ß-hydr -xylase sequence
10 Tomate präpariert. Dazu werden 100mg der gefrorenen, pulverisierten Blüten in ein Reaktionsgefäß überführt und in 0.8 ml Trizol- Puffer (LifeTechnologies) aufgenommen. Die Suspension wird mit 0.2 ml Chloroform extrahiert. Nach 15 minütiger Zentrifugation bei 12 000 g wird der wässrige Überstand abgenommen und in ein10 tomatoes prepared. For this, 100 mg of the frozen, powdered flowers are transferred to a reaction vessel and taken up in 0.8 ml Trizol buffer (LifeTechnologies). The suspension is extracted with 0.2 ml chloroform. After centrifugation at 12,000 g for 15 minutes, the aqueous supernatant is removed and placed in a
15 neues Reaktionsgefäß überführt und mit einem Volumen Ethanol extrahiert . Die RNA wird mit einem Volumen Isopropanol gefällt, mit 75% Ethanol gewaschen und das Pellet in DEPC Wasser (über Nacht Inkubation von Wasser mit 1/1000 Volumen Diethylpyrocarbonat bei Raumtemperatur, anschließend autoklaviert) gelöst. Die RNA-15 new reaction vessel transferred and extracted with a volume of ethanol. The RNA is precipitated with a volume of isopropanol, washed with 75% ethanol and the pellet is dissolved in DEPC water (overnight incubation of water with 1/1000 volume of diethyl pyrocarbonate at room temperature, then autoclaved). The RNA
20 Konzentration wird photometrisch bestimmt. Für die cDNA-Synthese werden 2.5 ug Gesamt-RNA für 10 min bei 60aC denaturiert, für 2 min auf Eis abgekühlt und mittels eines cDNA-Kits (Ready-tό-go- you-prime-beads , Pharmacia Biotech) nach Herstellerangaben unter Verwendung eines antisense spezifischen Primers (PR215 SEQ ID No.20 concentration is determined photometrically. For the cDNA synthesis, 2.5 µg of total RNA are denatured for 10 min at 60 a C, cooled on ice for 2 min and using a cDNA kit (Ready-to-go-you-prime beads, Pharmacia Biotech) according to the manufacturer's instructions using an antisense specific primer (PR215 SEQ ID No.
25 56) in cDNA umgeschrieben.25 56) rewritten in cDNA.
Die Bedingungen der anschließenden PCR-Reaktionen sind die folgenden:The conditions of the subsequent PCR reactions are as follows:
30 Die Nukleinsäure, kodierend die ß-Hydroxylase kodiert, wurde mittels "polymerase chain reaction" (PCR) aus Tomate unter Verwendung eines sense-spezifischen Primers (VPR204, SEQ ID No . 81) und eines antisense-spezifischen Primers (PR215 SEQ ID No . 82) amplifiziert.30 The nucleic acid encoding the β-hydroxylase was extracted from tomato by means of a "polymerase chain reaction" (PCR) using a sense-specific primer (VPR204, SEQ ID No. 81) and an antisense-specific primer (PR215 SEQ ID No . 82) amplified.
3535
Die PCR zur Amplifikation der DNA, die für ein ß-Hydroxylase Protein bestehend aus der gesamten Primärsequenz kodiert, erfolgte in einem 50 ul Reaktionsansatz, in dem enthalten war:The PCR for the amplification of the DNA, which codes for a β-hydroxylase protein consisting of the entire primary sequence, was carried out in a 50 μl reaction mixture which contained:
40 - 1 ul cDNA (hergestellt wie oben beschrieben)40-1 ul of cDNA (prepared as described above)
0.25 mM dNTPs0.25 mM dNTPs
0.2 uM VPR204 (SEQ ID No . 81)0.2 uM VPR204 (SEQ ID No. 81)
0.2 uM PR215 (SEQ ID No . 82)0.2 uM PR215 (SEQ ID No. 82)
5 ul 10X PCR-Puffer (TAKARA) 45 - 0.25 ul R Taq Polymerase (TAKARA)5 ul 10X PCR buffer (TAKARA) 45-0.25 ul R Taq polymerase (TAKARA)
28.8 ul Aq. Dest. Die PCR-Amplifikation mit VPR204 und PR215 resultiert in einem 1.040 bp Fragment (SEQ ID No. 83) das für die b-Hydroxylase codiert. Das Amplifikat wird in den PCR-Klonierungsvektor pCR 2.1 (Invitrogen) kloniert. Dieser Klon heisst pCrtR-b2.28.8 ul Aq. Least. The PCR amplification with VPR204 and PR215 results in a 1,040 bp fragment (SEQ ID No. 83) which codes for the b-hydroxylase. The amplificate is cloned into the PCR cloning vector pCR 2.1 (Invitrogen). This clone is called pCrtR-b2.
Sequenzierungen des Klons pCrtR-b2 mit den Primern M13-R und M13-R bestätigte eine Sequenz, welche mit der DNA-Sequenz von 33-558 des Datenbank-eintrages BE354440 identisch ist und mit der DNA-Sequenz von 1-1009 des Datenbank-eintrages Y14810 identisch ist . Der Klon pCrtR-b2 wird daher für die Klonierung in den Vektor pCSP02 verwendet (siehe unten).Sequencing of the clone pCrtR-b2 with the primers M13-R and M13-R confirmed a sequence which is identical to the DNA sequence from 33-558 of the database entry BE354440 and with the DNA sequence from 1-1009 of the database entry Y14810 is identical. The clone pCrtR-b2 is therefore used for the cloning into the vector pCSP02 (see below).
Der erste Klonierungsschritt erfolgt durch Isolierung des 1.034 bp Hindlll-EcoRI Fragmentes aus pCrtR-b2 , abgeleitet vom Klonie- rungsvektor pCR-2.1 (Invitrogen), und Ligierung mit dem Hindlll- EcoRI geschnittenen Vektor pJAP3P (siehe Beispiel 5) . Der Klon, der das b-Hydroxylase-Fragment CrtR-b2 enthält, heisst pCSP02.The first cloning step is carried out by isolating the 1,034 bp HindIII-EcoRI fragment from pCrtR-b2, derived from the cloning vector pCR-2.1 (Invitrogen), and ligation with the HindIII-EcoRI cut vector pJAP3P (see Example 5). The clone that contains the b-hydroxylase fragment CrtR-b2 is called pCSP02.
Der zweite Klonierungsschritt erfolgt durch Isolierung des 301bp EcoRI-XhoI Fragmentes aus pLB3 , abgeleitet vom Klonierungsvektor pCR-2.1 (Invitrogen), und Ligierung mit dem EcoRI-XhoI geschnittenen Vektor pCSP02. Der Klon, der den 296 bp Terminator LÖ3 enthält, heisst pCSP03. Durch die Ligation entsteht eine transkriptioneile Fusion zwischen dem Terminator LB3 und dem b-Hydroxy- lase-Fragment CrtR-b2. Zudem entsteht eine transkriptioneile Fusion zwischen dem AP3P Promoter und dem b-Hydroxylase-Fragment.The second cloning step is carried out by isolating the 301 bp EcoRI-XhoI fragment from pLB3, derived from the cloning vector pCR-2.1 (Invitrogen), and ligation with the EcoRI-XhoI cut vector pCSP02. The clone that contains the 296 bp terminator LÖ3 is called pCSP03. The ligation creates a transcriptional fusion between the terminator LB3 and the b-hydroxylase fragment CrtR-b2. In addition, a transcriptional fusion occurs between the AP3P promoter and the b-hydroxylase fragment.
Beispiel 18: Herstellung einer Expressionskassette zur fruchtspezifischen Ueberexpression des B-Genes aus Lycopersicon esculen- turn.Example 18: Production of an expression cassette for fruit-specific overexpression of the B gene from Lycopersicon esculenurn.
Die Expression des B-Genes aus Lycopersicon esculentum in Tomat (Lycopene b-cyclase; Datenbank-eintrages AF254793) erfolgt unter Kontrolle des fruchtspezifischen Promoters PDS (phytoene desatu- rase; Datenbank-eintrages U46919) aus Lycopersicon esculentum. Als Terminatorelement wird 35S aus CaMV verwendet. Die Sequenz des B-Genes wurde durch PCR aus genomischer DNA aus Lycopersicon esculentum hergestellt.The expression of the B gene from Lycopersicon esculentum in Tomat (Lycopene b-cyclase; database entry AF254793) takes place under the control of the fruit-specific promoter PDS (phytoene desaturase; database entry U46919) from Lycopersicon esculentum. 35S from CaMV is used as the terminator element. The sequence of the B gene was generated by PCR from genomic DNA from Lycopersicon esculentum.
Zur Isolation des B-Genes mittels PCR mit genomischer DNA von Lycopersicon esculentum wurden die Oligonukleotid Primer BGEN-1 (SEQ ID No. 85) und BGEN-2 (SEQ ID No. 86) verwendet.The oligonucleotide primers BGEN-1 (SEQ ID No. 85) and BGEN-2 (SEQ ID No. 86) were used to isolate the B gene by means of PCR with genomic DNA from Lycopersicon esculentum.
Die genomische DNA wurde aus Lycopersicon esculentum wie be- schrieben (Galbiati M et al. Funct. Integr. Genomics 2000, 20 1:25-34) isoliert. Die PCR Amplifikation wurde wie folgt durchgeführt:The genomic DNA was isolated from Lycopersicon esculentum as described (Galbiati M et al. Funct. Integr. Genomics 2000, 20 1: 25-34). The PCR amplification was carried out as follows:
80ng genomische DNA lx Expand Long Template PCR Puffer 5 2 , 5 mM MgCl2 je 350 μM dATP, dCTP, dGTP, dTTp 0.3 uM BGEN-1 (SEQ ID No . 85) 0.3 uM BGEN-2 (SEQ ID No . 86) 2 , 5 Units Expand Long Template Polymerase 10 in einem Endvolumen von 25 μl80ng genomic DNA lx Expand Long Template PCR buffer 5 2.5 mM MgCl2 each 350 μM dATP, dCTP, dGTP, dTTp 0.3 uM BGEN-1 (SEQ ID No. 85) 0.3 uM BGEN-2 (SEQ ID No. 86) 2 , 5 Units Expand Long Template Polymerase 10 in a final volume of 25 μl
Folgendes Temperaturprogramm wurde verwendet :The following temperature program was used:
1 Zyklus mit 120 sec bei 94°C 15 35 Zyklen mit 94°C für 10 sec, 48°C für 30 sec und 68°C für 3 min 1 Zyklus mit 68°C für 10 min1 cycle with 120 sec at 94 ° C 15 35 cycles with 94 ° C for 10 sec, 48 ° C for 30 sec and 68 ° C for 3 min 1 cycle with 68 ° C for 10 min
Die PCR-Amplifikation mit BGEN-1 und BGEN-2 resultiert in einemPCR amplification with BGEN-1 and BGEN-2 results in one
1.505 kb Fragment (SEQ ID No . 87) das für die b-Hydroxylase co-1,505 kb fragment (SEQ ID No. 87) which is co- for the b-hydroxylase
20 diert. Das Amplifikat wird in den PCR-Klonierungsvektor pCR-2.120 dated. The amplificate is in the PCR cloning vector pCR-2.1
(Invitrogen) kloniert. Dieser Klon heisst pBGEN. x(Invitrogen) cloned. This clone is called pBGEN. x
Sequenzierungen des Klons pBGEN mit den Primern M13-R und M13-F bestätigte eine Sequenz, welche mit der DNA-Sequenz von 1-1497 25 des Datenbank-eintrages AF254793 identisch ist. Der Klon pCrtR- b2 wird daher für die Klonierung in den Vektor pCSP02 verwendet (siehe unten) .Sequencing of the clone pBGEN with the primers M13-R and M13-F confirmed a sequence which is identical to the DNA sequence from 1-1497 25 of the database entry AF254793. The clone pCrtR-b2 is therefore used for the cloning into the vector pCSP02 (see below).
Für die Herstellung der PDS-Promotor-Sequenz aus Lycopersicon 30 esculentum wird genomische DNA aus Lycopersicon esculentum-Gewebe nach Standardmethoden isoliert und durch genomische PCR unter Verwendung der Primer PDS-1 und PDS-2 eingesetzt . Die PCR zur Amplifikation dieses PDS-PRomotor-Fragmentes , erfolgt in einem 50 ul . Reaktionsansatz, in dem enthalten ist: 35For the production of the PDS promoter sequence from Lycopersicon 30 esculentum, genomic DNA from Lycopersicon esculentum tissue is isolated according to standard methods and used by genomic PCR using the primers PDS-1 and PDS-2. The PCR for the amplification of this PDS-PRomotor fragment is carried out in a 50 ul. Reaction batch which contains: 35
1 ul genomische DNA (hergestellt wie oben beschrieben) 0.3 mM dNTPs1 µl genomic DNA (prepared as described above) 0.3 mM dNTPs
0.2 uM PDS-1 (SEQ ID No. 89) 0.2 uM PDS-2 (SEQ ID No . 90) 40 - 5 ul 10X Pfu-Turbo Polymerase (Stratagene) - 1 ul Pfu-Turbo Polymerase (Stratagene) 28.8 ul Aq. Dest .0.2 uM PDS-1 (SEQ ID No. 89) 0.2 uM PDS-2 (SEQ ID No. 90) 40 - 5 ul 10X Pfu-Turbo Polymerase (Stratagene) - 1 ul Pfu-Turbo Polymerase (Stratagene) 28.8 ul Aq. Dest.
Folgendes Temperaturprogramm wurde verwendet :The following temperature program was used:
4545
1 Zyklus mit.120 sec bei 94°C1 cycle with 120 sec at 94 ° C
36 Zyklen mit 94°C für 60 sec, 55°C für 120 sec und 72°C für 4 min 1 Zyklus mit 72°C für 10 min36 cycles with 94 ° C for 60 sec, 55 ° C for 120 sec and 72 ° C for 4 min 1 cycle at 72 ° C for 10 min
Die PCR-Amplifikation mit PDS-1 und PDS-2 resultiert in einem Fragment das die Sequenz für den PDS-Promotor enthaelt. Das Am- plifikat wird in den pCR4-BLUNT (Invitrogen) kloniert. Dieser Klon heisst pPDS.The PCR amplification with PDS-1 and PDS-2 results in a fragment that contains the sequence for the PDS promoter. The amplificate is cloned into the pCR4-BLUNT (Invitrogen). This clone is called pPDS.
Sequenzierungen mit den Primern M13-R und M13-F bestätigen eine zur Sequenz SEQ ID No . 91 identische Sequenz. Dieser Klon heisst pPDS und wird daher für die Klonierung in den Vektor pJBGEN verwendet (siehe unten) .Sequencing with the primers M13-R and M13-F confirm a sequence SEQ ID No. 91 identical sequence. This clone is called pPDS and is therefore used for cloning into the vector pJBGEN (see below).
Der erste Klonierungsschritt erfolgt durch Isolierung des 1.499 bp Ncol/EcoRI Fragmentes aus pBGEN, abgeleitet vom Klonierungs- vektor pCR2.1 (Invitrogen). Zunaechst wird pBGEN mit BamHI geschnitten, die 3 'Enden nach Standardmethoden (30 min bei 30°C) aufgefuellt (Klenow-fill-in) und dann ein Partialverdau mit Ncol durchgefuehrt , bei dem das entstehende 1.499 kb Fragment isoliert. Anschliessend wurde dieses Fragment in den pCSP02 klo- niert, welches vorher mit EcoRI geschnitten, die 3 'Enden nach Standardmethoden (30 min bei 30°C) aufgefuellt (Klenow-fill-in) und dann wird mit Ncol geschnitten. Der Klon, der das 1.497 bp B-Gen-Fragment BGEN enthält, heisst pJAP:BGEN. Durch die Ligation entsteht eine transkriptioneile Fusion zwischen dem 35S-Ter- minator und dem B-Gen.The first cloning step is carried out by isolating the 1,499 bp Ncol / EcoRI fragment from pBGEN, derived from the cloning vector pCR2.1 (Invitrogen). First, pBGEN is cut with BamHI, the 3 'ends are filled in according to standard methods (30 min at 30 ° C.) (Klenow-fill-in) and then a partial digestion is carried out with Ncol, in which the resulting 1,499 kb fragment is isolated. This fragment was then cloned into pCSP02, which had previously been cut with EcoRI, the 3 'ends filled in according to standard methods (30 min at 30 ° C.) (Klenow fill-in) and then cut with Ncol. The clone that contains the 1,497 bp B gene fragment BGEN is called pJAP: BGEN. The ligation creates a transcriptional fusion between the 35S terminator and the B gene.
Der zweite Klonierungsschritt erfolgt durch Isolierung des 2.078 bp PDS PROM Fragmentes aus pPDS . Zunaechst wird pPDS mit Smal geschnitten und dann ein Partialverdau mit Sacl durchgefuehrt, bei dem das entstehende 2.088 bp Fragment isoliert. Anschliessend wurde dieses Fragment in den pJAP:BGEN kloniert, welches vorher mit BamHI geschnitten, die 3' Enden nach Standardmethoden (30 min bei 30°C) aufgefuellt (Klenow-fill-in) und dann wird mit Sacl geschnitten. Durch die Ligation entsteht eine transkriptio- nelle Fusion zwischen dem Promotor PDS und dem B-Gen. Der Klon, der das 2.078 bp PDS Promotoren BGEN enthält, heisst pJPDS:BGEN.The second cloning step is carried out by isolating the 2,078 bp PDS PROM fragment from pPDS. First, pPDS is cut with Smal and then a partial digestion with Sacl is carried out, in which the resulting 2,088 bp fragment is isolated. This fragment was then cloned into the pJAP: BGEN, which had previously been cut with BamHI, the 3 'ends filled in using standard methods (30 min at 30 ° C.) (Klenow fill-in) and then cut with SacI. The ligation creates a transcriptional fusion between the promoter PDS and the B gene. The clone that contains the 2,078 bp PDS promoter BGEN is called pJPDS: BGEN.
Beispiel 19: Herstellung eines Dreifach-Expressionsvektors zur Ueberexpression des B-Genes, der Expression der Nostoc puncti- forme Ketolase NP196, sowie der Ueberexpression der chromoplastenspezifischen B-Hydroxylase aus Lycopersicon esculentum fruchtspezifisch in Lycopersicon esculentum .Example 19: Production of a triple expression vector for the overexpression of the B gene, the expression of the Nostoc punctiform ketolase NP196, and the overexpression of the chromoplast-specific B-hydroxylase from Lycopersicon esculentum fruit-specifically in Lycopersicon esculentum.
Zunaechst erfolgt die Herstellung eines Doppelkonstruktes, das Expressionskassetten zur Ueberexpression der Nostoc punctiforme ATCC 29133 NP196 Ketolase sowie zur Ueberexpression der B-Hydroxylase enthaelt. Zunaechst wird dem Fragment AP3P:b-Hydroxy- lase:LB3, das die B-Hydroxylase-Expressionskassette enthaelt, als 2104 bp Ecll36lI-XhoI Fragment isoliert aus pCSP03 (in Beispiel 18 beschrieben). Das Auffüllen der 3' Enden (30 min bei 30aC) erfolgt nach Standardmethoden (Klenow-fill-in) . Anschliessend, wurde dieses Fragment in der Vektor MSP120 (in Beispiel 10 beschrieben) mit Ecll36ll und EcoRI geschnitten, die 3 'Enden nach Standardmethoden (30 min bei 30°C) aufgefuellt (Klenow-fill-in) . Durch die Ligation entsteht eine T-DNA die zwei Expressionskassetten enthaelt: erstens eine Kassette zur chromoplastenspezifi- sehen Ueberexpression der B-Hydroxylase aus Lycopersicon esculentum, und zweitens eine Kassette zur Ueberexpression der Ketolase NP196 aus Nostoc punctiforme . Die B-Hydroxylase-Runterregulie- rungs-Kassette kann in zwei Orientierungen in den Vektor ligie- ren. Bevorzugt wird die Version verwendet, in der beide Expres- sionskassette in ihrer Orientierung uebereinstimmen (siehe Abbildung 14) . Diese Version kann durch PCR wie beschrieben identifiziert werden:First, a double construct is produced which contains expression cassettes for the overexpression of the Nostoc punctiform ATCC 29133 NP196 ketolase and for the overexpression of the B-hydroxylase. First the fragment AP3P: b-hydroxy lase: LB3, which contains the B-hydroxylase expression cassette, as a 2104 bp Ecll36lI-XhoI fragment isolated from pCSP03 (described in Example 18). The 3 'ends (30 min at 30 a C) are filled using standard methods (Klenow fill-in). Subsequently, this fragment was cut in the vector MSP120 (described in Example 10) with Ecll36ll and EcoRI, the 3 'ends were filled in according to standard methods (30 min at 30 ° C.) (Klenow fill-in). The ligation results in a T-DNA which contains two expression cassettes: firstly a cassette for the chromoplast-specific overexpression of the B-hydroxylase from Lycopersicon esculentum, and secondly a cassette for the overexpression of the ketolase NP196 from Nostoc punctiforme. The B-hydroxylase downregulation cassette can ligate into the vector in two orientations. The version in which both expression cassettes match in their orientation is preferred (see Figure 14). This version can be identified by PCR as described:
Die PCR zur Amplifikation des PR206-PR010 Plasmid-Fragmentes, das die Verbindung von LB3 terminator der B-Hydroxylase-Kassette und des AP3P-Promoters der Ketolase-Kassette enthaelt, erfolgt in einem 50 ul Reaktionsansatz, in dem enthalten ist:The PCR for the amplification of the PR206-PR010 plasmid fragment, which contains the compound of LB3 terminator of the B-hydroxylase cassette and the AP3P promoter of the ketolase cassette, is carried out in a 50 μl reaction mixture which contains:
1 ul Plasmid-DNA (nach Standardmethoden hergestellt) - 0.25 mM dNTPs1 µl of plasmid DNA (made using standard methods) - 0.25 mM dNTPs
0.2 uM PR010 (SEQ ID No. 92)0.2 uM PR010 (SEQ ID No. 92)
0.2 uM PR206 (SEQ ID No . 93)0.2 uM PR206 (SEQ ID No. 93)
5 ul 10X PCR-Puffer (TAKARA)5 ul 10X PCR buffer (TAKARA)
0.25 ul. R Taq Polymerase (TAKARA) - 28.8 ul. Aq. Dest.0.25 ul. R Taq Polymerase (TAKARA) - 28.8 ul. Aq. Least.
Die PCR-Amplifikation mit PR010 und PR206 resultiert in einem 1.080 Bp Fragment, das auf das Vorliegen der oben beschriebenen Verbindung von LB3-Terminator und AP3P-Promotor hinweist, und da- mit die bevorzugte Orientierung beider Expressionskassetten. Dieser Klon heisst pBHYX:NPl96.The PCR amplification with PR010 and PR206 results in a 1,080 bp fragment, which indicates the presence of the above-described connection of LB3 terminator and AP3P promoter, and thus the preferred orientation of both expression cassettes. This clone is called pBHYX: NPl96.
Zur Klonierung dieser B-Gen-Ueberexpressionskassette in Expressionsvektoren für die Agrobacterium-vermittelte Transformation von Tomate erfolgt durch Isolierung des 4.362 Bp EcoRV-XhoI Fragmentes aus pJPDS-.BGEN (siehe Beispiel 19) und Ligierung in dem Smal-Xhol-geschnittenen Vektor pBHYX:NPl96 (oben beschrieben) . Durch die Ligation entsteht eine T-DNA die drei Expressionskassetten enthaelt: erstens eine Kassette zur Ueberexpression des B- Genes, zweitens eine Kassette zur Ueberexpression der Ketolase NP196-1 aus Nostoc punctiforme, und drittens eine Kassette zur chromoplastenspezifischen Ueberexpression der B-Hydroxylase aus Lycopersicon esculentum (Abbildung 14, Konstruktkarte). Dieser Klon heisst MSP124. In der Abbildung 14 beinhaltet Fragment AP3P PROM (765 bp) den AP3P-Promoter, das Fragment BHYX b2 CDS (2 bp) die B-Hydroxylase CrtRb2, Fragment LB3 TERM (296 bp) den LB3 Ter- minator.To clone this B gene overexpression cassette into expression vectors for the Agrobacterium -mediated transformation of tomato, isolation of the 4,362 bp EcoRV-XhoI fragment from pJPDS-.BGEN (see Example 19) and ligation in the Smal-Xhol-cut vector pBHYX: NPl96 (described above). The ligation results in a T-DNA which contains three expression cassettes: first a cassette for overexpressing the B gene, secondly a cassette for overexpressing the ketolase NP196-1 from Nostoc punctiforme, and thirdly a cassette for chromoplast-specific overexpression of the B-hydroxylase Lycopersicon esculentum (Figure 14, construct map). This clone is called MSP124. In Figure 14, fragment AP3P PROM (765 bp) contains the AP3P promoter, fragment BHYX b2 CDS (2 bp) the B-hydroxylase CrtRb2, fragment LB3 TERM (296 bp) the LB3 terminator.
Weiterhin beinhaltet Fragment AP3P PROM (765 bp) den AP3P-Promo- ter, Fragment rbcS TP FRAGMENT (194 bp) das Transitpeptid des rbcS Gens aus Erbse, NP196 KETO CDS (761 bp) die Ketolase aus No- stoc punctiforme ATCC29133 , und OCS TERM (192 bp) das Polyadenylierungssignal des Octopin-Synthasegens .Fragment AP3P PROM (765 bp) also contains the AP3P promoter, fragment rbcS TP FRAGMENT (194 bp) the transit peptide of the rbcS gene from pea, NP196 KETO CDS (761 bp) the ketolase from Noctoc punctiform ATCC29133, and OCS TERM (192 bp) the polyadenylation signal of the octopine synthase gene.
Weiterhin beinhaltet Fragment PDS PROM (2078 bp) den PDS Promoter, Fragment BGEN CDS (1.497 bp) die B-Gen Sequenz, und Fragment 35S TERM (746 bp) den 35S Terminator.Furthermore, fragment PDS PROM (2078 bp) contains the PDS promoter, fragment BGEN CDS (1,497 bp) the B gene sequence, and fragment 35S TERM (746 bp) the 35S terminator.
Beispiel 20:Example 20:
Herstellung transgener Lycopersicon esculentum PflanzenProduction of transgenic Lycopersicon esculentum plants
Transformation und Regeneration von Tomatenpflanzen wurde in Beispiel 6 beschrieben. sTransformation and regeneration of tomato plants was described in Example 6. s
Gemäß der beschriebenen Transformationsmethode wurden mit folgen- den Expressionskonstrukten folgende Linien erhalten:According to the transformation method described, the following lines were obtained with the following expression constructs:
Mit MSP120 wurde erhalten: MSP120-1, MSP120-2, MSP120-3With MSP120 was obtained: MSP120-1, MSP120-2, MSP120-3
Mit MSP121 wurde erhalten: MSP121-1, MSP121-2, MSP121-3With MSP121 was obtained: MSP121-1, MSP121-2, MSP121-3
Mit MSP122 wurde erhalten: MSP122-1, MSP122-2, MSP122-3With MSP122 was obtained: MSP122-1, MSP122-2, MSP122-3
Mit MSP123 wurde erhalten: MSP123-1, MSP123-2, MSP123-3With MSP123 was obtained: MSP123-1, MSP123-2, MSP123-3
Mit MSP124 wurde erhalten: MSP124-1, MSP124-2, MSP124-3 With MSP124 was obtained: MSP124-1, MSP124-2, MSP124-3

Claims

Patentansprüche claims
1. Verfahren zur Herstellung von Ketocarotinoiden durch Kulti- vierung von genetisch veränderten Pflanzen, die in Früchten eine Ketolase-Aktivität aufweisen.1. Process for the preparation of ketocarotenoids by cultivating genetically modified plants which have a ketolase activity in fruit.
2. Verfahren nach Anspruch 1, dadurch gekennzeichnet, dass man genetisch veränderte Pflanzen verwendet, die in Früchten eine Ketolase exprimieren.2. The method according to claim 1, characterized in that one uses genetically modified plants that express a ketolase in fruits.
3. Verfahren nach Anspruch 1 oder 2, dadurch gekennzeichnet, dass man genetisch veränderte Pflanzen verwendet, die in Früchten mindestens eine Nukleinsäure, kodierend eine Keto- läse, enthalten.3. The method according to claim 1 or 2, characterized in that genetically modified plants are used which contain at least one nucleic acid, coding for a keto-lase, in fruits.
4. Verfahren nach Anspruch 3, dadurch gekennzeichnet, dass man genetisch veränderte Pflanzen verwendet, in die man ausgehend von einer Ausgangspflanze mindestens eine Nukleinsäure, kodierend eine Ketolase, eingebracht hat.4. The method according to claim 3, characterized in that one uses genetically modified plants, in which, starting from a starting plant, at least one nucleic acid coding for a ketolase has been introduced.
5. Verfahren nach Anspruch 4, dadurch gekennzeichnet, dass man Nukleinsäuren einbringt, die ein Protein kodieren, enthaltend die Aminosäuresequenz SEQ ID NO. 2 oder eine von dieser Sequenz durch Substitution, Insertion oder Deletion von Aminosäuren abgeleitete Sequenz, die eine Identität von mindestens 20% auf Aminosäureebene mit der Sequenz SEQ ID NO. 2 und die enzymatische Eigenschaft einer Ketolase aufweist.5. The method according to claim 4, characterized in that introducing nucleic acids encoding a protein containing the amino acid sequence SEQ ID NO. 2 or a sequence derived from this sequence by substitution, insertion or deletion of amino acids, which has an identity of at least 20% at the amino acid level with the sequence SEQ ID NO. 2 and has the enzymatic property of a ketolase.
6. Verfahren nach Anspruch 4, dadurch gekennzeichnet, dass man6. The method according to claim 4, characterized in that one
Nukleinsäuren, enthaltend die Sequenz SEQ ID NO . 1 einbringt.Nucleic acids containing the sequence SEQ ID NO. 1 brings.
7. Verfahren nach Anspruch 4, dadurch gekennzeichnet, dass man Nukleinsäuren einbringt die ein Protein kodieren, enthaltend die Aminosäuresequenz SEQ ID NO. 16 oder eine von dieser7. The method according to claim 4, characterized in that introducing nucleic acids encoding a protein containing the amino acid sequence SEQ ID NO. 16 or one of these
Sequenz durch Substitution, Insertion oder Deletion von Aminosäuren abgeleitete Sequenz, die eine Identität von mindestens 20% auf Aminosäureebene mit der Sequenz SEQ ID NO. 16 und die enzymatische Eigenschaft einer Ketolase aufweist .Sequence derived by substitution, insertion or deletion of amino acids, which has an identity of at least 20% at the amino acid level with the sequence SEQ ID NO. 16 and has the enzymatic property of a ketolase.
8. Verfahren nach Anspruch 6, dadurch gekennzeichnet, dass man Nukleinsäuren, enthaltend die Sequenz SEQ ID NO. 15 einbringt .8. The method according to claim 6, characterized in that nucleic acids containing the sequence SEQ ID NO. 15 brings.
Sequ. + Zeichn. Sequ. + Draw
9. Verfahren nach einem der Ansprüche 1 bis 8, dadurch gekennzeichnet, dass man genetisch veränderte Pflanzen verwendet, die in Früchten die höchste Expressionsrate einer Ketolase aufweisen.9. The method according to any one of claims 1 to 8, characterized in that one uses genetically modified plants which have the highest expression rate of a ketolase in fruits.
55
10. Verfahren nach Anspruch 9, dadurch gekennzeichnet, dass die Genexpression der Ketolase unter Kontrolle eines fruchtspezifischen Promotors erfolgt.10. The method according to claim 9, characterized in that the gene expression of the ketolase takes place under the control of a fruit-specific promoter.
10 11. Verfahren nach einem der Ansprüche 1 bis 10, dadurch gekennzeichnet, dass die Pflanzen zusätzlich gegenüber dem Wildtyp eine erhöhte Aktivität mindestens einer der Aktivitäten, ausgewählt aus der Gruppe Hydroxylase-Aktivität und ß-Cyclase- Aktivität aufweisen.11. The method according to any one of claims 1 to 10, characterized in that the plants additionally have an increased activity compared to the wild type of at least one of the activities selected from the group of hydroxylase activity and β-cyclase activity.
1515
12. Verfahren nach Anspruch 11, dadurch gekennzeichnet, dass man zur zusätzlichen Erhöhung mindestens einer der Aktivitäten, die Genexpression mindestens einer Nukleinsäure ausgewählt aus der Gruppe, Nukleinsäuren kodierend eine Hydroxylase und12. The method according to claim 11, characterized in that for additional increase of at least one of the activities, the gene expression of at least one nucleic acid selected from the group encoding a hydroxylase and nucleic acids
20 Nukleinsäuren kodierend eine ß-Cyclase gegenüber dem Wildtyp erhöht .20 nucleic acids encoding a β-cyclase increased compared to the wild type.
13. Verfahren nach Anspruch 12, dadurch gekennzeichnet, dass man zur Erhöhung der Genexpression mindestens' einer der Nuklein-13. The method according to claim 12, characterized in that to increase gene expression at least 'one of the nucleotides
25 säuren, mindestens eine Nukleinsäure ausgewählt aus der25 acids, at least one nucleic acid selected from the group
Gruppe, Nukleinsäuren kodierend eine Hydroxylase und Nukleinsäuren kodierend eine ß-Cyclase in die Pflanze einbringt.Group, encoding nucleic acids encoding a hydroxylase and nucleic acids encoding a β-cyclase into the plant.
14. Verfahren nach Anspruch 13, dadurch gekennzeichnet, dass man 30 als Nukleinsäure kodierend eine Hydroxylase, Nukleinsäuren einbringt die eine Hydroxylase kodieren, enthaltend die Aminosäuresequenz SEQ ID NO: 52 oder eine von dieser Sequenz durch Substitution, Insertion oder Deletion von Aminosäuren abgeleitete Sequenz, die eine Identität von mindestens 20 % 35 auf Aminosäureebene mit der Sequenz SEQ ID NO: 52 aufweist.14. The method according to claim 13, characterized in that 30 nucleic acid encoding a hydroxylase, nucleic acids encoding a hydroxylase are introduced, containing the amino acid sequence SEQ ID NO: 52 or a sequence derived from this sequence by substitution, insertion or deletion of amino acids, which has an identity of at least 20% 35 at the amino acid level with the sequence SEQ ID NO: 52.
15. Verfahren nach Anspruch 14, dadurch gekennzeichnet, dass man Nukleinsäuren, enthaltend die Sequenz SEQ ID NO: 51 einbringt .15. The method according to claim 14, characterized in that nucleic acids containing the sequence SEQ ID NO: 51 are introduced.
4040
16. Verfahren nach Anspruch 13, dadurch gekennzeichnet, dass man als Nukleinsäure kodierend eine ß-Cyclase, Nukleinsäuren einbringt die eine ß-Cyclase kodieren, enthaltend die Aminosäuresequenz SEQ ID NO: 54 oder eine von dieser Sequenz durch16. The method according to claim 13, characterized in that the nucleic acid encoding a β-cyclase, nucleic acids which encode a β-cyclase, containing the amino acid sequence SEQ ID NO: 54 or one of these sequences
45 Substitution, Insertion oder Deletion von Aminosäuren abge- leitete Sequenz, die eine Identität von mindestens 20 % auf Aminosäureebene mit der Sequenz SEQ ID NO: 54 aufweist.45 substitution, insertion or deletion of amino acids removed directed sequence that has at least 20% identity at the amino acid level with the sequence SEQ ID NO: 54.
17. Verfahren nach Anspruch 16, dadurch gekennzeichnet, dass man Nukleinsäuren, enthaltend die Sequenz SEQ ID NO: 53 einbringt .17. The method according to claim 16, characterized in that nucleic acids containing the sequence SEQ ID NO: 53 are introduced.
18. Verfahren nach einem der Ansprüche 11 bis 17, dadurch gekennzeichnet, dass man genetisch veränderte Pflanzen verwendet, die in Blüten die höchste Expressionsrate einer Hydroxylase und/oder ß-Cyclase aufweisen.18. The method according to any one of claims 11 to 17, characterized in that genetically modified plants are used which have the highest expression rate of a hydroxylase and / or β-cyclase in flowers.
19. Verfahren nach Anspruch 18, dadurch gekennzeichnet, dass die Genexpression der Hydroxylase und/oder ß-Cyclase unter Kontrolle eines blütenspezifischen Promotors erfolgt.19. The method according to claim 18, characterized in that the gene expression of the hydroxylase and / or β-cyclase takes place under the control of a flower-specific promoter.
20. Verfahren nach einem der Ansprüche 1 bis 10, dadurch gekennzeichnet, dass man als Pflanze eine Pflanze verwendet, die in Früchten Chromoplasten aufweist.20. The method according to any one of claims 1 to 10, characterized in that the plant used is a plant which has chromoplasts in fruits.
21. Verfahren nach einem der Ansprüche 1 bis 20, dadurch gekennzeichnet, dass man als Pflanze eine Pflanze ausgewählt' aus den Pflanzengattungen Actinophloeus, Aglaeonema, Ananas, Arbutus , Archontophoenix, Area, Aronia, Asparagus, Attalea, Berberis, Bixia, Brachychilum, Bryonia, Caliptocalix,21. The method according to any one of claims 1 to 20, characterized in that a plant selected as a plant 'from the plant genera Actinophloeus, Aglaeonema, pineapple, Arbutus, Archontophoenix, Area, Aronia, Asparagus, Attalea, Berberis, Bixia, Brachychilum, Bryonia , Caliptocalix,
Capsicum, Carica, Celastrus, Citrullus, Citrus, Convallaria, Cotoneaster, Crataegus, Cucumis, Cucurbita, Cuscuta, Cycas, Cyphomandra, Dioscorea, Diospyrus, Dura, Elaeagnus , Elaeis, Erythroxylon, Euonymus, Ficus, Fortunella, Fragaria, Gardi- nia, Gonocaryum, Gossypium, Guava, Guilielma, Hibiscus, Hippophaea, Iris, Lathyrus, Lonicera, Luffa, Lycium, Lycopersicum, Malpighia, Mangifera, Mormodica, Murraya, Musa, Nenga, Palisota, Pandanus, Passiflora, Persea, Physalis, Prunus, Ptychandra, Punica, Pyracantha, Pyrus, Ribes, Rosa, Rubus, Sabal, Sambucus, Seaforita, Shepherdia, Solanum,Capsicum, Carica, Celastrus, Citrullus, Citrus, Convallaria, Cotoneaster, Crataegus, Cucumis, Cucurbita, Cuscuta, Cycas, Cyphomandra, Dioscorea, Diospyrus, Dura, Elaeagnus, Elaeis, Erythroxylon, Euonymus, Ficus, Garduni- nia, Fragunellaia, Fragunellaia Gonocaryum, Gossypium, Guava, Guilielma, Hibiscus, Hippophaea, Iris, Lathyrus, Lonicera, Luffa, Lycium, Lycopersicum, Malpighia, Mangifera, Mormodica, Murraya, Musa, Nenga, Palisota, Pandanus, Passiflora, Persus, Palis, Pralis Punica, Pyracantha, Pyrus, Ribes, Rosa, Rubus, Sabal, Sambucus, Seaforita, Shepherdia, Solanum,
Sorbus, Synaspadix, Tabernae, Tamus, Taxus, Trichosanthes, Triphasia, Vaccinium, Viburnum, Vignia oder Vitis verwendet.Sorbus, Synaspadix, Tabernae, Tamus, Taxus, Trichosanthes, Triphasia, Vaccinium, Viburnum, Vignia or Vitis are used.
22. Verfahren nach einem der Ansprüche 1 bis 21, dadurch gekenn- zeichnet, dass man nach dem Kultivieren die genetisch veränderten Pflanzen erntet und anschließend die Ketocarotinoide aus den Früchten der Pflanzen isoliert. 22. The method according to any one of claims 1 to 21, characterized in that after cultivation, the genetically modified plants are harvested and then the ketocarotenoids are isolated from the fruits of the plants.
23. Verfahren nach einem der Ansprüche 1 bis 22, dadurch gekennzeichnet, dass die Ketocarotinoide ausgewählt sind aus der Gruppe Astaxanthin, Canthaxanthin, Echinenon, 3-Hydroxye- chinenon, 3 ' -Hydroxyechinenon, Adonirubin und Adonixanthin.23. The method according to any one of claims 1 to 22, characterized in that the ketocarotenoids are selected from the group of astaxanthin, canthaxanthin, echinenone, 3-hydroxyquinene, 3 'hydroxyechinenone, adonirubin and adonixanthin.
55
24. Nukleinsäurekonstrukt, enthaltend funktionell verknüpft einen fruchtspezifischen Promotor und eine Nukleinsäure kodierend eine Ketolase.24. Nucleic acid construct containing functionally linked a fruit-specific promoter and a nucleic acid encoding a ketolase.
10 25. Genetisch veränderte Pflanze, die in Früchten eine Ketolase- Aktivität aufweist .10 25. Genetically modified plant that shows a ketolase activity in fruits.
26. Genetisch veränderte Pflanze nach Anspruch 25, dadurch gekennzeichnet, dass die genetisch veränderte Pflanze in26. Genetically modified plant according to claim 25, characterized in that the genetically modified plant in
15 den Früchten eine Ketolase exprimiert.15 the fruit expressed a ketolase.
27. Genetisch veränderte Pflanze nach Anspruch 25 oder 26, enthaltend in Früchten mindestens eine Nukleinsäure, kodierend eine Ketolase.27. Genetically modified plant according to claim 25 or 26, containing in fruits at least one nucleic acid encoding a ketolase.
2020
28. Genetisch veränderte Pflanze nach einem der Ansprüche 25 bis28. Genetically modified plant according to one of claims 25 to
27, dadurch gekennzeichnet dass man in die Pflanze ausgehend von einer Ausgangspflanze mindestens eine Nukleinsäure, kodierend eine Ketolase, eingebracht hat.27, characterized in that at least one nucleic acid encoding a ketolase has been introduced into the plant starting from an initial plant.
2525
29. Genetisch veränderte Pflanze nach einem der Ansprüche 25 bis29. Genetically modified plant according to one of claims 25 to
28, dadurch gekennzeichnet, dass die genetische Veränderung zusätzlich mindestens eine der Aktivitäten, ausgewählt aus der Gruppe Hydroxlase-Aktivität und ß-Cyclase-Aktivität ge-28, characterized in that the genetic modification additionally comprises at least one of the activities selected from the group hydroxlase activity and β-cyclase activity.
30 genüber einer Wildtyppflanze erhöht.30 raised compared to a wild type plant.
30. Genetisch veränderte Pflanze, ausgewählt aus den Pflanzengattungen Actinophloeus , Aglaeonema, Ananas, Arbutus, Archon- tophoenix, Area, Aronia, Asparagus, Attalea, Berberis, Bixia,30. Genetically modified plant, selected from the plant genera Actinophloeus, Aglaeonema, pineapple, Arbutus, Archon-tophoenix, Area, Aronia, Asparagus, Attalea, Berberis, Bixia,
35 Brachychilum, Bryonia, Caliptocalix, Capsicum, Carica, Celas- trus, Citrullus, Citrus, Convallaria, Cotoneaster, Crataegus, Cucumis, Cucurbita, Cuscuta, Cycas, Cyphomandra, Dioscorea, Diospyrus, Dura, Elaeagnus, Elaeis, Erythroxylon, Euonymus, Ficus, Fortunella, Fragaria, Gardinia, Gonocaryum, Gossypium,35 Brachychilum, Bryonia, Caliptocalix, Capsicum, Carica, Celastus, Citrullus, Citrus, Convallaria, Cotoneaster, Crataegus, Cucumis, Cucurbita, Cuscuta, Cycas, Cyphomandra, Dioscorea, Diospyrus, Dura, Elaeagnus, Felicusonymus, Ericex , Fortunella, Fragaria, Gardinia, Gonocaryum, Gossypium,
40 Guava, Guilielma, Hibiscus, Hippophaea, Iris, Lathyrus, Lonicera, Luffa, Lycium, Lycopersicum, Malpighia, Mangifera, Mor- modica, Murraya, Musa, Nenga, Palisota, Pandanus, Passiflora, Persea, Physalis, Prunus, Ptychandra, Punica, Pyracantha, Pyrus, Ribes, Rosa, Rubus, Sabal, Sambucus , Seaforita,40 Guava, Guilielma, Hibiscus, Hippophaea, Iris, Lathyrus, Lonicera, Luffa, Lycium, Lycopersicum, Malpighia, Mangifera, Mormodica, Murraya, Musa, Nenga, Palisota, Pandanus, Passiflora, Persea, Physalis, Prunus, Ptychandra, Puny , Pyracantha, Pyrus, Ribes, Rosa, Rubus, Sabal, Sambucus, Seaforita,
45 Shepherdia, Solanum, Sorbus, Synaspadix, Tabernae, Tamus,45 Shepherdia, Solanum, Sorbus, Synaspadix, Tabernae, Tamus,
Taxus, Trichosanthes, Triphasia, Vaccinium, Viburnum, Vignia oder Vitis, enthaltend mindestens eine Nukleinsäure, kodierend eine Ketolase.Taxus, Trichosanthes, Triphasia, Vaccinium, Viburnum, Vignia or vitis containing at least one nucleic acid encoding a ketolase.
31. Genetisch veränderte Pflanze nach Anspruch 30, dadurch31. Genetically modified plant according to claim 30, characterized
5 gekennzeichnet, dass die Ketolase in Früchten exprimiert wird.5 characterized that the ketolase is expressed in fruits.
32. Genetisch veränderte Pflanze nach einem der Ansprüche 25 bis 31, dadurch gekennzeichnet, dass die Expressionsrate einer32. Genetically modified plant according to one of claims 25 to 31, characterized in that the expression rate of one
10 Ketolase in Früchten am höchsten ist.10 Ketolase is highest in fruits.
33. Verwendung der genetisch veränderten Pflanzen nach einem der Ansprüche 25 bis 32 als Futter- oder Nahrungsmittel.33. Use of the genetically modified plants according to one of claims 25 to 32 as feed or food.
15 34. Verwendung der Früchte der genetisch veränderten Pflanzen nach einem der Ansprüche 25 bis 32 zur Herstellung von Keto- carotinoid-haltigen Extrakten oder zur Herstellung von Futter- oder Nahrungsergänzungsmittel.15 34. Use of the fruits of the genetically modified plants according to one of claims 25 to 32 for the production of keto-carotenoid-containing extracts or for the production of feed or food supplements.
20 35. Verfahren zur Herstellung von genetisch veränderten Pflanzen gemäß Anspruch 32, dadurch gekennzeichnet, dass man ein Nukleinsäurekonstrukt , enthaltend funktionell verknüpfe einen fruchtspezifischen Promotor und Nukleinsäuren kodierend eine Ketolase in das Genom der Ausgangspflanze einführt .35. A method for producing genetically modified plants according to claim 32, characterized in that a nucleic acid construct containing functionally linking a fruit-specific promoter and coding for nucleic acids is introduced into the genome of the starting plant encoding a ketolase.
2525
3030
3535
4040
45 45
EP03792349A 2002-08-20 2003-08-18 Method for producing ketocarotinoids in plant fruit Withdrawn EP1532266A2 (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
DE10238980 2002-08-20
DE10238979A DE10238979A1 (en) 2002-08-20 2002-08-20 Preparing zeaxanthin and its precursors or products, useful as food and feed supplements, comprises growing transgenic plants that have reduced epsilon-cyclase activity
DE10238979 2002-08-20
DE2002138980 DE10238980A1 (en) 2002-08-20 2002-08-20 Method for preparing ketocarotenoids, useful e.g. as food or feed supplements, by increasing, or introducing, ketolase activity in the petals of transgenic plants, also new nucleic acid constructs
DE10238978 2002-08-20
DE10238978A DE10238978A1 (en) 2002-08-20 2002-08-20 Method for preparing ketocarotenoids, useful e.g. as food or feed supplements, by increasing, or introducing, ketolase activity in the fruits of transgenic plants, also new nucleic acid constructs
DE10253112 2002-11-13
DE2002153112 DE10253112A1 (en) 2002-11-13 2002-11-13 Production of ketocarotenoids with low hydroxylated by-product content, for use e.g. in pigmenting feedstuffs, by culturing genetically modified organisms having modified ketolase activity
DE2002158971 DE10258971A1 (en) 2002-12-16 2002-12-16 Use of astaxanthin-containing plant material, or extracts, from Tagetes for oral administration to animals, particularly for pigmentation of fish, crustacea, birds and their products
DE10258971 2002-12-16
PCT/EP2003/009107 WO2004018695A2 (en) 2002-08-20 2003-08-18 Method for producing ketocarotinoids in plant fruit

Publications (1)

Publication Number Publication Date
EP1532266A2 true EP1532266A2 (en) 2005-05-25

Family

ID=31950810

Family Applications (5)

Application Number Title Priority Date Filing Date
EP03792347A Withdrawn EP1542945A2 (en) 2002-08-20 2003-08-18 Method for the production of zeaxanthin and/or the biosynthetic intermediates and/or subsequent products thereof
EP03792350A Expired - Lifetime EP1531683B1 (en) 2002-08-20 2003-08-18 Use of astaxanthin-containing plants or parts of plants of the genus tagetes as animal feed
EP03792345A Withdrawn EP1532264A2 (en) 2002-08-20 2003-08-18 Method for the production of ketocarotinoids in flower petals on plants
EP03792348A Withdrawn EP1532265A2 (en) 2002-08-20 2003-08-18 Method for producing ketocarotinoids in genetically modified organisms
EP03792349A Withdrawn EP1532266A2 (en) 2002-08-20 2003-08-18 Method for producing ketocarotinoids in plant fruit

Family Applications Before (4)

Application Number Title Priority Date Filing Date
EP03792347A Withdrawn EP1542945A2 (en) 2002-08-20 2003-08-18 Method for the production of zeaxanthin and/or the biosynthetic intermediates and/or subsequent products thereof
EP03792350A Expired - Lifetime EP1531683B1 (en) 2002-08-20 2003-08-18 Use of astaxanthin-containing plants or parts of plants of the genus tagetes as animal feed
EP03792345A Withdrawn EP1532264A2 (en) 2002-08-20 2003-08-18 Method for the production of ketocarotinoids in flower petals on plants
EP03792348A Withdrawn EP1532265A2 (en) 2002-08-20 2003-08-18 Method for producing ketocarotinoids in genetically modified organisms

Country Status (12)

Country Link
US (5) US20060031963A1 (en)
EP (5) EP1542945A2 (en)
CN (1) CN1675367A (en)
AT (1) ATE484198T1 (en)
AU (5) AU2003253416A1 (en)
CA (5) CA2496207A1 (en)
DE (1) DE50313184D1 (en)
IL (4) IL166507A0 (en)
MX (5) MXPA05001899A (en)
NO (5) NO20050598L (en)
WO (5) WO2004018694A2 (en)
ZA (1) ZA200602230B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1532256A1 (en) * 2002-08-20 2005-05-25 Sungene GmbH & Co. KGaA Method for the production of $g(b)-carotinoids
EP1542945A2 (en) * 2002-08-20 2005-06-22 Sungene GmbH & Co. KGaA Method for the production of zeaxanthin and/or the biosynthetic intermediates and/or subsequent products thereof
AU2003250193A1 (en) * 2002-08-20 2004-04-08 Sungene Gmbh & Co. Kgaa Transgenic expression cassettes for the expression of nucleic acids in plant blooms
EP1554388A1 (en) * 2002-10-11 2005-07-20 Sungene GmbH & Co. KGaA Transgenic expression cassettes for the expression of nucleic acids in plant blooms
DE10300649A1 (en) * 2003-01-09 2004-07-22 Basf Ag Process for the production of ketocarotenoids by cultivating genetically modified organisms
JP4803739B2 (en) * 2004-06-04 2011-10-26 キリンホールディングス株式会社 Production of astaxanthin or its metabolites using carotenoid ketolase and carotenoid hydroxylase genes
UA94038C2 (en) 2005-03-18 2011-04-11 Майкробиа, Инк. Production of carotenoids in oleaginous yeast and fungi
CA2614659A1 (en) * 2005-07-11 2007-01-18 Commonwealth Scientific And Industrial Research Organisation Wheat pigment
WO2008042338A2 (en) 2006-09-28 2008-04-10 Microbia, Inc. Production of carotenoids in oleaginous yeast and fungi
AU2007351787A1 (en) * 2006-10-20 2008-10-30 Arizona Board Of Regents For And On Behalf Of Arizona State University Modified cyanobacteria
BRPI0806029A2 (en) * 2007-07-19 2009-11-10 Biosigma Sa plasmids for transformation of bacteria of the genus aciditiobacillus spp. and transformation method
US20090093015A1 (en) * 2007-10-09 2009-04-09 Kemin Foods, L.C. Beta-cryptoxanthin production using a novel lycopene beta-monocyclase gene
EP2199399A1 (en) * 2008-12-17 2010-06-23 BASF Plant Science GmbH Production of ketocarotenoids in plants
WO2010079032A1 (en) * 2008-12-17 2010-07-15 Basf Plant Science Gmbh Production of ketocarotenoids in plants
EP2742131B1 (en) * 2011-08-08 2018-11-28 Evolva SA Methods and materials for recombinant production of saffron compounds
CN104093414A (en) 2011-11-29 2014-10-08 神经噬菌体制药股份有限公司 Use of P3 of bacteriophage as amyloid binding agents
ES2558953B1 (en) * 2015-11-23 2016-11-18 Universitat De Lleida Corn enriched in antioxidants to improve the nutritional quality of the egg
JP2019165635A (en) 2016-08-10 2019-10-03 味の素株式会社 Method for producing L-amino acid
US10004253B1 (en) * 2017-09-05 2018-06-26 Jose-Odon Torres-Quiroga Method for increasing the health condition of crustaceans in aquaculture, survival rate and pigmentation
CN112458103B (en) * 2021-01-28 2022-09-30 青岛农业大学 Gene for regulating and controlling capsorubin accumulationCaBBX20And uses thereof

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9016012D0 (en) 1990-07-20 1990-09-05 Unilever Plc Pigments
DE69433969T2 (en) * 1993-12-27 2005-08-11 Kirin Beer K.K. DNA CHAIN FOR SYNTHESIS OF XANTHOPHYLL AND PROCESS FOR THE MANUFACTURE OF XANTHOPHYLL
US5916791A (en) * 1995-11-24 1999-06-29 Hirschberg; Joseph Polynucleotide molecule from Haematococcus pluvialis encoding a polypeptide having a β--C--4--oxygenase activity for biotechnological production of (3S,3S)astaxanthin
BR9713462A (en) * 1996-08-09 2000-03-28 Calgene Inc Methods for producing carotenoid compounds and special oils in plant seeds.
US6429356B1 (en) * 1996-08-09 2002-08-06 Calgene Llc Methods for producing carotenoid compounds, and specialty oils in plant seeds
US6221417B1 (en) * 1997-05-14 2001-04-24 Kemin Industries, Inc. Conversion of xanthophylls in plant material for use as a food colorant
US5876782A (en) * 1997-05-14 1999-03-02 Kemin Industries, Inc. Method for the conversion of xanthophylls in plant material
CA2333281A1 (en) * 1998-05-22 1999-12-02 University Of Maryland Carotenoid ketolase genes and gene products, production of ketocarotenoids and methods of modifying carotenoids using the genes
CA2330167A1 (en) * 1998-06-02 1999-12-09 University Of Maryland Genes of carotenoid biosynthesis and metabolism and methods of use thereof
US6232530B1 (en) * 1998-11-30 2001-05-15 University Of Nevada Marigold DNA encoding beta-cyclase
DE19916140A1 (en) * 1999-04-09 2000-10-12 Basf Ag Carotene hydroxylase and process for the preparation of xanthophyll derivatives
SE9903336D0 (en) 1999-09-17 1999-09-17 Astacarotene Ab DNA construct and its use
US20050003474A1 (en) * 2001-01-26 2005-01-06 Desouza Mervyn L. Carotenoid biosynthesis
DE10201458A1 (en) * 2001-04-11 2002-10-17 Adelbert Bacher New proteins involved in isoprenoid biosynthesis, useful in screening for inhibitors, also new intermediates, potential therapeutic agents, nucleic acids and antibodies
US6784351B2 (en) * 2001-06-29 2004-08-31 Ball Horticultural Company Targetes erecta marigolds with altered carotenoid compositions and ratios
US7575766B2 (en) * 2001-06-29 2009-08-18 Ball Horticultural Company Tagetes erecta with altered carotenoid compositions and ratios
US6372946B1 (en) * 2001-09-13 2002-04-16 Prodemex, S.A. De C.V. Preparation of 4,4′-diketo-β-carotene derivatives
US7383788B2 (en) * 2002-03-11 2008-06-10 Dsm Ip Assets B.V. Enhanced feeding and growth rates of aquatic animals fed an astaxanthin product derived from marigold extract
US7223909B2 (en) * 2002-03-21 2007-05-29 Ball Horticultural 4-ketocarotenoids in flower petals
EP1542945A2 (en) * 2002-08-20 2005-06-22 Sungene GmbH & Co. KGaA Method for the production of zeaxanthin and/or the biosynthetic intermediates and/or subsequent products thereof
DE10300649A1 (en) * 2003-01-09 2004-07-22 Basf Ag Process for the production of ketocarotenoids by cultivating genetically modified organisms
DE102004007623A1 (en) * 2004-02-17 2005-08-25 Sungene Gmbh & Co. Kgaa Use of specific promoters for expressing genes in Tagetes, useful for preparing biosynthetic products, specifically carotenoids, for use as e.g. pharmaceuticals, also the genetically modified plants

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2004018695A2 *

Also Published As

Publication number Publication date
WO2004017749A2 (en) 2004-03-04
CA2495235A1 (en) 2004-03-04
ZA200602230B (en) 2007-05-30
WO2004018385A3 (en) 2004-10-21
IL166507A0 (en) 2006-01-15
EP1531683A2 (en) 2005-05-25
US7385123B2 (en) 2008-06-10
NO20050598L (en) 2005-04-07
WO2004018693A2 (en) 2004-03-04
DE50313184D1 (en) 2010-11-25
AU2003258623A1 (en) 2004-03-11
WO2004018695A3 (en) 2004-10-14
CA2495878A1 (en) 2004-03-04
NO20050704L (en) 2005-05-13
MXPA05001948A (en) 2005-09-08
US20060031963A1 (en) 2006-02-09
MXPA05001659A (en) 2005-07-22
EP1532264A2 (en) 2005-05-25
US7381541B2 (en) 2008-06-03
NO20050703L (en) 2005-05-09
IL166771A0 (en) 2006-01-15
WO2004018693A3 (en) 2004-12-09
IL166770A0 (en) 2006-01-15
CA2496133A1 (en) 2004-03-04
CN1675367A (en) 2005-09-28
WO2004018694A2 (en) 2004-03-04
US20060112451A1 (en) 2006-05-25
AU2003260424A1 (en) 2004-03-11
US20060253927A1 (en) 2006-11-09
CA2495444A1 (en) 2004-03-04
NO20050705L (en) 2005-05-18
WO2004018695A2 (en) 2004-03-04
IL166767A0 (en) 2006-01-15
EP1532265A2 (en) 2005-05-25
EP1531683B1 (en) 2010-10-13
WO2004018694A3 (en) 2004-09-10
EP1542945A2 (en) 2005-06-22
AU2003264062B2 (en) 2008-01-03
WO2004017749A3 (en) 2004-10-14
MXPA05001811A (en) 2005-10-19
US20070094749A1 (en) 2007-04-26
ATE484198T1 (en) 2010-10-15
AU2003264062A1 (en) 2004-03-11
NO20050755L (en) 2005-05-19
CA2496207A1 (en) 2004-03-04
AU2003253416A1 (en) 2004-03-11
AU2003260423A1 (en) 2004-03-11
MXPA05001944A (en) 2005-06-22
US20050281909A1 (en) 2005-12-22
MXPA05001899A (en) 2005-08-29
WO2004018385A2 (en) 2004-03-04

Similar Documents

Publication Publication Date Title
EP1531683B1 (en) Use of astaxanthin-containing plants or parts of plants of the genus tagetes as animal feed
DE10300649A1 (en) Process for the production of ketocarotenoids by cultivating genetically modified organisms
DE10238980A1 (en) Method for preparing ketocarotenoids, useful e.g. as food or feed supplements, by increasing, or introducing, ketolase activity in the petals of transgenic plants, also new nucleic acid constructs
WO2005019467A1 (en) Method for producing ketocarotinoids in genetically modified, non-human organisms
DE102004007624A1 (en) Preparation of ketocarotenoids, useful in foods and animal feeds, by growing genetically modified organism, particularly plant, having altered ketolase activity
DE10238978A1 (en) Method for preparing ketocarotenoids, useful e.g. as food or feed supplements, by increasing, or introducing, ketolase activity in the fruits of transgenic plants, also new nucleic acid constructs
EP1532256A1 (en) Method for the production of $g(b)-carotinoids
DE10258971A1 (en) Use of astaxanthin-containing plant material, or extracts, from Tagetes for oral administration to animals, particularly for pigmentation of fish, crustacea, birds and their products
DE10253112A1 (en) Production of ketocarotenoids with low hydroxylated by-product content, for use e.g. in pigmenting feedstuffs, by culturing genetically modified organisms having modified ketolase activity
DE10238979A1 (en) Preparing zeaxanthin and its precursors or products, useful as food and feed supplements, comprises growing transgenic plants that have reduced epsilon-cyclase activity
EP1658372A2 (en) Novel ketolases and method for producing ketocarotinoids
EP1658377A1 (en) Method for producing ketocarotinoids in genetically modified, non-human organisms

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

17P Request for examination filed

Effective date: 20050414

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20070328

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20070828